Hereditary disease
MONDO:0003847A disease that is caused by genetic modifications where those modifications are inherited from a parent's genome.
Also known as: genetic condition, genetic disease, genetic disorder, hereditary disease, hereditary disease or disorder, hereditary diseases, inherited disease, inherited genetic disease
18235 clinical trials for this condition and its sub-types, 194 tagged with Hereditary disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hereditary disease
-
Hereditary neurological disease 6 trials · 5,791 incl. sub-types
264 sub-types
- Parkinson disease 1,169 trials · 1,296 incl. sub-types Sub-types →
- Anxiety 1,036 trials
- Hereditary neuromuscular disease 3 trials · 935 incl. sub-types Sub-types →
- Inherited neurodegenerative disorder 11 trials · 808 incl. sub-types Sub-types →
- Inherited retinal dystrophy 41 trials · 513 incl. sub-types Sub-types →
- Mendelian neurodevelopmental disorder 0 trials · 208 incl. sub-types Sub-types →
- Obsessive-compulsive disorder 197 trials
- Hereditary ataxia 2 trials · 119 incl. sub-types Sub-types →
- Essential tremor 102 trials · 104 incl. sub-types Sub-types →
- Neurofibromatosis 19 trials · 94 incl. sub-types Sub-types →
- Myalgic encephalomeyelitis/chronic fatigue syndrome 75 trials
- Inherited orthostatic hypotension 0 trials · 71 incl. sub-types Sub-types →
- Nonsyndromic genetic hearing loss 4 trials · 67 incl. sub-types Sub-types →
- Inherited vitreoretinopathy 0 trials · 58 incl. sub-types Sub-types →
- Paraganglioma 53 trials · 57 incl. sub-types Sub-types →
- Retinal detachment 28 trials · 52 incl. sub-types Sub-types →
- Tuberous sclerosis 41 trials · 44 incl. sub-types Sub-types →
- Combined pituitary hormone deficiencies, genetic form 1 trial · 42 incl. sub-types Sub-types →
- Endogenous depression 42 trials
- Specific phobia 22 trials · 42 incl. sub-types Sub-types →
- Tourette syndrome 41 trials
- Familial partial epilepsy 0 trials · 39 incl. sub-types Sub-types →
- Cerebral lipidosis with dementia 0 trials · 38 incl. sub-types Sub-types →
- Inherited dystonia 0 trials · 36 incl. sub-types Sub-types →
- Normal pressure hydrocephalus 36 trials
- Mismatch repair cancer syndrome 1 34 trials
- Hereditary generalized epilepsy 0 trials · 33 incl. sub-types Sub-types →
- X-linked deafness 0 trials · 32 incl. sub-types Sub-types →
- Familial isolated pituitary adenoma 1 trial · 31 incl. sub-types Sub-types →
- Von Hippel-Lindau disease 27 trials
- Specific language impairment 26 trials Sub-types →
- Stutter disorder 22 trials Sub-types →
- Moyamoya disease 20 trials Sub-types →
- Angelman syndrome 19 trials Sub-types →
- Cerebral amyloid angiopathy 16 trials · 17 incl. sub-types Sub-types →
- Li-Fraumeni syndrome 16 trials
- Childhood apraxia of speech 16 trials
- Intracranial berry aneurysm 12 trials Sub-types →
- Progressive myoclonus epilepsy 5 trials · 12 incl. sub-types Sub-types →
- DiGeorge syndrome 11 trials
- Auditory neuropathy 7 trials · 11 incl. sub-types Sub-types →
- Major affective disorder 6 11 trials
- Spastic quadriplegic cerebral palsy 10 trials Sub-types →
- Chiari malformation type I 9 trials
- Neurohypophyseal diabetes insipidus 9 trials
- Sturge-Weber syndrome 8 trials
- Progressive external ophthalmoplegia 4 trials · 8 incl. sub-types Sub-types →
- Qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan 0 trials · 8 incl. sub-types Sub-types →
- Red-green color blindness 7 trials
- Duane retraction syndrome 6 trials Sub-types →
- Arthrogryposis 4 trials · 6 incl. sub-types Sub-types →
- Inborn aminoacylase deficiency 0 trials · 6 incl. sub-types Sub-types →
- Undetermined early-onset epileptic encephalopathy 1 trial · 6 incl. sub-types Sub-types →
- GLUT1 deficiency syndrome 4 trials · 5 incl. sub-types Sub-types →
- Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease 5 trials
- Congenital nystagmus 4 trials · 5 incl. sub-types Sub-types →
- Congenital stationary night blindness 2 trials · 5 incl. sub-types Sub-types →
- Narcolepsy 1 5 trials
- Nevoid basal cell carcinoma syndrome 5 trials Sub-types →
- Qualitative or quantitative defects of beta-sarcoglycan 0 trials · 5 incl. sub-types Sub-types →
- TTN-related myopathy 2 trials · 4 incl. sub-types Sub-types →
- Corpus callosum, agenesis of 4 trials Sub-types →
- Glutaryl-CoA dehydrogenase deficiency 4 trials
- Qualitative or quantitative defects of gamma-sarcoglycan 1 trial · 4 incl. sub-types Sub-types →
- Velocardiofacial syndrome 4 trials
- Hoyeraal-Hreidarsson syndrome 3 trials
- Riley-Day syndrome 3 trials
- TPM2-related myopathy 1 trial · 3 incl. sub-types Sub-types →
- Bilirubin encephalopathy 3 trials Sub-types →
- Central nervous system lupus 3 trials
- Congenital hydrocephalus 1 trial · 3 incl. sub-types Sub-types →
- Encephalopathy, acute, infection-induced 2 trials · 3 incl. sub-types Sub-types →
- Familial congenital mirror movements 3 trials Sub-types →
- Familial porencephaly 0 trials · 3 incl. sub-types Sub-types →
- Inherited reflex epilepsy 0 trials · 3 incl. sub-types Sub-types →
- Megalencephaly-capillary malformation-polymicrogyria syndrome 3 trials
- Neuromuscular disease caused by qualitative or quantitative defects of dysferlin 0 trials · 3 incl. sub-types Sub-types →
- Pontocerebellar hypoplasia 1 trial · 3 incl. sub-types Sub-types →
- Pyridoxine-dependent epilepsy 3 trials Sub-types →
- Qualitative or quantitative defects of alpha-sarcoglycan 0 trials · 3 incl. sub-types Sub-types →
- ATP1A3-associated neurological disorder 0 trials · 2 incl. sub-types Sub-types →
- Chiari malformation type II 2 trials
- PAX6-related ocular dysgenesis 0 trials · 2 incl. sub-types Sub-types →
- SPAST-related motor disorder 0 trials · 2 incl. sub-types Sub-types →
- Childhood-onset nemaline myopathy 1 trial · 2 incl. sub-types Sub-types →
- Choroid plexus papilloma 2 trials
- Dyskinesia with orofacial involvement, autosomal dominant 2 trials
- Hereditary retinoblastoma 2 trials
- Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome 2 trials
- Isolated hereditary congenital facial paralysis 2 trials Sub-types →
- Leukoencephalopathy, megalencephalic 0 trials · 2 incl. sub-types Sub-types →
- Pyridoxal phosphate-responsive seizures 2 trials
- Qualitative or quantitative defects of delta-sarcoglycan 0 trials · 2 incl. sub-types Sub-types →
- Retinal ciliopathy 0 trials · 2 incl. sub-types Sub-types →
- 2-hydroxyglutaric aciduria 0 trials · 1 incl. sub-types Sub-types →
- Brown syndrome 1 trial
- Gerstmann-Straussler-Scheinker syndrome 1 trial
- Guillain-Barre syndrome, familial 1 trial
- PRRT2-associated paroxysmal movement disorder 0 trials · 1 incl. sub-types Sub-types →
- TH-deficient dopa-responsive dystonia 1 trial
- TPM3-related myopathy 1 trial Sub-types →
- Anencephaly 1 trial Sub-types →
- Bilateral striopallidodentate calcinosis 1 trial Sub-types →
- Biotin-responsive basal ganglia disease 1 trial
- Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder 1 trial
- Coloboma of optic nerve 1 trial Sub-types →
- Dilated cardiomyopathy 3B 1 trial
- Epilepsy with myoclonic atonic seizures 1 trial
- Familial hemiplegic migraine 0 trials · 1 incl. sub-types Sub-types →
- Familial meningioma 1 trial
- Familial periodic paralysis 0 trials · 1 incl. sub-types Sub-types →
- Familial pterygium of the conjunctiva 1 trial
- Famililal cerebral cavernous malformations 1 trial Sub-types →
- Iris hypoplasia with glaucoma 1 trial
- Isolated cerebellar hypoplasia/agenesis 1 trial
- Linear nevus sebaceous syndrome 1 trial
- Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome 1 trial
- Multiminicore myopathy 1 trial Sub-types →
- Myoclonus, familial 1 trial Sub-types →
- Myopathy caused by variation in POMGNT1 0 trials · 1 incl. sub-types Sub-types →
- Neurocutaneous melanocytosis 1 trial
- Neuromuscular disease caused by qualitative or quantitative defects of plectin 0 trials · 1 incl. sub-types Sub-types →
- Neuromuscular disease caused by qualitative or quantitative defects of telethonin 0 trials · 1 incl. sub-types Sub-types →
- Qualitative or quantitative defects of desmin 0 trials · 1 incl. sub-types Sub-types →
- Rhabdoid tumor predisposition syndrome 2 1 trial
- Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked 1 trial
- Severe congenital nemaline myopathy 0 trials · 1 incl. sub-types Sub-types →
- B4GALT1-congenital disorder of glycosylation 0 trials
- Bailey-Bloch congenital myopathy 0 trials
- Behr syndrome 0 trials
- Behrens Baumann dust syndrome 0 trials
- Brody myopathy 0 trials
- DHDDS-related syndrome 0 trials Sub-types →
- Frey syndrome 0 trials
- Griscelli syndrome type 1 0 trials
- HSD10 mitochondrial disease 0 trials Sub-types →
- Johanson-Blizzard syndrome 0 trials
- KIF5A-related neurological disorder 0 trials Sub-types →
- LSM7-related leukodystrophy and cerebellar atrophy 0 trials
- Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome 0 trials
- NPHP3-related Meckel-like syndrome 0 trials
- PEHO-like syndrome 0 trials
- PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome 0 trials
- PrP systemic amyloidosis 0 trials
- Prader-Willi-like syndrome 0 trials Sub-types →
- Ritscher-Schinzel syndrome 0 trials Sub-types →
- SERAC1-related neurological disorder 0 trials Sub-types →
- SLC39A8-CDG 0 trials
- SLC6A3-related dopamine transporter deficiency syndrome 0 trials Sub-types →
- TELO2-related intellectual disability-neurodevelopmental disorder 0 trials
- TUBB3-related tubulinopathy 0 trials Sub-types →
- Uner Tan Syndrome 0 trials
- VPS11-related neurological disorder 0 trials Sub-types →
- Valence-Farazi cerebellar ataxia syndrome 0 trials
- X-linked immunoneurologic disorder 0 trials
- X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome 0 trials
- Achromatopsia 6 0 trials
- Adult-onset nemaline myopathy 0 trials
- Age-related hearing impairment 1 0 trials
- Age-related hearing impairment 2 0 trials
- Alpha-actinopathy 0 trials Sub-types →
- Angioid streaks 0 trials Sub-types →
- Aniridia 2 0 trials
- Aniridia 3 0 trials
- Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome 0 trials
- Band heterotopia of brain 0 trials
- Benign familial infantile epilepsy 0 trials Sub-types →
- Benign neonatal seizures 0 trials Sub-types →
- Bilateral frontoparietal polymicrogyria 0 trials
- Bilateral generalized polymicrogyria 0 trials
- Bilateral parasagittal parieto-occipital polymicrogyria 0 trials
- Blue color blindness 0 trials
- Bradyopsia 0 trials Sub-types →
- Brain malformations with or without urinary tract defects 0 trials
- Brain-lung-thyroid syndrome 0 trials
- Cathepsin a-related arteriopathy-strokes-leukoencephalopathy 0 trials
- Caveolinopathy 0 trials Sub-types →
- Cerebellar-facial-dental syndrome 0 trials
- Chorea, remitting, with nystagmus and cataract 0 trials
- Choreoathetosis, familial inverted 0 trials
- Cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome 0 trials
- Cluster headache, familial 0 trials
- Complex cortical dysplasia with other brain malformations 0 trials Sub-types →
- Congenital insensitivity to pain with severe intellectual disability 0 trials
- Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome 0 trials
- Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive 0 trials
- Encephalopathy due to mitochondrial and peroxisomal fission defect 0 trials Sub-types →
- Encephalopathy, acute transient 0 trials
- Encephalopathy, recurrent, of childhood 0 trials
- Epilepsy, X-linked, with or without impaired intellectual development and dysmorphic features 0 trials Sub-types →
- Epilepsy, familial adult myoclonic 0 trials Sub-types →
- Familial Alzheimer-like prion disease 0 trials
- Familial congenital palsy of trochlear nerve 0 trials
- Familial hemophagocytic lymphohistiocytosis type 1 0 trials
- Familial hyperprolactinemia 0 trials
- Familial infantile myoclonic epilepsy 0 trials
- Familial panic disorder 0 trials Sub-types →
- Familial retinal arterial macroaneurysm 0 trials
- Familial schizencephaly 0 trials
- Familial syringomyelia 0 trials
- Fatty acyl-CoA reductase 1 upregulation 0 trials
- Febrile seizures, familial, 11 0 trials
- Folinic acid-responsive seizures 0 trials
- Glycine encephalopathy 0 trials Sub-types →
- Hereditary hyperekplexia 0 trials Sub-types →
- Hereditary progressive chorea without dementia 0 trials
- Holoprosencephaly 0 trials Sub-types →
- Hyperlexia 0 trials
- Hypermanganesemia with dystonia 2 0 trials
- Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly 0 trials
- Infection-induced acute-onset axonal neuropathy 0 trials
- Intracranial extraskeletal myxoid chondrosarcoma 0 trials
- Lateral meningocele syndrome 0 trials
- Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome 0 trials
- Lissencephaly spectrum disorders 0 trials Sub-types →
- Macrocephaly/megalencephaly syndrome, autosomal recessive 0 trials
- Major affective disorder 1 0 trials
- Major affective disorder 2 0 trials
- Major affective disorder 3 0 trials
- Major affective disorder 4 0 trials
- Major affective disorder 5 0 trials
- Major affective disorder 7 0 trials
- Major affective disorder 8 0 trials
- Major affective disorder 9 0 trials
- Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome 0 trials Sub-types →
- Melanoma and neural system tumor syndrome 0 trials
- Microangiopathy and leukoencephalopathy, pontine, autosomal dominant 0 trials
- Microcephaly-complex motor and sensory axonal neuropathy syndrome 0 trials
- Multiple pterygium-malignant hyperthermia syndrome 0 trials
- Myofibrillar myopathy 5 0 trials
- Myopathy due to calsequestrin and SERCA1 protein overload 0 trials
- Myopic macular degeneration 0 trials
- Myosclerosis 0 trials
- Narcolepsy 3 0 trials
- Narcolepsy 7 0 trials
- Neuromuscular disease caused by qualitative or quantitative defects of TRIM32 0 trials Sub-types →
- Neuromuscular disease caused by qualitative or quantitative defects of beta-myosin heavy chain (MYH7) 0 trials Sub-types →
- Neuromuscular disease caused by qualitative or quantitative defects of perlecan 0 trials Sub-types →
- Neuroocular syndrome 0 trials Sub-types →
- Occipital pachygyria and polymicrogyria 0 trials
- Oculocerebrocutaneous syndrome 0 trials
- Orofaciodigital syndrome type 6 0 trials
- Parietal foramina 0 trials Sub-types →
- Parkinsonism with polyneuropathy 0 trials
- Paroxysmal extreme pain disorder 0 trials
- Periventricular nodular heterotopia 0 trials Sub-types →
- Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome 0 trials
- Phakomatosis pigmentokeratotica 0 trials
- Polyhydramnios, megalencephaly, and symptomatic epilepsy 0 trials
- Polymicrogyria, bilateral perisylvian, autosomal recessive 0 trials
- Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis 0 trials
- Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome 0 trials
- Prosopagnosia, hereditary 0 trials
- Proximal myopathy with extrapyramidal signs 0 trials
- Red color blindness 0 trials
- Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome 0 trials
- Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome 0 trials
- Schizophrenia 15 0 trials
- Schizophrenia 16 0 trials
- Schizophrenia 19 0 trials
- Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome 0 trials
- Severe neonatal-onset encephalopathy with microcephaly 0 trials
- Spongiform encephalopathy with neuropsychiatric features 0 trials
- Typical nemaline myopathy 0 trials Sub-types →
-
Inborn errors of metabolism 48 trials · 2,231 incl. sub-types
93 sub-types
- Inherited lipid metabolism disorder 201 trials · 644 incl. sub-types Sub-types →
- Inborn carbohydrate metabolic disorder 3 trials · 370 incl. sub-types Sub-types →
- Abdominal obesity-metabolic syndrome 302 trials · 359 incl. sub-types Sub-types →
- Lysosomal storage disease 38 trials · 303 incl. sub-types Sub-types →
- Inborn disorder of energy metabolism 2 trials · 235 incl. sub-types Sub-types →
- Inborn disorder of amino acid and other organic acid metabolism 0 trials · 225 incl. sub-types Sub-types →
- Waldenstrom macroglobulinemia 136 trials Sub-types →
- DNA repair disease 13 trials · 105 incl. sub-types Sub-types →
- Hereditary amyloidosis 19 trials · 79 incl. sub-types Sub-types →
- Inborn disorder of porphyrin metabolism 0 trials · 63 incl. sub-types Sub-types →
- Mucopolysaccharidosis or mucopolysaccharidosis-like disorder 0 trials · 62 incl. sub-types Sub-types →
- Inborn metal metabolism disorder 1 trial · 60 incl. sub-types Sub-types →
- Disorder of metabolite absorption and transport 0 trials · 59 incl. sub-types Sub-types →
- Inborn disorder of purine or pyrimidine metabolism 1 trial · 50 incl. sub-types Sub-types →
- Plasma protein metabolism disease 0 trials · 47 incl. sub-types Sub-types →
- Peroxisomal disease 2 trials · 38 incl. sub-types Sub-types →
- Congenital disorder of glycosylation 7 trials · 36 incl. sub-types Sub-types →
- Monogenic diabetes 9 trials · 24 incl. sub-types Sub-types →
- Glycoprotein metabolism disease 1 trial · 23 incl. sub-types Sub-types →
- Disorder of lysosomal-related organelles 0 trials · 17 incl. sub-types Sub-types →
- Familial intrahepatic cholestasis 1 trial · 17 incl. sub-types Sub-types →
- Hereditary lipodystrophy 2 trials · 17 incl. sub-types Sub-types →
- Hypophosphatasia 13 trials Sub-types →
- Familial hypoparathyroidism 0 trials · 10 incl. sub-types Sub-types →
- Inborn disorder of biogenic amine metabolism and transport 0 trials · 10 incl. sub-types Sub-types →
- Inherited thyroid metabolism disease 0 trials · 8 incl. sub-types Sub-types →
- Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types Sub-types →
- Inborn vitamin metabolic disorder 0 trials · 7 incl. sub-types Sub-types →
- Inborn aminoacylase deficiency 0 trials · 6 incl. sub-types Sub-types →
- Disorder of peptide and amine metabolism 0 trials · 4 incl. sub-types Sub-types →
- Congenital disorder of deglycosylation 0 trials · 2 incl. sub-types Sub-types →
- Diastrophic dysplasia 2 trials
- Hypercalcemia, infantile 2 trials Sub-types →
- Hypoalphalipoproteinemia, primary, 1 2 trials
- 2-hydroxyglutaric aciduria 0 trials · 1 incl. sub-types Sub-types →
- Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome 1 trial
- Diabetes mellitus, noninsulin-dependent, 1 1 trial
- Diabetes mellitus, noninsulin-dependent, 2 1 trial
- Familial hypocalciuric hypercalcemia 0 trials · 1 incl. sub-types Sub-types →
- Fish eye disease 1 trial
- Hereditary recurrent myoglobinuria 0 trials · 1 incl. sub-types Sub-types →
- Thiopurine metabolic disease 0 trials · 1 incl. sub-types Sub-types →
- 4-hydroxyphenylacetic aciduria 0 trials
- 5-nucleotidase syndrome 0 trials
- APO A-i deficiency 0 trials
- CFTR-related metabolic syndrome/CF screen positive, inconclusive diagnosis 0 trials
- Ehlers-Danlos syndrome, spondylodysplastic type 0 trials Sub-types →
- Lane Hamilton syndrome 0 trials
- NAD(P)HX dehydratase deficiency 0 trials
- SQSTM1-related multisystem proteinopathy 0 trials Sub-types →
- Achondrogenesis type IB 0 trials
- Antigen-peptide-transporter 2 deficiency 0 trials
- Apolipoprotein c-III deficiency 0 trials
- Aromatase excess syndrome 0 trials
- Atelosteogenesis type II 0 trials
- Autosomal dominant dopa-responsive dystonia 0 trials Sub-types →
- Autosomal dominant myoglobinuria 0 trials
- Autosomal dominant proximal renal tubular acidosis 0 trials
- Autosomal recessive proximal renal tubular acidosis 0 trials
- Cardiomyopathy hypogonadism metabolic anomalies 0 trials
- Chondrocalcinosis 2 0 trials
- Chondrodysplasia with joint dislocations, gPAPP type 0 trials
- Combined ApoA-I and ApoC-III deficiency 0 trials
- Defective apolipoprotein b-100 0 trials
- Deficiency of coenzyme q cytochrome c reductase 0 trials
- Diabetes mellitus, noninsulin-dependent, 3 0 trials
- Diabetes mellitus, noninsulin-dependent, 4 0 trials
- Diabetes mellitus, noninsulin-dependent, 5 0 trials
- Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome 0 trials
- Ferro-cerebro-cutaneous syndrome 0 trials
- Gluthathione peroxidase deficiency 0 trials
- Hemolytic anemia due to diphosphoglycerate mutase deficiency 0 trials
- Hypercholesterolemia, familial, 4 0 trials
- Hypermanganesemia with dystonia 0 trials Sub-types →
- Hypertriglyceridemia 1 0 trials
- Hypertriglyceridemia 2 0 trials
- Hypoalphalipoproteinemia, primary, 2 0 trials Sub-types →
- Hypotonia-failure to thrive-microcephaly syndrome 0 trials
- Inborn disorder of aspartate family metabolism 0 trials Sub-types →
- Inborn glycerol kinase deficiency 0 trials Sub-types →
- Inherited threoninemia 0 trials
- Multiple epiphyseal dysplasia type 4 0 trials
- Normophosphatemic familial tumoral calcinosis 0 trials
- Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss 0 trials
- Spondyloepimetaphyseal dysplasia, PAPSS2 type 0 trials
- Spondyloepiphyseal dysplasia with congenital joint dislocations 0 trials
- Striatonigral degeneration 0 trials Sub-types →
- Sulfide quinone oxidoreductase deficiency 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 1 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 2 0 trials
- Tumoral calcinosis, hyperphosphatemic, familial, 3 0 trials
- Uridine-cytidineuria 0 trials
- Weinstein kliman scully syndrome 0 trials
-
Autosomal genetic disease 0 trials · 1,670 incl. sub-types
8 sub-types
- Autosomal recessive disease 4 trials · 999 incl. sub-types Sub-types →
- Autosomal dominant disease 0 trials · 699 incl. sub-types Sub-types →
- Congenital factor XII deficiency 1 trial
- Septooptic dysplasia 1 trial Sub-types →
- Weill-Marchesani syndrome 0 trials Sub-types →
- Brachydactyly-syndactyly syndrome 0 trials
- Camptodactyly-tall stature-scoliosis-hearing loss syndrome 0 trials
- Congenital factor XI deficiency 0 trials
-
Hereditary disorder of connective tissue 0 trials · 1,314 incl. sub-types
88 sub-types
- Systemic lupus erythematosus 518 trials · 524 incl. sub-types Sub-types →
- Chronic myelogenous leukemia, BCR-ABL1 positive 211 trials · 253 incl. sub-types Sub-types →
- Uterine corpus leiomyoma 104 trials · 109 incl. sub-types Sub-types →
- Acquired polycythemia vera 90 trials
- Chondrosarcoma 39 trials · 44 incl. sub-types Sub-types →
- Type 2 collagenopathy 0 trials · 39 incl. sub-types Sub-types →
- CHILD syndrome 37 trials
- Desmoid tumor 36 trials Sub-types →
- Familial isolated pituitary adenoma 1 trial · 31 incl. sub-types Sub-types →
- Inherited acute myeloid leukemia 1 trial · 25 incl. sub-types Sub-types →
- Hereditary periodic fever syndrome 5 trials · 24 incl. sub-types Sub-types →
- Marfan and Marfan-related disorder 1 trial · 22 incl. sub-types Sub-types →
- VEXAS syndrome 18 trials
- Hypermobility spectrum disorder 17 trials
- Peyronie disease 12 trials
- Aicardi-Goutieres syndrome 9 trials Sub-types →
- Autosomal recessive inherited pseudoxanthoma elasticum 7 trials
- Ewing sarcoma of bone 5 trials
- TREX1-related type 1 interferonopathy 0 trials · 5 incl. sub-types Sub-types →
- Camptodactyly-arthropathy-coxa vara-pericarditis syndrome 4 trials
- Chronic recurrent multifocal osteomyelitis 3 trials · 4 incl. sub-types Sub-types →
- Blau syndrome 3 trials
- Ollier disease 3 trials
- Autoimmune interstitial lung disease-arthritis syndrome 3 trials Sub-types →
- Deficiency of adenosine deaminase 2 3 trials
- Hereditary multiple osteochondromas 3 trials Sub-types →
- Inherited torticollis 3 trials
- Maffucci syndrome 2 trials
- STING-associated vasculopathy with onset in infancy 2 trials
- Familial chilblain lupus 2 trials Sub-types →
- Proteosome-associated autoinflammatory syndrome 2 trials Sub-types →
- Sweet syndrome 2 trials
- ADAR-related type 1 interferonopathy 0 trials · 1 incl. sub-types Sub-types →
- Singleton-Merten dysplasia 1 trial Sub-types →
- Arterial tortuosity syndrome 1 trial
- Cherubism 1 trial Sub-types →
- Hyperparathyroidism 2 with jaw tumors 1 trial
- Infantile myofibromatosis 1 trial Sub-types →
- Neonatal severe primary hyperparathyroidism 1 trial
- Ossification of the posterior longitudinal ligament of the spine 1 trial
- EMILIN-1-related connective tissue disease 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type 1 0 trials
- IFIH1-related type 1 interferonopathy 0 trials Sub-types →
- IL10-related early-onset inflammatory bowel disease 0 trials Sub-types →
- LAMA5-related multisystemic syndrome 0 trials
- MASS syndrome 0 trials
- Pelger-Huet-like anomaly and episodic fever with abdominal pain 0 trials
- RNASEH2A-related type 1 interferonopathy 0 trials Sub-types →
- RNASEH2B-related type 1 interferonopathy 0 trials Sub-types →
- RNASEH2C-related type 1 interferonopathy 0 trials Sub-types →
- RNU7-1-related type 1 interferonopathy 0 trials Sub-types →
- SAMHD1-related type 1 interferonopathy 0 trials Sub-types →
- Sharpin-related autoinflammatory syndrome 0 trials
- Spondyloenchondrodysplasia with immune dysregulation 0 trials
- X-linked reticulate pigmentary disorder 0 trials
- Acroosteolysis dominant type 0 trials
- Aneurysmal bone cyst 0 trials
- Arterial tortuosity-bone fragility syndrome 0 trials
- Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation 0 trials
- Autoinflammatory disease, X-linked 0 trials
- Autoinflammatory disease, multisystem, with immune dysregulation, X-linked 0 trials Sub-types →
- Autoinflammatory disease, systemic, with vasculitis 0 trials
- Autoinflammatory syndrome with immunodeficiency 0 trials
- Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis 0 trials
- Autoinflammatory syndrome, familial, Behcet-like 0 trials Sub-types →
- Bone fragility with contractures, arterial rupture, and deafness 0 trials
- Brittle cornea syndrome 0 trials Sub-types →
- Chondrocalcinosis 2 0 trials
- Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome 0 trials
- Diaphyseal medullary stenosis-bone malignancy syndrome 0 trials
- Encephalocraniocutaneous lipomatosis 0 trials
- Familial ossifying fibroma 0 trials
- Hyperparathyroidism 1 0 trials
- Hyperparathyroidism 3 0 trials
- Hyperparathyroidism 4 0 trials
- Idiopathic juvenile osteoporosis 0 trials
- Jugulotympanic paraganglioma 0 trials Sub-types →
- Juvenile hyaline fibromatosis 0 trials
- Linkeropathy 0 trials Sub-types →
- Multiple epiphyseal dysplasia due to collagen 9 anomaly 0 trials Sub-types →
- Multiple symmetric lipomatosis 0 trials Sub-types →
- Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
- Progeroid and marfanoid aspect-lipodystrophy syndrome 0 trials
- Pseudo-TORCH syndrome 2 0 trials
- Psoriasis 14, pustular 0 trials
- Pyogenic arthritis-pyoderma gangrenosum-acne syndrome 0 trials
- Thrombocytopenia 6 0 trials
- Trichohepatoenteric syndrome 0 trials Sub-types →
-
Inflammatory bowel disease 430 trials · 1,081 incl. sub-types
40 sub-types
- Colitis 41 trials · 679 incl. sub-types Sub-types →
- Crohn disease 563 trials · 569 incl. sub-types Sub-types →
- Proctitis 2 trials · 21 incl. sub-types Sub-types →
- Inflammatory bowel disease 1 3 trials
- Undetermined colitis 3 trials
- Ulcerative proctosigmoiditis 2 trials
- ALPI-related inflammatory bowel disease 0 trials
- IL10-related early-onset inflammatory bowel disease 0 trials Sub-types →
- TRIM22-related inflammatory bowel disease 0 trials
- Cap polyposis 0 trials
- Cutaneous photosensitivity-lethal colitis syndrome 0 trials
- Inflammatory bowel disease (infantile ulcerative colitis) 31, autosomal recessive 0 trials
- Inflammatory bowel disease 10 0 trials
- Inflammatory bowel disease 11 0 trials
- Inflammatory bowel disease 12 0 trials
- Inflammatory bowel disease 13 0 trials
- Inflammatory bowel disease 14 0 trials
- Inflammatory bowel disease 15 0 trials
- Inflammatory bowel disease 16 0 trials
- Inflammatory bowel disease 17 0 trials
- Inflammatory bowel disease 18 0 trials
- Inflammatory bowel disease 19 0 trials
- Inflammatory bowel disease 2 0 trials
- Inflammatory bowel disease 20 0 trials
- Inflammatory bowel disease 21 0 trials
- Inflammatory bowel disease 22 0 trials
- Inflammatory bowel disease 23 0 trials
- Inflammatory bowel disease 24 0 trials
- Inflammatory bowel disease 26 0 trials
- Inflammatory bowel disease 27 0 trials
- Inflammatory bowel disease 29 0 trials
- Inflammatory bowel disease 3 0 trials
- Inflammatory bowel disease 30 0 trials
- Inflammatory bowel disease 4 0 trials
- Inflammatory bowel disease 5 0 trials
- Inflammatory bowel disease 6 0 trials
- Inflammatory bowel disease 7 0 trials
- Inflammatory bowel disease 8 0 trials
- Inflammatory bowel disease 9 0 trials
- Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
-
Hereditary skin disorder 7 trials · 885 incl. sub-types
114 sub-types
- Psoriasis 381 trials Sub-types →
- Acne 92 trials Sub-types →
- Hereditary angioedema 58 trials · 60 incl. sub-types Sub-types →
- Ectodermal dysplasia syndrome 3 trials · 45 incl. sub-types Sub-types →
- Inherited epidermolysis bullosa 5 trials · 38 incl. sub-types Sub-types →
- CHILD syndrome 37 trials
- Inherited ichthyosis 6 trials · 33 incl. sub-types Sub-types →
- Hereditary photodermatosis 0 trials · 31 incl. sub-types Sub-types →
- Lichen sclerosus et atrophicus 10 trials · 20 incl. sub-types Sub-types →
- Hereditary lipodystrophy 2 trials · 17 incl. sub-types Sub-types →
- Hereditary palmoplantar keratoderma 0 trials · 13 incl. sub-types Sub-types →
- Familial multiple nevi flammei 12 trials
- Syndromic oculocutaneous albinism 0 trials · 12 incl. sub-types Sub-types →
- Cowden disease 11 trials Sub-types →
- Familial pityriasis rubra pilaris 10 trials
- Lentigo 8 trials
- Subcutaneous panniculitis-like T-cell lymphoma 8 trials
- Large congenital melanocytic nevus 7 trials
- Alopecia, isolated 0 trials · 6 incl. sub-types Sub-types →
- Neutrophil actin dysfunction 6 trials
- Seborrheic keratosis 6 trials Sub-types →
- CLOVES syndrome 5 trials
- Legius syndrome 5 trials
- Reticulate pigment disorder 0 trials · 5 incl. sub-types Sub-types →
- Hailey-Hailey disease 4 trials
- Chronic mucocutaneous candidiasis 4 trials Sub-types →
- Lamellar ichthyosis 4 trials Sub-types →
- Oculocutaneous albinism 4 trials Sub-types →
- Piebaldism 4 trials
- Aplasia cutis congenita 3 trials Sub-types →
- Hereditary mucosal leukokeratosis 3 trials Sub-types →
- Schwannomatosis 3 trials Sub-types →
- Maffucci syndrome 2 trials
- Sneddon syndrome 2 trials
- Autosomal dominant vibratory urticaria 2 trials
- Blue rubber bleb nevus 2 trials
- Familial chilblain lupus 2 trials Sub-types →
- Keratosis pilaris atrophicans 2 trials Sub-types →
- Stiff skin syndrome 2 trials Sub-types →
- Sweet syndrome 2 trials
- Darier disease 1 trial
- Tietz syndrome 1 trial
- X-linked chondrodysplasia punctata 2 1 trial
- Acrokeratosis verruciformis 1 trial
- Dyschromatosis universalis hereditaria 1 trial Sub-types →
- Familial primary localized cutaneous amyloidosis 1 trial Sub-types →
- Linear nevus sebaceous syndrome 1 trial
- Neurocutaneous melanocytosis 1 trial
- Nevus, epidermal 1 trial Sub-types →
- Urticaria, aquagenic 1 trial
- Urticaria, familial localized heat 1 trial
- Becker nevus syndrome 0 trials Sub-types →
- Cobb syndrome 0 trials
- DK1-congenital disorder of glycosylation 0 trials
- H syndrome 0 trials
- MEDNIK syndrome 0 trials
- PENS syndrome 0 trials
- VPS13A-related neurodegenerative disease 0 trials
- X-linked reticulate pigmentary disorder 0 trials
- Absence of fingerprints-congenital milia syndrome 0 trials
- Acrogeria 0 trials
- Albinism-hearing loss syndrome 0 trials
- Anhidrosis, familial generalized, with abnormal or absent sweat glands 0 trials
- Autosomal recessive cutis laxa type 2A 0 trials Sub-types →
- Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency 0 trials
- Cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis 0 trials
- Combined immunodeficiency with skin granulomas 0 trials
- Deafness, congenital, with total albinism 0 trials
- Dermatitis herpetiformis, familial 0 trials
- Dermatosis papulosa nigra 0 trials
- Encephalocraniocutaneous lipomatosis 0 trials
- Epidermodysplasia verruciformis 0 trials Sub-types →
- Familial acanthosis nigricans 0 trials
- Familial acne inversa 0 trials Sub-types →
- Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome 0 trials
- Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome 0 trials
- Familial keratoacanthoma 0 trials
- Familial multiple discoid fibromas 0 trials
- Familial multiple fibrofolliculoma 0 trials
- Generalized basaloid follicular hamartoma syndrome 0 trials
- Hereditary mucoepithelial dysplasia 0 trials
- Hereditary papulotranslucent acrokeratoderma 0 trials
- Hereditary sclerosing poikiloderma with tendon and pulmonary involvement 0 trials
- Hydroa vacciniforme, familial 0 trials
- Hyperkeratosis-hyperpigmentation syndrome 0 trials
- Hyperpigmentation with or without hypopigmentation, familial progressive 0 trials Sub-types →
- Inflammatory poikiloderma with hair abnormalities and acral keratoses 0 trials
- Infundibulocystic basal cell carcinoma 0 trials
- Isolated anhidrosis with normal sweat glands 0 trials
- Isolated congenital adermatoglyphia 0 trials
- Isolated hyperchlorhidrosis 0 trials
- Juvenile hyaline fibromatosis 0 trials
- Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome 0 trials
- Lichen planus, familial 0 trials
- Linear skin defects with multiple congenital anomalies 0 trials Sub-types →
- Lipoid proteinosis 0 trials
- Monilethrix 0 trials Sub-types →
- Multiple benign circumferential skin creases on limbs 1 0 trials
- Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
- Nevus comedonicus syndrome 0 trials
- Osteopathia striata-pigmentary dermopathy-white forelock syndrome 0 trials
- Phakomatosis pigmentokeratotica 0 trials
- Pilomatrixoma 0 trials
- Poikiloderma with neutropenia 0 trials
- Porokeratosis 0 trials Sub-types →
- Progressive osseous heteroplasia 0 trials
- Scalp defects-postaxial polydactyly syndrome 0 trials
- Sebocystomatosis 0 trials
- Seborrhea-like dermatitis with psoriasiform elements 0 trials
- Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome 0 trials
- Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome 0 trials
- Skin creases, congenital symmetric circumferential, 2 0 trials
- Spinocerebellar ataxia type 34 0 trials
- Vasculitis, lymphocytic, nodular 0 trials
-
Immunodeficiency disease 55 trials · 779 incl. sub-types
95 sub-types
- T-cell immunodeficiency 4 trials · 484 incl. sub-types Sub-types →
- B cell deficiency 5 trials · 86 incl. sub-types Sub-types →
- Myalgic encephalomeyelitis/chronic fatigue syndrome 75 trials
- Combined immunodeficiency 3 trials · 57 incl. sub-types Sub-types →
- Complement deficiency 2 trials · 28 incl. sub-types Sub-types →
- X-linked lymphoproliferative syndrome 7 trials · 11 incl. sub-types Sub-types →
- GATA2 deficiency with susceptibility to MDS/AML 5 trials · 8 incl. sub-types Sub-types →
- Idiopathic CD4 lymphocytopenia 7 trials
- IKBKG-related immunodeficiency with or without ectodermal dysplasia 0 trials · 4 incl. sub-types Sub-types →
- Immunodeficiency due to selective anti-polysaccharide antibody deficiency 2 trials
- IRF4-related immune disorder 1 trial Sub-types →
- PTEN harmartoma tumor syndrome with immune disorder 1 trial
- Immunodeficiency 23 1 trial
- Immunodeficiency 31B 1 trial
- DNAJC21-related Shwachman Diamond syndrome 0 trials
- DOCK2 deficiency 0 trials
- FADD-related immunodeficiency 0 trials
- FASLG-related immunodeficiency 0 trials
- FNIP1-associated syndrome 0 trials
- Shwachman-Diamond syndrome 1 0 trials
- TFRC-related combined immunodeficiency 0 trials
- TNFRSF9-related immunodeficiency 0 trials Sub-types →
- Wiskott-Aldrich syndrome 2 0 trials
- Wiskott-Aldrich syndrome, autosomal dominant form 0 trials
- Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome 0 trials
- Chronic mucocutaneous candidiasis and connective tissue disease due to JNK1 haploinsufficiency 0 trials
- Cryptosporidiosis-chronic cholangitis-liver disease syndrome 0 trials
- Hatipoglu immunodeficiency syndrome 0 trials
- Hypoproteinemia, hypercatabolic 0 trials
- Immune deficiency due to impaired neutrophil phagocytosis and migration 0 trials
- Immunodeficiency 101 (varicella zoster virus-specific) 0 trials
- Immunodeficiency 102 0 trials
- Immunodeficiency 106, susceptibility to viral infections 0 trials
- Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection 0 trials
- Immunodeficiency 112 0 trials
- Immunodeficiency 113 with autoimmunity and autoinflammation 0 trials
- Immunodeficiency 114, folate-responsive 0 trials
- Immunodeficiency 115 with autoinflammation 0 trials
- Immunodeficiency 117 0 trials
- Immunodeficiency 118 0 trials
- Immunodeficiency 119 0 trials
- Immunodeficiency 11b with atopic dermatitis 0 trials
- Immunodeficiency 121 with autoinflammation 0 trials
- Immunodeficiency 122 0 trials
- Immunodeficiency 123 with HPV-related verrucosis 0 trials
- Immunodeficiency 125 0 trials
- Immunodeficiency 126, susceptibility to 0 trials
- Immunodeficiency 127 0 trials
- Immunodeficiency 128 0 trials
- Immunodeficiency 132b 0 trials
- Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy 0 trials
- Immunodeficiency 134 (Epstein-Barr virus-specific) 0 trials
- Immunodeficiency 14b, autosomal recessive 0 trials
- Immunodeficiency 15a 0 trials
- Immunodeficiency 35 0 trials
- Immunodeficiency 45 0 trials
- Immunodeficiency 53 0 trials
- Immunodeficiency 57 0 trials
- Immunodeficiency 60 0 trials
- Immunodeficiency 62 0 trials
- Immunodeficiency 63 with lymphoproliferation and autoimmunity 0 trials
- Immunodeficiency 64 0 trials
- Immunodeficiency 65, susceptibility to viral infections 0 trials
- Immunodeficiency 66 0 trials
- Immunodeficiency 67 0 trials
- Immunodeficiency 69 0 trials
- Immunodeficiency 70 0 trials
- Immunodeficiency 72 with autoinflammation 0 trials
- Immunodeficiency 74, COVID-19-related, X-linked 0 trials
- Immunodeficiency 75 0 trials
- Immunodeficiency 76 0 trials
- Immunodeficiency 77 0 trials
- Immunodeficiency 78 with autoimmunity and developmental delay 0 trials
- Immunodeficiency 80 with or without congenital cardiomyopathy 0 trials
- Immunodeficiency 81 0 trials
- Immunodeficiency 82 with systemic inflammation 0 trials
- Immunodeficiency 84 0 trials
- Immunodeficiency 85 and autoimmunity 0 trials
- Immunodeficiency 86 0 trials
- Immunodeficiency 87 and autoimmunity 0 trials
- Immunodeficiency 88 0 trials
- Immunodeficiency 89 and autoimmunity 0 trials
- Immunodeficiency 91 and hyperinflammation 0 trials
- Immunodeficiency 92 0 trials
- Immunodeficiency 93 and hypertrophic cardiomyopathy 0 trials
- Immunodeficiency 95 0 trials
- Immunodeficiency 96 0 trials
- Immunodeficiency 97 with autoinflammation 0 trials
- Immunodeficiency 98 with autoinflammation, X-linked 0 trials
- Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias 0 trials
- Immunodeficiency due to CD25 deficiency 0 trials
- Lymphoproliferative syndrome 1 0 trials
- Primary immunodeficiency due to calcium channel deficiency 0 trials
- Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency 0 trials
- Pyogenic bacterial infections due to MyD88 deficiency 0 trials
-
Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types
117 sub-types
- Glioma susceptibility 0 trials · 133 incl. sub-types Sub-types →
- Neurofibromatosis 19 trials · 94 incl. sub-types Sub-types →
- Hereditary nonpolyposis colon cancer 5 trials · 88 incl. sub-types Sub-types →
- Multiple endocrine neoplasia 7 trials · 62 incl. sub-types Sub-types →
- Intestinal polyposis syndrome 3 trials · 53 incl. sub-types Sub-types →
- Tuberous sclerosis 41 trials · 44 incl. sub-types Sub-types →
- Leukemia, acute lymphocytic, susceptibility to, 1 41 trials
- BRCA2-related cancer predisposition 36 trials · 38 incl. sub-types Sub-types →
- Hereditary breast ovarian cancer syndrome 35 trials · 38 incl. sub-types Sub-types →
- Mismatch repair cancer syndrome 1 34 trials
- BRCA1-related cancer predisposition 23 trials · 27 incl. sub-types Sub-types →
- Nasopharyngeal carcinoma, susceptibility to, 1 21 trials
- Li-Fraumeni syndrome 16 trials
- PALB2-related cancer predisposition 14 trials Sub-types →
- Dyskeratosis congenita 12 trials Sub-types →
- Wiskott-Aldrich syndrome 10 trials
- PTEN hamartoma tumor syndrome 6 trials · 8 incl. sub-types Sub-types →
- Hereditary leiomyomatosis and renal cell cancer 8 trials
- CHEK2-related cancer predisposition 7 trials
- Susceptibility to familial cutaneous melanoma 0 trials · 7 incl. sub-types Sub-types →
- BAP1-related tumor predisposition syndrome 6 trials
- Beckwith-Wiedemann syndrome 6 trials Sub-types →
- RAD51C-related cancer predisposition 6 trials
- Hereditary pheochromocytoma-paraganglioma 6 trials Sub-types →
- Hereditary thrombocytopenia and hematologic cancer predisposition syndrome 1 trial · 5 incl. sub-types Sub-types →
- Nevoid basal cell carcinoma syndrome 5 trials Sub-types →
- RAD51D-related cancer predisposition 4 trials
- Kostmann syndrome 3 trials
- Li-fraumeni-like syndrome 3 trials
- Familial atypical multiple mole melanoma syndrome 3 trials Sub-types →
- Hereditary multiple osteochondromas 3 trials Sub-types →
- BARD1-related cancer predisposition 2 trials
- Brooke-Spiegler syndrome 0 trials · 2 incl. sub-types Sub-types →
- Maffucci syndrome 2 trials
- Blue rubber bleb nevus 2 trials
- Hereditary retinoblastoma 2 trials
- Inherited hematologic cancer-predisposing syndrome 2 trials
- Leukemia, chronic lymphocytic, susceptibility to, 2 2 trials
- Neuroblastoma, susceptibility to, 3 2 trials
- Rothmund-Thomson syndrome 1 trial Sub-types →
- SAMD9-related spectrum and myeloid neoplasm risk 1 trial
- SAMD9L-related spectrum and myeloid neoplasm risk 1 trial
- WAGR syndrome 1 trial Sub-types →
- Cherubism 1 trial Sub-types →
- Familial rhabdoid tumor 0 trials · 1 incl. sub-types Sub-types →
- Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors 1 trial
- Hyperparathyroidism 2 with jaw tumors 1 trial
- ATM-related cancer predisposition 0 trials
- CDH1-related diffuse gastric and lobular breast cancer syndrome 0 trials
- Carney-Stratakis syndrome 0 trials
- Cobb syndrome 0 trials
- DDX41-related hematologic malignancy predisposition syndrome 0 trials
- EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition 0 trials
- GPR161-related medulloblastoma predisposition 0 trials
- HAVCR2-related cancer predisposition 0 trials
- Kaposi sarcoma, susceptibility to 0 trials
- N syndrome 0 trials
- NTHL1-deficiency tumor predisposition syndrome 0 trials
- Basal cell carcinoma, susceptibility to, 7 0 trials
- Breast cancer, familial, susceptibility to, 1 0 trials
- Breast cancer, familial, susceptibility to, 2 0 trials
- Breast cancer, familial, susceptibility to, 3 0 trials
- Cholangiocarcinoma, susceptibility to 0 trials
- Colorectal cancer, susceptibility to, 1 0 trials
- Colorectal cancer, susceptibility to, 10 0 trials
- Colorectal cancer, susceptibility to, 11 0 trials
- Colorectal cancer, susceptibility to, 12 0 trials
- Colorectal cancer, susceptibility to, 2 0 trials
- Colorectal cancer, susceptibility to, 3 0 trials
- Colorectal cancer, susceptibility to, 4 0 trials
- Colorectal cancer, susceptibility to, 5 0 trials
- Colorectal cancer, susceptibility to, 6 0 trials
- Colorectal cancer, susceptibility to, 7 0 trials
- Colorectal cancer, susceptibility to, 8 0 trials
- Colorectal cancer, susceptibility to, 9 0 trials
- Colorectal cancer, susceptibility to, on chromosome 15 0 trials
- Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate 0 trials
- Erythroleukemia, familial, susceptibility to 0 trials
- Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome 0 trials
- Familial isolated hyperparathyroidism 0 trials Sub-types →
- Familial multiple fibrofolliculoma 0 trials
- Follicular lymphoma, susceptibility to 0 trials Sub-types →
- Hemangioma, capillary infantile, susceptibility to 0 trials
- Leukemia, acute lymphoblastic, susceptibility to, 3 0 trials
- Leukemia, acute lymphocytic, susceptibility to, 2 0 trials
- Leukemia, acute myeloid, susceptibility to 0 trials
- Leukemia, chronic lymphocytic, susceptibility to, 1 0 trials
- Leukemia, chronic lymphocytic, susceptibility to, 3 0 trials
- Leukemia, chronic lymphocytic, susceptibility to, 4 0 trials
- Leukemia, chronic lymphocytic, susceptibility to, 5 0 trials
- Lung cancer susceptibility 1 0 trials
- Lung cancer susceptibility 3 0 trials
- Lung cancer susceptibility 4 0 trials
- Lung cancer susceptibility 5 0 trials
- Melanoma and neural system tumor syndrome 0 trials
- Mosaic neurofibromatosis/schwannomatosis 0 trials Sub-types →
- Mosaic variegated aneuploidy syndrome 0 trials Sub-types →
- Multiple self-healing squamous epithelioma 0 trials
- Nasopharyngeal carcinoma, susceptibility to, 2 0 trials
- Nasopharyngeal carcinoma, susceptibility to, 3 0 trials
- Neuroblastoma, susceptibility to, 1 0 trials
- Neuroblastoma, susceptibility to, 2 0 trials
- Neuroblastoma, susceptibility to, 4 0 trials
- Neuroblastoma, susceptibility to, 5 0 trials
- Neuroblastoma, susceptibility to, 6 0 trials
- Neuroblastoma, susceptibility to, 7 0 trials
- Ovarian cancer, familial, susceptibility to, 1 0 trials
- Ovarian cancer, familial, susceptibility to, 2 0 trials
- Ovarian cancer, familial, susceptibility to, 3 0 trials
- Ovarian cancer, susceptibility to, 1 0 trials
- Pancreatic cancer, susceptibility to, 1 0 trials
- Pancreatic cancer, susceptibility to, 5 0 trials
- Progeroid features-hepatocellular carcinoma predisposition syndrome 0 trials
- Prostate cancer, hereditary, X-linked 3 0 trials
- Prostate cancer/brain cancer susceptibility 0 trials
- Susceptibility to uveal melanoma 0 trials Sub-types →
- Tumor predisposition syndrome 2 0 trials
-
Skeletal dysplasia 1 trial · 663 incl. sub-types
119 sub-types
- Osteochondrodysplasia 12 trials · 381 incl. sub-types Sub-types →
- Lysosomal storage disease with skeletal involvement 0 trials · 64 incl. sub-types Sub-types →
- Chondrodysplasia punctata 0 trials · 39 incl. sub-types Sub-types →
- Type 2 collagenopathy 0 trials · 39 incl. sub-types Sub-types →
- Non-syndromic limb reduction defect 0 trials · 35 incl. sub-types Sub-types →
- FGFR3-related chondrodysplasia 0 trials · 33 incl. sub-types Sub-types →
- Abnormal mineralization disorder 0 trials · 22 incl. sub-types Sub-types →
- Syndromic craniosynostosis 1 trial · 22 incl. sub-types Sub-types →
- Osteopetrosis 6 trials · 14 incl. sub-types Sub-types →
- Amniotic band syndrome 8 trials · 9 incl. sub-types Sub-types →
- Primordial dwarfism and slender bone disorder 0 trials · 9 incl. sub-types Sub-types →
- Acromelic dysplasia 0 trials · 8 incl. sub-types Sub-types →
- SHOX-related short stature 6 trials
- Polydactyly-syndactyly-triphalangism 0 trials · 6 incl. sub-types Sub-types →
- McCune-Albright syndrome 5 trials
- Primary osteolysis 0 trials · 5 incl. sub-types Sub-types →
- Filamin-related bone disorder 0 trials · 4 incl. sub-types Sub-types →
- Ollier disease 3 trials
- Proteus syndrome 2 trials
- SLC26A2-related skeletal dysplasia 0 trials · 2 incl. sub-types Sub-types →
- Acheiria 0 trials · 2 incl. sub-types Sub-types →
- Bent bone dysplasia 0 trials · 2 incl. sub-types Sub-types →
- Congenital absence of both forearm and hand 1 trial · 2 incl. sub-types Sub-types →
- Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome 2 trials
- Short rib dysplasia 0 trials · 2 incl. sub-types Sub-types →
- Spondylodysplastic dysplasia 0 trials · 2 incl. sub-types Sub-types →
- 2q37 microdeletion syndrome 1 trial
- COMP-related skeletal dysplasia 0 trials · 1 incl. sub-types Sub-types →
- Currarino triad 1 trial
- Sotos syndrome 1 trial
- Chondromalacia patellae 1 trial
- Coxopodopatellar syndrome 1 trial
- Craniofrontonasal syndrome 1 trial
- Bruck syndrome 0 trials Sub-types →
- Camurati-Engelmann disease 0 trials Sub-types →
- Catel-Manzke syndrome 0 trials
- Cole-Carpenter syndrome 0 trials Sub-types →
- Eiken syndrome 0 trials
- FAM111A-related skeletal dysplasia 0 trials Sub-types →
- Hartsfield-Bixler-Demyer syndrome 0 trials
- LRP5-related primary osteoporosis 0 trials
- Larsen-like osseous dysplasia-short stature syndrome 0 trials
- Larsen-like syndrome, B3GAT3 type 0 trials
- Lenz-Majewski hyperostotic dwarfism 0 trials
- Marshall-Smith syndrome 0 trials
- Richieri Costa-Pereira syndrome 0 trials
- Robinow syndrome 0 trials Sub-types →
- TRIP11-related skeletal dysplasia 0 trials Sub-types →
- TRPV4-related bone disorder 0 trials Sub-types →
- Tatton-Brown-Rahman overgrowth syndrome 0 trials
- Weaver syndrome 0 trials
- Yunis-Varon syndrome 0 trials
- Acrocoxomesomelic dysplasia 0 trials
- Adactyly of foot 0 trials Sub-types →
- Apodia 0 trials Sub-types →
- Autosomal dominant osteosclerosis, Worth type 0 trials
- Autosomal recessive cutis laxa type 2 0 trials Sub-types →
- Baby rattle pelvis dysplasia 0 trials
- Bird headed-dwarfism, Montreal type 0 trials
- Bone dysplasia Moore type 0 trials
- Bone dysplasia corpus callosum agenesis 0 trials
- Brachydactyly-elbow wrist dysplasia syndrome 0 trials
- Calvarial doughnut lesions with bone fragility and spondylometaphyseal dysplasia 0 trials
- Carpotarsal osteochondromatosis 0 trials
- Cerebrocostomandibular syndrome 0 trials
- Chondroectodermal dysplasia with night blindness 0 trials
- Cleidorhizomelic syndrome 0 trials
- Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome 0 trials
- Colobomatous microphthalmia-rhizomelic dysplasia syndrome 0 trials
- Complex lethal osteochondrodysplasia 0 trials
- Congenital absence of both lower leg and foot 0 trials Sub-types →
- Congenital absence of thigh and lower leg with foot present 0 trials Sub-types →
- Congenital absence of upper arm and forearm with hand present 0 trials
- Craniometadiaphyseal dysplasia, wormian bone type 0 trials
- Craniotubular dysplasia, Ikegawa type 0 trials
- De la Chapelle dysplasia 0 trials
- Delayed membranous cranial ossification 0 trials
- Diaphyseal medullary stenosis-bone malignancy syndrome 0 trials
- Dyschondrosteosis-nephritis syndrome 0 trials
- Dysplasia epiphysealis hemimelica 0 trials
- Dysplasia of head of femur, Meyer type 0 trials
- Dysspondyloenchondromatosis 0 trials
- Epimetaphyseal skeletal dysplasia 0 trials
- Familial osteodysplasia, Anderson type 0 trials
- Fibular aplasia-ectrodactyly syndrome 0 trials
- Genitopatellar syndrome 0 trials
- Genochondromatosis 0 trials Sub-types →
- Ghosal hematodiaphyseal dysplasia 0 trials
- Hyperostosis corticalis generalisata 0 trials
- Melorheostosis with osteopoikilosis 0 trials
- Mesomelic dwarfism-cleft palate-camptodactyly syndrome 0 trials
- Mesomelic dysplasia-digital anomalies-intellectual disability syndrome 0 trials
- Metaphyseal acroscyphodysplasia 0 trials
- Metaphyseal anadysplasia 0 trials Sub-types →
- Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome 0 trials
- Metaphyseal dysplasia, Braun-Tinschert type 0 trials
- Microcephalic primordial dwarfism due to ZNF335 deficiency 0 trials
- Oculodentodigital dysplasia 0 trials Sub-types →
- Omodysplasia 0 trials Sub-types →
- Osteofibrous dysplasia 0 trials
- Osteoglophonic dysplasia 0 trials
- Pancreatic insufficiency-anemia-hyperostosis syndrome 0 trials
- Parietal foramina 0 trials Sub-types →
- Parietal foramina with cleidocranial dysplasia 0 trials
- Pelvic dysplasia-arthrogryposis of lower limbs syndrome 0 trials
- Proximal femoral focal deficiency 0 trials
- Pseudodiastrophic dysplasia 0 trials
- Rhizomelic dysplasia, Ain-Naz type 0 trials
- Rhizomelic dysplasia, Patterson-Lowry type 0 trials
- Rhizomelic syndrome, Urbach type 0 trials
- Short stature-advanced bone age-early-onset osteoarthritis syndrome 0 trials
- Skeletal dysplasia-epilepsy-short stature syndrome 0 trials
- Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome 0 trials
- Split hand-foot malformation 1 with sensorineural hearing loss 0 trials
- Spondylometaphyseal dysplasia 0 trials Sub-types →
- Synpolydactyly 0 trials Sub-types →
- Tall stature-scoliosis-macrodactyly of the great toes syndrome 0 trials
- Thin ribs-tubular bones-dysmorphism syndrome 0 trials
- Tricho-dento-osseous syndrome 0 trials
-
Cardiogenetic disease 3 trials · 618 incl. sub-types
73 sub-types
- Familial cardiomyopathy 2 trials · 219 incl. sub-types Sub-types →
- Atrial septal defect 45 trials · 78 incl. sub-types Sub-types →
- Postural orthostatic tachycardia syndrome 71 trials
- Cardiogenetic rhythm disorder 2 trials · 68 incl. sub-types Sub-types →
- Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome 53 trials
- Tetralogy of fallot 34 trials
- Patent ductus arteriosus 28 trials Sub-types →
- Ventricular septal defect 24 trials · 26 incl. sub-types Sub-types →
- Familial bicuspid aortic valve 6 trials · 21 incl. sub-types Sub-types →
- NOTCH1-related AOS spectrum disorder 0 trials · 16 incl. sub-types Sub-types →
- Alagille syndrome 15 trials Sub-types →
- DiGeorge syndrome 11 trials
- Hypoplastic left heart syndrome 10 trials Sub-types →
- CHARGE syndrome 4 trials Sub-types →
- Velocardiofacial syndrome 4 trials
- Supravalvular aortic stenosis 3 trials
- Dextro-looped transposition of the great arteries 2 trials Sub-types →
- Ellis-van Creveld syndrome 1 trial Sub-types →
- Coronary artery disease, autosomal dominant, 1 1 trial
- Dextrocardia 1 trial
- Inherited mitral valve disease 0 trials · 1 incl. sub-types Sub-types →
- Structural congenital heart disease, multiple types - GATA4 0 trials · 1 incl. sub-types Sub-types →
- 8q24.3 microdeletion syndrome 0 trials
- ACTC1-related distal arthrogryposis with congenital heart disease 0 trials
- ACTN2-related cardiac and skeletal myopathy 0 trials Sub-types →
- CHIME syndrome 0 trials
- COG1-congenital disorder of glycosylation 0 trials
- Ehlers-Danlos syndrome, cardiac valvular type 0 trials
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- GATA6-related congenital heart disease with or without pancreatic agenesis or neonatal diabetes 0 trials Sub-types →
- HAND1 related congenital heart defect 0 trials
- HAND2 related congenital heart defect 0 trials
- Holt-Oram syndrome 0 trials Sub-types →
- Hordnes Engebretsen Knudtson syndrome 0 trials
- LMNA-related cardiocutaneous progeria syndrome 0 trials
- Larsen-like syndrome, B3GAT3 type 0 trials
- MGAT2-congenital disorder of glycosylation 0 trials
- MYH-6 related congenital heart defects 0 trials
- PLD1-related congenital heart disease 0 trials
- Peters plus syndrome 0 trials
- RBFOX2-related congenital heart disorder 0 trials
- Sengers syndrome 0 trials
- TARP syndrome 0 trials
- TFAP2B-related congenital heart disease spectrum disorder 0 trials Sub-types →
- TNNT2-related cardiomyopathy 0 trials Sub-types →
- Alveolar capillary dysplasia with misalignment of pulmonary veins 0 trials
- Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0 trials
- Cardiac anomalies - developmental delay - facial dysmorphism syndrome 0 trials
- Cardiac conduction disease with or without cardiomyoopathy 0 trials Sub-types →
- Cardiac valvular dysplasia, X-linked 0 trials
- Congenital alveolar dysplasia due to FGF10 0 trials
- Congenital alveolar dysplasia due to TBX4 0 trials
- Congenital heart defects, multiple types, 2 0 trials
- Congenital heart defects, multiple types, 3 0 trials
- Congenital heart defects, multiple types, 5 0 trials
- Congenital heart defects, multiple types, 8, with or without heterotaxy 0 trials
- Congenital heart defects, multiple types, 9 0 trials
- Congenital vertebral-cardiac-renal anomalies syndrome 0 trials Sub-types →
- Coronary artery disease, autosomal dominant 2 0 trials
- Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome 0 trials
- Familial atrial myxoma 0 trials
- Familial atrioventricular septal defect 0 trials Sub-types →
- Familial retinal arterial macroaneurysm 0 trials
- Fibromuscular dysplasia of the coronary arteries 0 trials
- Heart defects-limb shortening syndrome 0 trials
- Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome 0 trials
- Mehta lewis patton syndrome 0 trials
- Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome 0 trials
- Pericardial effusion, chronic 0 trials
- Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome 0 trials
- Sinoatrial node dysfunction and deafness 0 trials
- Transketolase deficiency 0 trials
- Tricuspid atresia 0 trials
-
Inherited hemoglobinopathy 38 trials · 440 incl. sub-types
17 sub-types
- Sickle cell disease 343 trials Sub-types →
- Thalassemia 49 trials · 129 incl. sub-types Sub-types →
- Beta-thalassemia and related diseases 0 trials · 99 incl. sub-types Sub-types →
- Congenital nonspherocytic hemolytic anemia 1 trial · 12 incl. sub-types Sub-types →
- Sickle cell-beta-thalassemia disease syndrome 5 trials · 9 incl. sub-types Sub-types →
- Hemoglobin C disease 2 trials
- Hereditary methemoglobinemia 0 trials · 1 incl. sub-types Sub-types →
- Unstable hemoglobin disease 1 trial
- Hemoglobin D disease 0 trials
- Hemoglobin E disease 0 trials
- Hemoglobinopathy Toms River 0 trials
- Hereditary persistence of fetal hemoglobin 0 trials
- Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome 0 trials
- Homozygous hemoglobin O Arab disease 0 trials
- Sickle cell-hemoglobin E disease syndrome 0 trials
- Sickle cell-hemoglobin d disease syndrome 0 trials
- Sulfhemoglobinemia, congenital 0 trials
-
COPD, severe early onset 406 trials
-
Hereditary skeletal muscle disorder 1 trial · 406 incl. sub-types
33 sub-types
- Muscular dystrophy 74 trials · 290 incl. sub-types Sub-types →
- Congenital myopathy 8 trials · 75 incl. sub-types Sub-types →
- Congenital diaphragmatic hernia 45 trials Sub-types →
- Myopathy caused by variation in FKRP 0 trials · 8 incl. sub-types Sub-types →
- Hereditary inclusion-body myopathy 1 trial · 6 incl. sub-types Sub-types →
- Poland syndrome 2 trials
- Myopathy caused by variation in FKTN 1 trial · 2 incl. sub-types Sub-types →
- Inherited rippling muscle disease 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in CRPPA 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in GMPPB 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMGNT1 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMT1 0 trials · 1 incl. sub-types Sub-types →
- Myopathy caused by variation in POMT2 0 trials · 1 incl. sub-types Sub-types →
- Myopathy due to myoadenylate deaminase deficiency 1 trial
- Paramyotonia congenita of Von Eulenburg 1 trial
- Polyglucosan body myopathy 0 trials · 1 incl. sub-types Sub-types →
- ACTN2-related cardiac and skeletal myopathy 0 trials Sub-types →
- Brody myopathy 0 trials
- FHL1-related myopathy 0 trials Sub-types →
- Wieacker-Wolff syndrome (spectrum) 0 trials Sub-types →
- Hereditary continuous muscle fiber activity 0 trials
- Hereditary myopathy with lactic acidosis due to ISCU deficiency 0 trials
- Metabolic myopathy due to lactate transporter defect 0 trials
- Myopathy caused by variation in POMGNT2 0 trials Sub-types →
- Myopathy due to calsequestrin and SERCA1 protein overload 0 trials
- Myopathy with abnormal lipid metabolism 0 trials
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 0 trials
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 2 0 trials
- Myopathy, sarcoplasmic body 0 trials
- Myosclerosis 0 trials
- Potassium-aggravated myotonia 0 trials Sub-types →
- Proximal myopathy with extrapyramidal signs 0 trials
- Proximal myopathy with focal depletion of mitochondria 0 trials
-
X-linked disease 19 trials · 327 incl. sub-types
50 sub-types
- Hemophilia A 180 trials Sub-types →
- X-linked deafness 0 trials · 32 incl. sub-types Sub-types →
- Adrenoleukodystrophy 19 trials · 20 incl. sub-types Sub-types →
- X-linked intellectual disability 1 trial · 15 incl. sub-types Sub-types →
- X-linked hypophosphatemic rickets 11 trials · 12 incl. sub-types Sub-types →
- X-linked lymphoproliferative syndrome 7 trials · 11 incl. sub-types Sub-types →
- Wiskott-Aldrich syndrome 10 trials
- X-linked dominant disease 0 trials · 10 incl. sub-types Sub-types →
- X-linked erythropoietic protoporphyria 10 trials
- X-linked recessive disease 0 trials · 10 incl. sub-types Sub-types →
- Choroideremia 6 trials Sub-types →
- X-linked myotubular myopathy 4 trials Sub-types →
- X-linked retinoschisis 4 trials
- X-linked Alport syndrome 3 trials
- Dyskeratosis congenita, X-linked 0 trials · 3 incl. sub-types Sub-types →
- Hyper-IgM syndrome type 1 3 trials
- Charcot-Marie-Tooth disease type X 1 trial · 2 incl. sub-types Sub-types →
- X-linked cone-rod dystrophy 0 trials · 2 incl. sub-types Sub-types →
- X-linked Emery-Dreifuss muscular dystrophy 1 trial Sub-types →
- X-linked chondrodysplasia punctata 1 trial Sub-types →
- X-linked hydrocephalus with stenosis of the aqueduct of Sylvius 1 trial
- Diabetes insipidus, nephrogenic, X-linked 1 trial
- Spondyloepiphyseal dysplasia tarda, X-linked 1 trial
- Aarskog-Scott syndrome, X-linked 0 trials
- Aland island eye disease 0 trials
- Dyggve-Melchior-Clausen syndrome, X-linked 0 trials
- X-linked Ehlers-Danlos syndrome 0 trials
- X-linked Opitz G/BBB syndrome 0 trials
- X-linked acrogigantism due to Xq26 microduplication 0 trials
- X-linked adrenal hypoplasia congenita 0 trials Sub-types →
- X-linked central congenital hypothyroidism with late-onset testicular enlargement 0 trials
- X-linked cerebellar ataxia 0 trials Sub-types →
- X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome 0 trials
- X-linked complex neurodevelopmental disorder 0 trials Sub-types →
- X-linked congenital hemolytic anemia 0 trials
- X-linked congenital stationary night blindness 0 trials Sub-types →
- X-linked distal spinal muscular atrophy type 3 0 trials
- X-linked hypohidrotic ectodermal dysplasia 0 trials
- X-linked immunoneurologic disorder 0 trials
- X-linked lethal multiple pterygium syndrome 0 trials
- X-linked lissencephaly with abnormal genitalia 0 trials
- X-linked mandibulofacial dysostosis 0 trials
- X-linked severe congenital neutropenia 0 trials
- X-linked sideroblastic anemia 1 0 trials
- Cone dystrophy, X-linked, with tapetal-like sheen 0 trials
- Epidermodysplasia verruciformis, X-linked 0 trials
- Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders 0 trials
- Exudative vitreoretinopathy 2, X-linked 0 trials
- Leukemia, acute, X-linked 0 trials
- Macular dystrophy, X-linked 0 trials
-
Inherited blood coagulation disorder 8 trials · 323 incl. sub-types
39 sub-types
- Hemophilia A 180 trials Sub-types →
- Hemophilia B 84 trials · 91 incl. sub-types Sub-types →
- Hereditary von Willebrand disease 18 trials · 29 incl. sub-types Sub-types →
- Inherited thrombophilia 0 trials · 28 incl. sub-types Sub-types →
- Hereditary hemolytic uremic syndrome 0 trials · 19 incl. sub-types Sub-types →
- Wiskott-Aldrich syndrome 10 trials
- Glanzmann thrombasthenia 8 trials Sub-types →
- Platelet-type bleeding disorder 10 8 trials
- Congenital thrombotic thrombocytopenic purpura 5 trials
- Hereditary thrombocytopenia and hematologic cancer predisposition syndrome 1 trial · 5 incl. sub-types Sub-types →
- Hermansky-Pudlak syndrome 4 trials Sub-types →
- Congenital vitamin K-dependent coagulation factors deficiency 0 trials · 4 incl. sub-types Sub-types →
- Congenital factor XII deficiency 1 trial
- Congenital plasminogen activator inhibitor type 1 deficiency 1 trial
- Hypoplasminogenemia 1 trial
- Ehlers-Danlos syndrome, fibronectinemic type 0 trials
- Scott syndrome 0 trials
- Tatsumi factor deficiency 0 trials
- Alpha-2-plasmin inhibitor deficiency 0 trials
- Congenital factor V deficiency 0 trials
- Congenital factor XI deficiency 0 trials
- Congenital high-molecular-weight kininogen deficiency 0 trials
- Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder 0 trials
- Dysplasminogenemia 0 trials
- Factor 5 and Factor VIII, combined deficiency of, 2 0 trials
- Factor V and factor VIII, combined deficiency of, type 1 0 trials
- Factor VII and Factor VIII, combined deficiency of 0 trials
- Factor XIII, A subunit, deficiency of 0 trials
- Factor XIII, b subunit, deficiency of 0 trials
- Familial thrombomodulin anomalies 0 trials
- Hereditary thrombocytosis with transverse limb defect 0 trials
- Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency 0 trials
- Inherited prekallikrein deficiency 0 trials
- Plasminogen deficiency, type II 0 trials
- Platelet-type bleeding disorder 12 0 trials
- Platelet-type bleeding disorder 14 0 trials
- Platelet-type bleeding disorder 16 0 trials
- Platelet-type bleeding disorder 18 0 trials
- Platelet-type bleeding disorder 8 0 trials
-
Hereditary dementia 2 trials · 322 incl. sub-types
15 sub-types
- Frontotemporal dementia 132 trials · 178 incl. sub-types Sub-types →
- Familial Alzheimer disease 13 trials · 55 incl. sub-types Sub-types →
- Autosomal dominant cerebellar ataxia 11 trials · 33 incl. sub-types Sub-types →
- Adrenoleukodystrophy 19 trials · 20 incl. sub-types Sub-types →
- Corticobasal syndrome 20 trials
- Metachromatic leukodystrophy 20 trials Sub-types →
- Frontotemporal dementia with motor neuron disease 14 trials · 19 incl. sub-types Sub-types →
- Huntington disease-like syndrome 0 trials · 17 incl. sub-types Sub-types →
- Posterior cortical atrophy 12 trials
- Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types Sub-types →
- Alzheimer disease 17 1 trial
- Alzheimer disease 18 1 trial
- Neuronal intranuclear inclusion disease 1 trial
- PRKAR1B-related neurodegenerative dementia with intermediate filaments 0 trials
- Hereditary sensory neuropathy-deafness-dementia syndrome 0 trials
-
Inherited kidney disorder 1 trial · 317 incl. sub-types
26 sub-types
- Hereditary nephritis 17 trials · 152 incl. sub-types Sub-types →
- Familial cystic renal disease 0 trials · 72 incl. sub-types Sub-types →
- Inherited renal tubular disease 0 trials · 40 incl. sub-types Sub-types →
- Familial nephrotic syndrome 0 trials · 22 incl. sub-types Sub-types →
- Congenital anomaly of kidney and urinary tract 7 trials · 14 incl. sub-types Sub-types →
- Nephrolithiasis, calcium oxalate 13 trials Sub-types →
- Neurohypophyseal diabetes insipidus 9 trials
- Hereditary renal cell carcinoma 1 trial · 7 incl. sub-types Sub-types →
- Inherited focal segmental glomerulosclerosis 1 trial · 4 incl. sub-types Sub-types →
- Inherited pseudohypoaldosteronism 0 trials · 4 incl. sub-types Sub-types →
- Renal agenesis 1 trial · 2 incl. sub-types Sub-types →
- Liddle syndrome 1 trial Sub-types →
- Hereditary kidney oncocytoma 1 trial
- Prune belly syndrome 1 trial
- Alsing syndrome 0 trials
- Gitelman-like kidney tubulopathy due to mitochondrial DNA mutation 0 trials
- Familial juvenile hyperuricemic nephropathy 0 trials Sub-types →
- Familial renal glucosuria 0 trials
- Fibronectin glomerulopathy 0 trials Sub-types →
- Hypophosphatemic nephrolithiasis/osteoporosis 1 0 trials
- Hypophosphatemic nephrolithiasis/osteoporosis 2 0 trials
- Inherited distal renal tubular acidosis 0 trials Sub-types →
- Nail-patella-like renal disease 0 trials
- Nephrolithiasis, X-linked recessive, with renal failure 0 trials
- Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis 0 trials
- Renal tubular dysgenesis of genetic origin 0 trials Sub-types →
-
Cataract 294 trials · 305 incl. sub-types
29 sub-types
- Senile cataract 49 trials · 52 incl. sub-types Sub-types →
- Nuclear cataract 5 trials · 6 incl. sub-types Sub-types →
- Diabetic cataract 1 trial
- Early-onset non-syndromic cataract 1 trial Sub-types →
- Hypermature cataract 1 trial Sub-types →
- Immature cataract 1 trial
- Mature cataract 1 trial
- Kozlowski Rafinski Klicharska syndrome 0 trials
- Autosomal dominant cataract 0 trials Sub-types →
- Bhaskar jagannathan syndrome 0 trials
- Cataract 1 multiple types 0 trials
- Cataract 12 multiple types 0 trials
- Cataract 18 0 trials
- Cataract 2, multiple types 0 trials
- Cataract 28 0 trials
- Cataract 29 0 trials
- Cataract 3 multiple types 0 trials
- Cataract 34 multiple types 0 trials
- Cataract 36 0 trials
- Cataract 4 multiple types 0 trials
- Cataract 48 0 trials
- Cataract 49 0 trials
- Cataract 50 with or without glaucoma 0 trials
- Cataract 9 multiple types 0 trials
- Cortical cataract 0 trials Sub-types →
- Craniostenosis cataract 0 trials
- Diabetes mellitus type 2 associated cataract 0 trials
- Myotonic cataract 0 trials
- Tetanic cataract 0 trials
-
Myopia 259 trials · 274 incl. sub-types
30 sub-types
- Degenerative myopia 38 trials
- Myopia, high, with cataract and vitreoretinal degeneration 1 trial
- Myopia 1, X-linked 0 trials
- Myopia 10 0 trials
- Myopia 11, autosomal dominant 0 trials
- Myopia 12, autosomal dominant 0 trials
- Myopia 13, X-linked 0 trials
- Myopia 14 0 trials
- Myopia 15, autosomal dominant 0 trials
- Myopia 16, autosomal dominant 0 trials
- Myopia 17, autosomal dominant 0 trials
- Myopia 18, autosomal recessive 0 trials
- Myopia 19, autosomal dominant 0 trials
- Myopia 2, autosomal dominant 0 trials
- Myopia 20, autosomal dominant 0 trials
- Myopia 21, autosomal dominant 0 trials
- Myopia 22, autosomal dominant 0 trials
- Myopia 23, autosomal recessive 0 trials
- Myopia 24, autosomal dominant 0 trials
- Myopia 25, autosomal dominant 0 trials
- Myopia 26, X-linked, female-limited 0 trials
- Myopia 27 0 trials
- Myopia 28, autosomal recessive 0 trials
- Myopia 3, autosomal dominant 0 trials
- Myopia 5, autosomal dominant 0 trials
- Myopia 6 0 trials
- Myopia 7 0 trials
- Myopia 8 0 trials
- Myopia 9 0 trials
- Schizophrenia 16 0 trials
-
Preeclampsia 232 trials · 236 incl. sub-types
7 sub-types
- Severe pre-eclampsia 27 trials · 38 incl. sub-types Sub-types →
- Mild pre-eclampsia 9 trials
- Preeclampsia/eclampsia 1 1 trial
- Preeclampsia/eclampsia 2 0 trials
- Preeclampsia/eclampsia 3 0 trials
- Preeclampsia/eclampsia 4 0 trials
- Preeclampsia/eclampsia 5 0 trials
-
Burkitt lymphoma 221 trials
2 sub-types
- Colon Burkitt lymphoma 0 trials
- Small intestinal Burkitt lymphoma 0 trials
-
Gastroesophageal reflux disease 217 trials
1 sub-type
- Duodenogastric reflux 0 trials
-
Intervertebral disk degenerative disorder 123 trials · 217 incl. sub-types
3 sub-types
- Lumbar disk degenerative disorder 165 trials
- Cervical disk degenerative disorder 42 trials
- Thoracic disk degenerative disorder 2 trials
-
Polycystic ovary syndrome 201 trials
-
Classic Hodgkin lymphoma 147 trials · 149 incl. sub-types
4 sub-types
-
Ewing sarcoma 125 trials · 126 incl. sub-types
2 sub-types
- Ewing sarcoma of bone 5 trials
- Extraskeletal Ewing sarcoma 3 trials
-
Bronchiectasis 119 trials · 120 incl. sub-types
1 sub-type
- Idiopathic bronchiectasis 3 trials Sub-types →
-
Inherited auditory system disease 0 trials · 120 incl. sub-types
12 sub-types
- Nonsyndromic genetic hearing loss 4 trials · 67 incl. sub-types Sub-types →
- X-linked deafness 0 trials · 32 incl. sub-types Sub-types →
- Benign paroxysmal positional vertigo 18 trials
- Meniere disease 16 trials Sub-types →
- Motion sickness 14 trials · 16 incl. sub-types Sub-types →
- Auditory neuropathy 7 trials · 11 incl. sub-types Sub-types →
- Otosclerosis 4 trials Sub-types →
- Johanson-Blizzard syndrome 0 trials
- Age-related hearing impairment 1 0 trials
- Age-related hearing impairment 2 0 trials
- Tympanic paraganglioma 0 trials
- Vertigo, benign recurrent, 1 0 trials
-
Hereditary otorhinolaryngologic disease 0 trials · 102 incl. sub-types
21 sub-types
- X-linked mixed hearing loss with perilymphatic gusher 32 trials
- Benign paroxysmal positional vertigo 18 trials
- Meniere disease 16 trials Sub-types →
- Motion sickness 14 trials · 16 incl. sub-types Sub-types →
- Familial congenital nasolacrimal duct obstruction 7 trials
- Choanal atresia 4 trials Sub-types →
- Otosclerosis 4 trials Sub-types →
- Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome 2 trials
- Familial thyroglossal duct cyst 2 trials
- BNAR syndrome 1 trial
- Aural atresia, congenital 1 trial
- Second branchial cleft anomaly 1 trial
- Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome 1 trial
- X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome 0 trials
- Bifid nose, autosomal recessive 0 trials Sub-types →
- Familial nasal acilia 0 trials
- Isolated congenital anosmia 0 trials
- Nasal dermoid cyst 0 trials
- Tonsillar lymphoma 0 trials
- Tympanic paraganglioma 0 trials
- Vertigo, benign recurrent, 1 0 trials
-
Osteonecrosis of genetic origin 0 trials · 102 incl. sub-types
12 sub-types
- Familial avascular necrosis of femoral head 20 trials · 39 incl. sub-types Sub-types →
- Scheuermann disease 24 trials
- Osteochondritis dissecans 20 trials
- Gaucher disease type I 12 trials
- Legg-Calve-Perthes disease 9 trials
- Dihydropyrimidine dehydrogenase deficiency 3 trials
- Epiphysiolysis of the hip 3 trials
- Hereditary antithrombin deficiency 3 trials
- Thiemann disease, familial form 0 trials
- Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency 0 trials
- Pseudohypoparathyroidism type 1C 0 trials
- Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans 0 trials
-
RASopathy 9 trials · 101 incl. sub-types
4 sub-types
- Neurofibromatosis type 1 73 trials Sub-types →
- Noonan syndrome and Noonan-related syndrome 1 trial · 29 incl. sub-types Sub-types →
- Neurofibromatosis-Noonan syndrome 2 trials Sub-types →
- CBL-related disorder 1 trial
-
Lymphoproliferative syndrome 70 trials · 100 incl. sub-types
8 sub-types
- Castleman disease 8 trials · 18 incl. sub-types Sub-types →
- Autoimmune lymphoproliferative syndrome 11 trials · 12 incl. sub-types Sub-types →
- X-linked lymphoproliferative syndrome 7 trials · 11 incl. sub-types Sub-types →
- Dianzani autoimmune lymphoproliferative disease 0 trials
- Atypical lymphoproliferative disorder 0 trials
- Lymphoproliferative syndrome 1 0 trials
- Lymphoproliferative syndrome 2 0 trials
- Severe combined immunodeficiency due to CD70 deficiency 0 trials
-
Hypogonadotropic hypogonadism 19 trials · 100 incl. sub-types
10 sub-types
- Congenital hypogonadotropic hypogonadism 0 trials · 83 incl. sub-types Sub-types →
- Kallmann syndrome 3 trials Sub-types →
- Hypogonadotropic hypogonadism 24 without anosmia 1 trial
- Hypogonadotropic hypogonadism 10 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 12 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 13 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 23 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 25 with anosmia 0 trials
- Hypogonadotropic hypogonadism 26 with or without anosmia 0 trials
- Hypogonadotropic hypogonadism 27 without anosmia 0 trials
-
Gastrointestinal stromal tumor 93 trials
-
Familial polycythemia 1 trial · 92 incl. sub-types
8 sub-types
- Acquired polycythemia vera 90 trials
- Erythrocytosis, familial, 4 2 trials
- Chuvash polycythemia 0 trials
- Erythrocytosis, familial, 3 0 trials
- Erythrocytosis, familial, 5 0 trials
- Erythrocytosis, familial, 6 0 trials
- Erythrocytosis, familial, 7 0 trials
- Primary familial polycythemia due to EPO receptor mutation 0 trials
-
Familial colorectal cancer 3 trials · 91 incl. sub-types
4 sub-types
- Hereditary nonpolyposis colon cancer 5 trials · 88 incl. sub-types Sub-types →
- POLD1-related polyposis and colorectal cancer syndrome 0 trials
- POLE-related polyposis and colorectal cancer syndrome 0 trials
- Colon Burkitt lymphoma 0 trials
-
Celiac disease 81 trials
1 sub-type
- Lane Hamilton syndrome 0 trials
-
Cirrhosis, familial 4 trials · 79 incl. sub-types
3 sub-types
- Primary biliary cholangitis 74 trials Sub-types →
- Isolated congenital hepatic fibrosis 2 trials
- Cirrhosis, familial, with antigenemia 0 trials
-
Spondylolisthesis 77 trials
1 sub-type
- Jaffer-Beighton syndrome 0 trials
-
Orofacial cleft 4 trials · 69 incl. sub-types
16 sub-types
- Cleft palate 34 trials · 35 incl. sub-types Sub-types →
- Cleft lip 31 trials Sub-types →
- Cleft lip/palate 31 trials Sub-types →
- Cleft lip and alveolus 17 trials Sub-types →
- Orofacial cleft 1 1 trial
- ARHGAP29-related non-syndromic orofacial cleft 0 trials
- GRHL3-related orofacial clefting 0 trials
- Cleft lip/palate-ectodermal dysplasia syndrome 0 trials
- Familial median cleft of the upper and lower lips 0 trials
- Orofacial cleft 12 0 trials
- Orofacial cleft 13 0 trials
- Orofacial cleft 2 0 trials
- Orofacial cleft 4 0 trials
- Orofacial cleft 7 0 trials
- Orofacial cleft 8 0 trials
- Orofacial cleft 9 0 trials
-
Developmental dysplasia of the hip 62 trials
4 sub-types
- Developmental dysplasia of the hip 1 5 trials
- Developmental dysplasia of the hip 2 0 trials
- Developmental dysplasia of the hip 3 0 trials
- Developmental dysplasia of the hip 4 0 trials
-
Keratoconus 61 trials
11 sub-types
- Keratoconus, stable condition 2 trials
- Acute hydrops keratoconus 0 trials
- Keratoconus 1 0 trials
- Keratoconus 2 0 trials
- Keratoconus 3 0 trials
- Keratoconus 4 0 trials
- Keratoconus 5 0 trials
- Keratoconus 6 0 trials
- Keratoconus 7 0 trials
- Keratoconus 8 0 trials
- Keratoconus 9 0 trials
-
Anodontia 59 trials
3 sub-types
- Aloi Tomasini Isaia syndrome 0 trials
- Mehta lewis patton syndrome 0 trials
- Microdontia hypodontia short stature 0 trials
-
Enterocolitis 3 trials · 58 incl. sub-types
2 sub-types
- Necrotizing enterocolitis 51 trials Sub-types →
- Food protein-induced enterocolitis syndrome 5 trials
-
Lymphatic malformation 17 trials · 56 incl. sub-types
28 sub-types
- Noonan syndrome 22 trials · 25 incl. sub-types Sub-types →
- Lymphatic malformation 5 8 trials
- Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome 4 trials
- Lymphatic malformation 12 2 trials
- MPI-congenital disorder of glycosylation 1 trial
- Deafness-lymphedema-leukemia syndrome 1 trial
- Dahlberg-Borer-Newcomer syndrome 0 trials
- Hennekam syndrome 0 trials Sub-types →
- Norman-Roberts syndrome 0 trials
- Campomelia, Cumming type 0 trials
- Congenital primary lymphedema of Gordon 0 trials
- Hypotrichosis-lymphedema-telangiectasia syndrome 0 trials
- Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 0 trials
- Lymphatic malformation 1 0 trials
- Lymphatic malformation 10 0 trials
- Lymphatic malformation 11 0 trials
- Lymphatic malformation 13 0 trials
- Lymphatic malformation 14 0 trials
- Lymphatic malformation 2 0 trials
- Lymphatic malformation 3 0 trials
- Lymphatic malformation 4 0 trials
- Lymphatic malformation 6 0 trials
- Lymphatic malformation 7 0 trials
- Lymphatic malformation 8 0 trials
- Lymphatic malformation 9 0 trials
- Lymphedema-distichiasis syndrome 0 trials
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Yellow nail syndrome 0 trials
-
Synovial sarcoma 53 trials
5 sub-types
- Biphasic synovial sarcoma 0 trials
- Breast synovial sarcoma 0 trials
- Fibrous synovial sarcoma 0 trials
- Mediastinum synovial sarcoma 0 trials
- Monophasic synovial sarcoma 0 trials Sub-types →
-
Inherited aplastic anemia 2 trials · 53 incl. sub-types
5 sub-types
- Fanconi anemia 29 trials · 42 incl. sub-types Sub-types →
- Diamond-Blackfan anemia 17 trials Sub-types →
- WT limb-blood syndrome 0 trials
- Autosomal dominant aplasia and myelodysplasia 0 trials
- Pancytopenia-developmental delay syndrome 0 trials
-
Hereditary glaucoma 0 trials · 50 incl. sub-types
12 sub-types
- Exfoliation syndrome 32 trials
- Juvenile open angle glaucoma 7 trials · 15 incl. sub-types Sub-types →
- Congenital glaucoma 7 trials · 8 incl. sub-types Sub-types →
- Anterior segment dysgenesis 3 1 trial
- Iris hypoplasia with glaucoma 1 trial
- OPTN-related open angle glaucoma 0 trials
- TEK-related primary glaucoma 0 trials Sub-types →
- Glaucoma 1, open angle, O 0 trials
- Glaucoma 1, open angle, P 0 trials
- Glaucoma secondary to spherophakia/ectopia lentis and megalocornea 0 trials
- Glaucoma with elevated episcleral venous pressure 0 trials
- Hereditary glaucoma, primary closed-angle 0 trials
-
Ciliopathy 2 trials · 49 incl. sub-types
36 sub-types
- Primary ciliary dyskinesia 34 trials Sub-types →
- Bardet-Biedl syndrome 6 trials · 7 incl. sub-types Sub-types →
- Nephronophthisis 1 4 trials
- CEP290-related ciliopathy 0 trials · 2 incl. sub-types Sub-types →
- Jeune syndrome 1 trial · 2 incl. sub-types Sub-types →
- Joubert syndrome 2 trials Sub-types →
- KIF7-related ciliopathy 0 trials · 2 incl. sub-types Sub-types →
- Senior-Loken syndrome 1 trial · 2 incl. sub-types Sub-types →
- Retinal ciliopathy 0 trials · 2 incl. sub-types Sub-types →
- Alstrom syndrome 1 trial
- BBS1-related ciliopathy 0 trials · 1 incl. sub-types Sub-types →
- MKS1-related ciliopathy 0 trials · 1 incl. sub-types Sub-types →
- Meckel syndrome 0 trials · 1 incl. sub-types Sub-types →
- OFD1-related ciliopathy 0 trials · 1 incl. sub-types Sub-types →
- ARL6-related ciliopathy 0 trials Sub-types →
- Alsahan-Harris syndrome 0 trials
- BBS10-related ciliopathy 0 trials Sub-types →
- BBS12-related ciliopathy 0 trials Sub-types →
- BBS2-related ciliopathy 0 trials Sub-types →
- BBS4-related ciliopathy 0 trials Sub-types →
- BBS5-related ciliopathy 0 trials Sub-types →
- BBS7-related ciliopathy 0 trials Sub-types →
- BBS9-related ciliopathy 0 trials Sub-types →
- CEP164-related ciliopathy 0 trials Sub-types →
- CFAP418-related ciliopathy 0 trials Sub-types →
- IFT140-related recessive ciliopathy 0 trials Sub-types →
- INTU-related skeletal ciliopathy 0 trials Sub-types →
- LZTFL1-related ciliopathy 0 trials Sub-types →
- MKKS-related ciliopathy 0 trials Sub-types →
- Marden-Walker syndrome 0 trials
- SDCCAG8-related ciliopathy 0 trials Sub-types →
- TTC8-related ciliopathy 0 trials Sub-types →
- TUBB4B-related ciliopathy 0 trials Sub-types →
- WDPCP-related ciliopathy 0 trials Sub-types →
- Ciliopathy-IFT74 0 trials Sub-types →
- Oculocerebrodental syndrome 0 trials
-
Bone marrow failure syndrome 48 trials
8 sub-types
- AMED syndrome, digenic 0 trials
- Ziegler-Huang syndrome 0 trials
- Autosomal dominant aplasia and myelodysplasia 0 trials
- Bone marrow failure syndrome 3 0 trials
- Bone marrow failure syndrome 4 0 trials
- Bone marrow failure syndrome 5 0 trials
- Bone marrow failure syndrome 6 0 trials
- Pancytopenia-developmental delay syndrome 0 trials
-
Inherited primary ovarian failure 2 trials · 48 incl. sub-types
41 sub-types
- Turner syndrome 29 trials Sub-types →
- Ataxia telangiectasia 11 trials Sub-types →
- Classic galactosemia 3 trials
- Trisomy X 3 trials
- 46 XX gonadal dysgenesis 1 trial Sub-types →
- Congenital lipoid adrenal hyperplasia due to STAR deficency 1 trial Sub-types →
- Premature ovarian failure 1 1 trial Sub-types →
- 46,XX ovarian dysgenesis-short stature syndrome 0 trials
- Perrault syndrome 0 trials Sub-types →
- Satoyoshi syndrome 0 trials
- X small rings 0 trials
- Aromatase deficiency 0 trials
- Blepharophimosis, ptosis, and epicanthus inversus syndrome 0 trials Sub-types →
- Osteosclerosis-ichthyosis-premature ovarian failure syndrome 0 trials
- Premature ovarian failure 10 0 trials
- Premature ovarian failure 11 0 trials
- Premature ovarian failure 12 0 trials
- Premature ovarian failure 13 0 trials
- Premature ovarian failure 14 0 trials
- Premature ovarian failure 15 0 trials
- Premature ovarian failure 16 0 trials
- Premature ovarian failure 17 0 trials
- Premature ovarian failure 18 0 trials
- Premature ovarian failure 19 0 trials
- Premature ovarian failure 20 0 trials
- Premature ovarian failure 21 0 trials
- Premature ovarian failure 22 0 trials
- Premature ovarian failure 23 0 trials
- Premature ovarian failure 24 0 trials
- Premature ovarian failure 25 0 trials
- Premature ovarian failure 26 0 trials
- Premature ovarian failure 2A 0 trials
- Premature ovarian failure 2B 0 trials
- Premature ovarian failure 3 0 trials
- Premature ovarian failure 4 0 trials
- Premature ovarian failure 5 0 trials
- Premature ovarian failure 6 0 trials
- Premature ovarian failure 7 0 trials
- Premature ovarian failure 8 0 trials
- Premature ovarian failure 9 0 trials
- Tetrasomy X 0 trials
-
Ehlers-Danlos syndrome 20 trials · 46 incl. sub-types
25 sub-types
- Ehlers-Danlos syndrome, hypermobility type 15 trials
- Joint laxity, familial 14 trials
- Ehlers-Danlos syndrome, vascular type 6 trials Sub-types →
- Bethlem myopathy 2 0 trials
- COL1A1-related Ehlers-Danlos syndrome 0 trials Sub-types →
- COL1A2-related Ehlers-Danlos syndrome 0 trials Sub-types →
- Ehlers-Danlos syndrome due to tenascin-X deficiency 0 trials
- Ehlers-Danlos syndrome, Beasley-Cohen type 0 trials
- Ehlers-Danlos syndrome, arthrochalasia type 0 trials Sub-types →
- Ehlers-Danlos syndrome, autosomal dominant, type unspecified 0 trials
- Ehlers-Danlos syndrome, classic type 0 trials Sub-types →
- Ehlers-Danlos syndrome, classic-like, 2 0 trials
- Ehlers-Danlos syndrome, classic-like, 3 0 trials
- Ehlers-Danlos syndrome, dermatosparaxis type 0 trials
- Ehlers-Danlos syndrome, fibronectinemic type 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type 1 0 trials
- Ehlers-Danlos syndrome, kyphoscoliotic type, 2 0 trials
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- Ehlers-Danlos syndrome, periodontitis type 0 trials Sub-types →
- Ehlers-Danlos syndrome, spondylodysplastic type 0 trials Sub-types →
- Ehlers-Danlos syndrome, vascular-like type 0 trials
- Ehlers-Danlos/osteogenesis imperfecta syndrome 0 trials Sub-types →
- X-linked Ehlers-Danlos syndrome 0 trials
- Brittle cornea syndrome 0 trials Sub-types →
- Spondylodysplastic Ehlers-Danlos syndrome 0 trials
-
Craniosynostosis 17 trials · 39 incl. sub-types
29 sub-types
- Syndromic craniosynostosis 1 trial · 22 incl. sub-types Sub-types →
- Isolated craniosynostosis 1 trial · 3 incl. sub-types Sub-types →
- Craniosynostosis syndrome, autosomal recessive 0 trials · 2 incl. sub-types Sub-types →
- Hordnes Engebretsen Knudtson syndrome 0 trials
- Iida Kannari syndrome 0 trials
- Craniosynostosis Fontaine type 0 trials
- Craniosynostosis Maroteaux Fonfria type 0 trials
- Craniosynostosis alopecia brain defect 0 trials
- Craniosynostosis arthrogryposis cleft palate 0 trials
- Craniosynostosis autosomal dominant 0 trials
- Craniosynostosis cleft lip palate arthrogryposis 0 trials
- Craniosynostosis contractures cleft 0 trials
- Craniosynostosis exostoses nevus epibulbar dermoid 0 trials
- Craniosynostosis intellectual disability heart defects 0 trials
- Craniosynostosis with ectopia lentis 0 trials
- Craniosynostosis with ocular abnormalities and hallucal defects 0 trials
- Craniosynostosis, Adelaide type 0 trials
- Mehta lewis patton syndrome 0 trials
- Non-syndromic bicoronal and metopic craniosynostosis 0 trials
- Non-syndromic bicoronal and sagittal craniosynostosis 0 trials
- Non-syndromic bilambdoid craniosynostosis 0 trials
- Non-syndromic metopic and sagittal craniosynostosis 0 trials
- Non-syndromic multisutural craniosynostosis 0 trials
- Non-syndromic non-specific multisutural craniosynostosis 0 trials
- Non-syndromic unicoronal and sagittal craniosynostosis 0 trials
- Non-syndromic unicoronal craniosynostosis 0 trials
- Non-syndromic unifrontosphenoidal craniosynostosis 0 trials
- Non-syndromic unilambdoid craniosynostosis 0 trials
- Non-syndromic unisquamosal craniosynostosis 0 trials
-
Chronic granulomatous disease 37 trials
7 sub-types
- Granulomatous disease, chronic, X-linked 10 trials
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1 3 trials
- Granulomatous disease with defect in neutrophil chemotaxis 0 trials
- Granulomatous disease, chronic, autosomal recessive, 5 0 trials
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative 0 trials
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 0 trials
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 0 trials
-
Hypospadias 35 trials
5 sub-types
- Hypospadias 1, X-linked 0 trials
- Hypospadias 2, X-linked 0 trials
- Hypospadias 3, autosomal 0 trials
- Hypospadias 4, X-linked 0 trials
- Isolated female hypospadias 0 trials
-
Hereditary hyperparathyroidism 1 trial · 35 incl. sub-types
2 sub-types
- Familial primary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Hyperparathyroidism, transient neonatal 0 trials
-
Fragile X syndrome 34 trials
4 sub-types
- Fragile X syndrome type 1 0 trials
- Fragile X syndrome type 2 0 trials
- Fragile X syndrome type 3 0 trials
- Symptomatic form of fragile X syndrome in female carrier 0 trials
-
Fuchs' endothelial dystrophy 33 trials
8 sub-types
- Corneal dystrophy, Fuchs endothelial, 1 1 trial
- Corneal dystrophy, Fuchs endothelial, 3 0 trials
- Corneal dystrophy, Fuchs endothelial, 4 0 trials
- Corneal dystrophy, Fuchs endothelial, 6 0 trials
- Corneal dystrophy, Fuchs endothelial, 8 0 trials
- Corneal dystrophy, fuchs endothelial, 2 0 trials
- Corneal dystrophy, fuchs endothelial, 5 0 trials
- Corneal dystrophy, fuchs endothelial, 7 0 trials
-
Pilonidal sinus 33 trials
-
Spondylosis, cervical 33 trials
-
Arteriovenous malformations of the brain 32 trials
-
MALT lymphoma 30 trials · 31 incl. sub-types
5 sub-types
-
Deafness, unilateral 30 trials
-
Hirschsprung disease 29 trials
-
Inherited thrombocytopenia 2 trials · 29 incl. sub-types
21 sub-types
- Thrombocytopenia 1 9 trials
- Syndromic constitutional thrombocytopenia 0 trials · 8 incl. sub-types Sub-types →
- Congenital amegakaryocytic thrombocytopenia 4 trials · 6 incl. sub-types Sub-types →
- Congenital thrombotic thrombocytopenic purpura 5 trials
- Alpha granule disease 0 trials Sub-types →
- Autosomal dominant macrothrombocytopenia 0 trials Sub-types →
- Congenital autosomal recessive small-platelet thrombocytopenia 0 trials
- Isolated delta-storage pool disease 0 trials
- Macrothrombocytopenia, isolated 0 trials Sub-types →
- Thrombocytopenia 10 0 trials
- Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies 0 trials
- Thrombocytopenia 12 with or without myopathy 0 trials
- Thrombocytopenia 13, syndromic 0 trials
- Thrombocytopenia 2 0 trials
- Thrombocytopenia 3 0 trials
- Thrombocytopenia 4 0 trials
- Thrombocytopenia 5 0 trials
- Thrombocytopenia 7 0 trials
- Thrombocytopenia 9 0 trials
- Thrombocytopenia, X-linked, with or without dyserythropoietic anemia 0 trials Sub-types →
- Thrombocytopenia, cyclic 0 trials
-
Pathological gambling 28 trials
-
Familial hemolytic anemia 4 trials · 27 incl. sub-types
23 sub-types
- Congenital nonspherocytic hemolytic anemia 1 trial · 12 incl. sub-types Sub-types →
- Congenital dyserythropoietic anemia 4 trials · 5 incl. sub-types Sub-types →
- Abetalipoproteinemia 2 trials
- Cutaneous porphyria 2 trials
- Hereditary spherocytosis 2 trials Sub-types →
- Southeast Asian ovalocytosis 2 trials
- Glycogen storage disease VII 1 trial
- Glycogen storage disease due to aldolase A deficiency 1 trial
- Rh deficiency syndrome 0 trials
- X-linked congenital hemolytic anemia 0 trials
- Cryohydrocytosis 0 trials
- Dehydrated hereditary stomatocytosis 2 0 trials
- Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema 0 trials
- Elliptocytosis 1 0 trials
- Elliptocytosis 2 0 trials
- Familial pseudohyperkalemia 0 trials
- Hemolytic anemia due to diphosphoglycerate mutase deficiency 0 trials
- Hemolytic disease of fetus and newborn, RH-induced 0 trials
- Hereditary cryohydrocytosis with reduced stomatin 0 trials
- Overhydrated hereditary stomatocytosis 0 trials
- Primary CD59 deficiency 0 trials
- Renal tubular acidosis, distal, 4, with hemolytic anemia 0 trials
- Triosephosphate isomerase deficiency 0 trials
-
Syncope, familial vasovagal 26 trials
-
Inherited bleeding disorder, platelet-type 6 trials · 26 incl. sub-types
28 sub-types
- Glanzmann thrombasthenia 8 trials Sub-types →
- Platelet-type bleeding disorder 10 8 trials
- Congenital thrombotic thrombocytopenic purpura 5 trials
- Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss 1 trial
- Bernard-Soulier syndrome 0 trials Sub-types →
- Ehlers-Danlos syndrome, fibronectinemic type 0 trials
- Quebec platelet disorder 0 trials
- Scott syndrome 0 trials
- Bleeding diathesis due to thromboxane synthesis deficiency 0 trials
- Bleeding disorder, platelet-type, 21 0 trials
- Bleeding disorder, platelet-type, 22 0 trials
- Bleeding disorder, platelet-type, 24 0 trials
- Bleeding disorder, platelet-type, 25 0 trials
- Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder 0 trials
- Gray platelet syndrome 0 trials
- Platelet-type bleeding disorder 11 0 trials
- Platelet-type bleeding disorder 12 0 trials
- Platelet-type bleeding disorder 14 0 trials
- Platelet-type bleeding disorder 15 0 trials
- Platelet-type bleeding disorder 16 0 trials
- Platelet-type bleeding disorder 17 0 trials
- Platelet-type bleeding disorder 18 0 trials
- Platelet-type bleeding disorder 19 0 trials
- Platelet-type bleeding disorder 20 0 trials
- Platelet-type bleeding disorder 8 0 trials
- Platelet-type bleeding disorder 9 0 trials
- Platelet-type von Willebrand disease 0 trials
- Primary release disorder of platelets 0 trials
-
Laminopathy 4 trials · 26 incl. sub-types
14 sub-types
- Familial partial lipodystrophy 13 trials · 14 incl. sub-types Sub-types →
- Hutchinson-Gilford progeria syndrome 3 trials
- Adult-onset autosomal dominant demyelinating leukodystrophy 3 trials Sub-types →
- Autosomal dominant Emery-Dreifuss muscular dystrophy 0 trials · 3 incl. sub-types Sub-types →
- Greenberg dysplasia 2 trials
- Charcot-Marie-Tooth disease type 2B1 1 trial
- X-linked Emery-Dreifuss muscular dystrophy 1 trial Sub-types →
- Buschke-Ollendorff syndrome 0 trials
- Emery-Dreifuss muscular dystrophy 3, autosomal recessive 0 trials
- Pelger-Huet anomaly 0 trials
- Atypical Werner syndrome 0 trials
- Mandibuloacral dysplasia with type A lipodystrophy 0 trials
- Mandibuloacral dysplasia with type B lipodystrophy 0 trials
- Restrictive dermopathy 1 0 trials
-
Hereditary hypoparathyroidism 0 trials · 26 incl. sub-types
3 sub-types
- Familial hypoparathyroidism 0 trials · 10 incl. sub-types Sub-types →
- Pseudohypoparathyroidism 8 trials · 9 incl. sub-types Sub-types →
- Autoimmune polyendocrine syndrome type 1 8 trials
-
Hypogonadism, male 24 trials
-
Trigger thumb 23 trials
-
Speech-sound disorder 22 trials
-
Tooth agenesis 22 trials
12 sub-types
- Hypodontia/oligodontia with orofacial cleft 0 trials
- Tooth agenesis, selective, 1 0 trials
- Tooth agenesis, selective, 10 0 trials
- Tooth agenesis, selective, 2 0 trials
- Tooth agenesis, selective, 3 0 trials
- Tooth agenesis, selective, 4 0 trials
- Tooth agenesis, selective, 5 0 trials
- Tooth agenesis, selective, 7 0 trials
- Tooth agenesis, selective, 8 0 trials
- Tooth agenesis, selective, 9 0 trials
- Tooth agenesis, selective, X-linked, 1 0 trials
- Tooth agenesis, selective, with orofacial cleft 0 trials
-
Anterior segment dysgenesis 2 trials · 21 incl. sub-types
8 sub-types
- Congenital primary aphakia 17 trials
- Iridogoniodysgenesis 0 trials · 2 incl. sub-types Sub-types →
- Peters anomaly 1 trial Sub-types →
- Anterior segment dysgenesis 1 1 trial
- Anterior segment dysgenesis 6 1 trial
- Anterior segment dysgenesis 7 0 trials
- Anterior segment dysgenesis 8 0 trials
- Isolated iridoschisis 0 trials
-
Alveolar soft part sarcoma 20 trials
2 sub-types
- Cervical alveolar soft part sarcoma 0 trials
- Vulvar alveolar soft part sarcoma 0 trials
-
Pectus excavatum 20 trials
-
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 16 trials · 19 incl. sub-types
3 sub-types
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 19 trials
- Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 0 trials Sub-types →
- Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1 0 trials
-
Hereditary hypophosphatemic rickets 1 trial · 18 incl. sub-types
4 sub-types
- X-linked hypophosphatemic rickets 11 trials · 12 incl. sub-types Sub-types →
- Autosomal recessive hypophosphatemic rickets 5 trials · 6 incl. sub-types Sub-types →
- Hereditary hypophosphatemic rickets with hypercalciuria 1 trial
- Autosomal dominant hypophosphatemic rickets 0 trials
-
Familial clubfoot with or without associated lower limb anomalies 0 trials · 18 incl. sub-types
2 sub-types
- Clubfoot 18 trials Sub-types →
- Familial clubfoot due to 17q23.1q23.2 microduplication 0 trials
-
Hereditary hemophagocytic lymphohistiocytosis 8 trials · 16 incl. sub-types
11 sub-types
- Chediak-Higashi syndrome 9 trials
- Griscelli syndrome type 2 1 trial
- Familial hemophagocytic lymphohistiocytosis 3 1 trial
- Hermansky-Pudlak syndrome 2 0 trials
- Hermansky-Pudlak syndrome 9 0 trials
- Familial hemophagocytic lymphohistiocytosis 2 0 trials
- Familial hemophagocytic lymphohistiocytosis 4 0 trials
- Familial hemophagocytic lymphohistiocytosis 5 0 trials
- Familial hemophagocytic lymphohistiocytosis type 1 0 trials
- Hemophagocytic lymphohistiocytosis due to RhoG deficiency 0 trials
- Hemophagocytic lymphohistiocytosis, familial, 6 0 trials
-
Familial osteosclerosis 0 trials · 16 incl. sub-types
3 sub-types
- Osteopetrosis 6 trials · 14 incl. sub-types Sub-types →
- Craniometaphyseal dysplasia 1 trial · 2 incl. sub-types Sub-types →
- Axial osteomalacia 0 trials
-
Familial nonmedullary thyroid carcinoma 3 trials · 15 incl. sub-types
3 sub-types
- Familial papillary or follicular thyroid carcinoma 1 trial · 13 incl. sub-types Sub-types →
- Thyroid cancer, nonmedullary, 1 1 trial
- Familial papillary thyroid carcinoma with renal papillary neoplasia 0 trials
-
Arts syndrome 14 trials
-
Klippel-Feil syndrome 14 trials
6 sub-types
- Calabro syndrome 0 trials
- Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome 0 trials
- Klippel-Feil syndrome 1, autosomal dominant 0 trials
- Klippel-Feil syndrome 2, autosomal recessive 0 trials
- Klippel-Feil syndrome 3, autosomal dominant 0 trials
- Wildervanck syndrome 0 trials
-
Cryptorchidism 14 trials
1 sub-type
- Arroyo Garcia Cimadevilla syndrome 0 trials
-
Essential hypertension, genetic 14 trials
-
Periodontitis, chronic, adult 14 trials
-
Pregnancy loss, recurrent, 4 14 trials
-
Visceral leishmaniasis 14 trials
-
Chiari malformation 13 trials · 14 incl. sub-types
4 sub-types
- Chiari malformation type I 9 trials
- Chiari malformation type II 2 trials
- Chiari malformation type 3 0 trials
- Chiari malformation type 4 0 trials
-
Aorta coarctation 13 trials
2 sub-types
- Atypical coarctation of aorta 0 trials
- Autosomal dominant coarctation of aorta 0 trials
-
Familial spontaneous pneumothorax 13 trials
-
Hereditary anemia 2 trials · 13 incl. sub-types
14 sub-types
- Vitamin B12- and folate-independent constitutional megaloblastic anemia 0 trials · 7 incl. sub-types Sub-types →
- Methylmalonic aciduria and homocystinuria 1 trial · 3 incl. sub-types Sub-types →
- Homocystinuria without methylmalonic aciduria 0 trials · 2 incl. sub-types Sub-types →
- Atransferrinemia 1 trial
- Hereditary intrinsic factor deficiency 1 trial Sub-types →
- Transcobalamin II deficiency 1 trial
- IRIDA syndrome 0 trials
- Imerslund-Grasbeck syndrome 0 trials Sub-types →
- Aceruloplasminemia 0 trials
- Constitutional megaloblastic anemia with severe neurologic disease 0 trials
- Formiminoglutamic aciduria 0 trials
- Hereditary folate malabsorption 0 trials
- Microcytic anemia with liver iron overload 0 trials
- Severe congenital hypochromic anemia with ringed sideroblasts 0 trials
-
Ovarian hyperstimulation syndrome 12 trials
-
Pleomorphic adenoma 12 trials
-
Familial thoracic aortic aneurysm and aortic dissection 11 trials · 12 incl. sub-types
9 sub-types
- Aortic aneurysm, familial thoracic 1 1 trial
- Aortic aneurysm, familial thoracic 9 1 trial
- Aortic aneurysm, familial thoracic 10 0 trials
- Aortic aneurysm, familial thoracic 12 0 trials
- Aortic aneurysm, familial thoracic 2 0 trials
- Aortic aneurysm, familial thoracic 4 0 trials
- Aortic aneurysm, familial thoracic 6 0 trials
- Aortic aneurysm, familial thoracic 7 0 trials
- Aortic aneurysm, familial thoracic 8 0 trials
-
Spermatogenic failure 1 trial · 12 incl. sub-types
113 sub-types
- Spermatogenic failure 3 9 trials
- Spermatogenic failure, Y-linked, 2 5 trials
- Spermatogenic failure 34 1 trial
- Spermatogenic failure 6 1 trial
- X-linked spermatogenic failure 1 0 trials
- Spermatogenic failure 1 0 trials
- Spermatogenic failure 10 0 trials
- Spermatogenic failure 100 0 trials
- Spermatogenic failure 101 0 trials
- Spermatogenic failure 102 0 trials
- Spermatogenic failure 11 0 trials
- Spermatogenic failure 12 0 trials
- Spermatogenic failure 13 0 trials
- Spermatogenic failure 14 0 trials
- Spermatogenic failure 15 0 trials
- Spermatogenic failure 16 0 trials
- Spermatogenic failure 17 0 trials
- Spermatogenic failure 18 0 trials
- Spermatogenic failure 19 0 trials
- Spermatogenic failure 2 0 trials
- Spermatogenic failure 20 0 trials
- Spermatogenic failure 21 0 trials
- Spermatogenic failure 22 0 trials
- Spermatogenic failure 23 0 trials
- Spermatogenic failure 24 0 trials
- Spermatogenic failure 25 0 trials
- Spermatogenic failure 26 0 trials
- Spermatogenic failure 27 0 trials
- Spermatogenic failure 28 0 trials
- Spermatogenic failure 29 0 trials
- Spermatogenic failure 30 0 trials
- Spermatogenic failure 31 0 trials
- Spermatogenic failure 32 0 trials
- Spermatogenic failure 33 0 trials
- Spermatogenic failure 35 0 trials
- Spermatogenic failure 36 0 trials
- Spermatogenic failure 37 0 trials
- Spermatogenic failure 38 0 trials
- Spermatogenic failure 39 0 trials
- Spermatogenic failure 4 0 trials
- Spermatogenic failure 40 0 trials
- Spermatogenic failure 41 0 trials
- Spermatogenic failure 42 0 trials
- Spermatogenic failure 43 0 trials
- Spermatogenic failure 44 0 trials
- Spermatogenic failure 45 0 trials
- Spermatogenic failure 46 0 trials
- Spermatogenic failure 47 0 trials
- Spermatogenic failure 48 0 trials
- Spermatogenic failure 49 0 trials
- Spermatogenic failure 5 0 trials
- Spermatogenic failure 50 0 trials
- Spermatogenic failure 51 0 trials
- Spermatogenic failure 52 0 trials
- Spermatogenic failure 53 0 trials
- Spermatogenic failure 54 0 trials
- Spermatogenic failure 55 0 trials
- Spermatogenic failure 56 0 trials
- Spermatogenic failure 57 0 trials
- Spermatogenic failure 58 0 trials
- Spermatogenic failure 59 0 trials
- Spermatogenic failure 60 0 trials
- Spermatogenic failure 61 0 trials
- Spermatogenic failure 62 0 trials
- Spermatogenic failure 63 0 trials
- Spermatogenic failure 64 0 trials
- Spermatogenic failure 65 0 trials
- Spermatogenic failure 66 0 trials
- Spermatogenic failure 67 0 trials
- Spermatogenic failure 68 0 trials
- Spermatogenic failure 69 0 trials
- Spermatogenic failure 7 0 trials
- Spermatogenic failure 70 0 trials
- Spermatogenic failure 71 0 trials
- Spermatogenic failure 72 0 trials
- Spermatogenic failure 73 0 trials
- Spermatogenic failure 74 0 trials
- Spermatogenic failure 75 0 trials
- Spermatogenic failure 76 0 trials
- Spermatogenic failure 77 0 trials
- Spermatogenic failure 78 0 trials
- Spermatogenic failure 79 0 trials
- Spermatogenic failure 8 0 trials
- Spermatogenic failure 80 0 trials
- Spermatogenic failure 81 0 trials
- Spermatogenic failure 82 0 trials
- Spermatogenic failure 83 0 trials
- Spermatogenic failure 84 0 trials
- Spermatogenic failure 85 0 trials
- Spermatogenic failure 86 0 trials
- Spermatogenic failure 87 0 trials
- Spermatogenic failure 88 0 trials
- Spermatogenic failure 89 0 trials
- Spermatogenic failure 9 0 trials
- Spermatogenic failure 90 0 trials
- Spermatogenic failure 91 0 trials
- Spermatogenic failure 92 0 trials
- Spermatogenic failure 93 0 trials
- Spermatogenic failure 94 0 trials
- Spermatogenic failure 95 0 trials
- Spermatogenic failure 96 0 trials
- Spermatogenic failure 97 0 trials
- Spermatogenic failure 98 0 trials
- Spermatogenic failure 99 0 trials
- Spermatogenic failure, X-linked, 2 0 trials
- Spermatogenic failure, X-linked, 3 0 trials
- Spermatogenic failure, X-linked, 4 0 trials
- Spermatogenic failure, X-linked, 5 0 trials
- Spermatogenic failure, X-linked, 6 0 trials
- Spermatogenic failure, X-linked, 7 0 trials
- Spermatogenic failure, X-linked, 8 0 trials
- Spermatogenic failure, X-linked, 9 0 trials
- Spermatogenic failure, Y-linked, 1 0 trials
-
SMAD6-related disease 0 trials · 12 incl. sub-types
3 sub-types
- Aortic valve disease 2 12 trials
- Craniosynostosis 7 0 trials
- Radioulnar synostosis, nonsyndromic, susceptibility to 0 trials
-
CGF1 11 trials
-
Ankyloglossia 11 trials
-
Parasomnia, sleep bruxism type 11 trials
-
Tardive dyskinesia 11 trials
-
Thyroid Hurthle cell carcinoma 11 trials
-
Trichotillomania 11 trials
-
Heritable pulmonary arterial hypertension 10 trials · 11 incl. sub-types
7 sub-types
- Pulmonary hypertension, primary, 2 1 trial
- Pulmonary hypertension, primary, 3 1 trial
- Pulmonary hypertension, primary, 4 1 trial
- Pulmonary hypertension, primary, 1 0 trials
- Pulmonary hypertension, primary, 5 0 trials
- Pulmonary hypertension, primary, 6 0 trials
- Pulmonary hypertension, primary, 7 0 trials
-
CDKL5 disorder 8 trials · 11 incl. sub-types
1 sub-type
-
Inherited interstitial lung disease 5 trials · 11 incl. sub-types
13 sub-types
- Interstitial lung disease 2 2 trials
- Hermansky-Pudlak syndrome with pulmonary fibrosis 0 trials · 1 incl. sub-types Sub-types →
- Niemann-Pick disease type B 1 trial
- Rajab interstitial lung disease with brain calcifications 0 trials · 1 incl. sub-types Sub-types →
- Familial hypocalciuric hypercalcemia 0 trials · 1 incl. sub-types Sub-types →
- Pulmonary fibrosis and/or bone marrow failure, telomere-related 1 trial Sub-types →
- Lane Hamilton syndrome 0 trials
- SFTPC-related interstitial lung disease 0 trials
- Alveolar capillary dysplasia with misalignment of pulmonary veins 0 trials
- Hypersensitivity pneumonitis, familial 0 trials
- Interstitial lung disease 1 0 trials
- Interstitial lung disease due to ABCA3 deficiency 0 trials
- Lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome 0 trials
-
Progeroid syndrome 3 trials · 11 incl. sub-types
16 sub-types
- Cockayne syndrome 6 trials Sub-types →
- Hutchinson-Gilford progeria syndrome 3 trials
- Werner syndrome 2 trials
- Fischer-Zirnsak progeroid syndrome 0 trials
- Fontaine progeroid syndrome 0 trials
- Garg-Mishra progeroid syndrome 0 trials
- Marbach-Rustad progeroid syndrome 0 trials
- Nestor-Guillermo progeria syndrome 0 trials
- RECON progeroid syndrome 0 trials
- Wiedemann-Rautenstrauch syndrome 0 trials
- XFE progeroid syndrome 0 trials
- Achalasia-progeroid syndrome 0 trials
- Mandibular hypoplasia-deafness-progeroid syndrome 0 trials
- Mandibuloacral dysplasia progeroid syndrome 0 trials
- Progeroid and marfanoid aspect-lipodystrophy syndrome 0 trials
- Progeroid facial appearance with hand anomalies 0 trials
-
Familial long QT syndrome 1 trial · 11 incl. sub-types
19 sub-types
- Long QT syndrome 3 6 trials
- Long QT syndrome 2 3 trials
- Jervell and Lange-Nielsen syndrome 2 trials Sub-types →
- Timothy syndrome 1 trial Sub-types →
- Long QT syndrome 1 1 trial
- Long QT syndrome 5 0 trials · 1 incl. sub-types Sub-types →
- Andersen-Tawil syndrome 0 trials
- Cardiac arrhythmia, ankyrin-B-related 0 trials
- Long QT syndrome 10 0 trials
- Long QT syndrome 11 0 trials
- Long QT syndrome 12 0 trials
- Long QT syndrome 13 0 trials
- Long QT syndrome 14 0 trials
- Long QT syndrome 15 0 trials
- Long QT syndrome 16 0 trials
- Long QT syndrome 4 0 trials
- Long QT syndrome 6 0 trials
- Long QT syndrome 8 0 trials
- Long QT syndrome 9 0 trials
-
Syndromic microphthalmia 0 trials · 11 incl. sub-types
19 sub-types
- Matthew-Wood syndrome 5 trials
- Anophthalmia/microphthalmia-esophageal atresia syndrome 4 trials
- COFS syndrome 1 trial Sub-types →
- MMEP syndrome 1 trial
- Behrens Baumann dust syndrome 0 trials
- RAB18 deficiency 0 trials Sub-types →
- X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome 0 trials
- Colobomatous microphthalmia-rhizomelic dysplasia syndrome 0 trials
- Linear skin defects with multiple congenital anomalies 0 trials Sub-types →
- Microphthalmia microtia fetal akinesia 0 trials
- Microphthalmia with brain and digit anomalies 0 trials
- Microphthalmia, Lenz type 0 trials
- Microphthalmia, syndromic 1 0 trials
- Microphthalmia, syndromic 11 0 trials
- Microphthalmia, syndromic 12 0 trials
- Microphthalmia, syndromic 2 0 trials
- Microphthalmia-brain atrophy syndrome 0 trials
- Oculoauricular syndrome 0 trials
- Syndromic microphthalmia type 5 0 trials
-
Phelan-McDermid syndrome 10 trials
2 sub-types
-
Raynaud disease 10 trials
-
Arthritis, sacroiliac 10 trials
-
Bile duct cyst 10 trials
-
Fibrodysplasia ossificans progressiva 10 trials
-
Hereditary breast carcinoma 10 trials
1 sub-type
-
Multinodular goiter 10 trials
3 sub-types
- Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors 1 trial
- Goiter, multinodular 2 0 trials
- Goiter, multinodular 3 0 trials
-
Myostatin-related muscle hypertrophy 10 trials
-
Central precocious puberty 9 trials · 10 incl. sub-types
7 sub-types
- Idiopathic central precocious puberty 1 trial
- Central precocious puberty 1 0 trials
- Central precocious puberty in male 0 trials Sub-types →
- Genetic central precocious puberty in female 0 trials
- Precocious puberty, central, 2 0 trials
- Secondary central precocious puberty 0 trials
- Secondary central precocious puberty in female 0 trials
-
Erythromelalgia 3 trials · 10 incl. sub-types
2 sub-types
- Primary erythermalgia 8 trials
- Secondary erythromelalgia 0 trials
-
IgE responsiveness, atopic 9 trials
-
Familial pancreatic carcinoma 9 trials
-
Immunodeficiency 32B 9 trials
-
Impacted teeth, multiple 9 trials
-
Neuropathy, painful 9 trials
-
Obesity-hypoventilation syndrome 9 trials
-
Inherited obesity 8 trials · 9 incl. sub-types
7 sub-types
- Obesity due to pro-opiomelanocortin deficiency 2 trials
- Obesity due to congenital leptin deficiency 1 trial
- Obesity due to leptin receptor gene deficiency 1 trial
- Obesity due to prohormone convertase I deficiency 1 trial
- Obesity due to CEP19 deficiency 0 trials
- Obesity due to SIM1 deficiency 0 trials
- Obesity due to melanocortin 4 receptor deficiency 0 trials
-
Syndactyly 3 trials · 9 incl. sub-types
2 sub-types
- Polydactyly-syndactyly-triphalangism 0 trials · 6 incl. sub-types Sub-types →
- Non-syndromic syndactyly 0 trials Sub-types →
-
Polydactyly 2 trials · 9 incl. sub-types
2 sub-types
- Polydactyly-syndactyly-triphalangism 0 trials · 6 incl. sub-types Sub-types →
- Non-syndromic polydactyly 0 trials · 1 incl. sub-types Sub-types →
-
Hyperhidrosis palmaris ET plantaris 8 trials
-
Masticatory muscles, hypertrophy of 8 trials
-
Van der Woude syndrome 8 trials
2 sub-types
- Van der Woude syndrome 1 0 trials
- Van der Woude syndrome 2 0 trials
-
Severe congenital neutropenia 5 trials · 8 incl. sub-types
8 sub-types
- Autosomal recessive severe congenital neutropenia 0 trials · 3 incl. sub-types Sub-types →
- Neutropenia, severe congenital, 8, autosomal dominant 1 trial
- X-linked severe congenital neutropenia 0 trials
- Autosomal dominant severe congenital neutropenia 0 trials Sub-types →
- Neutropenia, severe congenital, 10, autosomal recessive 0 trials
- Neutropenia, severe congenital, 11, autosomal dominant 0 trials
- Neutropenia, severe congenital, 12, autosomal recessive 0 trials
- Neutropenia, severe congenital, 9, autosomal dominant 0 trials
-
Spondylocostal dysostosis 5 trials · 8 incl. sub-types
4 sub-types
-
Familial ovarian cancer 1 trial · 8 incl. sub-types
2 sub-types
- Familial ovarian carcinoma 5 trials
- Hereditary site-specific ovarian cancer syndrome 2 trials
-
Silver-Russell syndrome 7 trials
11 sub-types
- Russell-silver syndrome, X-linked 0 trials
- Silver-Russell syndrome 1 0 trials
- Silver-Russell syndrome 3 0 trials
- Silver-Russell syndrome 5 0 trials
- Silver-Russell syndrome due to 11p15 microduplication 0 trials
- Silver-Russell syndrome due to 7p11.2p13 microduplication 0 trials
- Silver-Russell syndrome due to an imprinting defect of 11p15 0 trials
- Silver-Russell syndrome due to maternal uniparental disomy of chromosome 11 0 trials
- Silver-Russell syndrome due to maternal uniparental disomy of chromosome 7 0 trials
- Silver-russell syndrome 2 0 trials
- Silver-russell syndrome 4 0 trials
-
Arterial calcification of infancy 7 trials
2 sub-types
-
Extraskeletal myxoid chondrosarcoma 7 trials
1 sub-type
-
Protein-losing enteropathy 7 trials
-
Spermatic cord torsion 7 trials
-
Febrile seizures, familial 4 trials · 7 incl. sub-types
13 sub-types
- Generalized epilepsy with febrile seizures plus, type 2 3 trials
- Familial febrile seizures 9 0 trials
- Febrile seizures, familial, 1 0 trials
- Febrile seizures, familial, 10 0 trials
- Febrile seizures, familial, 11 0 trials
- Febrile seizures, familial, 2 0 trials
- Febrile seizures, familial, 3a 0 trials
- Febrile seizures, familial, 3b 0 trials
- Febrile seizures, familial, 4 0 trials
- Febrile seizures, familial, 5 0 trials
- Febrile seizures, familial, 6 0 trials
- Febrile seizures, familial, 7 0 trials
- Febrile seizures, familial, 8 0 trials
-
Amelogenesis imperfecta 3 trials · 7 incl. sub-types
7 sub-types
- Hypocalcified amelogenesis imperfecta 0 trials · 3 incl. sub-types Sub-types →
- Amelogenesis imperfecta type 1G 1 trial
- X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2 0 trials
- Amelogenesis imperfecta type 1 0 trials Sub-types →
- Amelogenesis imperfecta type 2 0 trials Sub-types →
- Amelogenesis imperfecta, IIa 1K 0 trials
- Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism 0 trials
-
Inherited sideroblastic anemia 2 trials · 7 incl. sub-types
8 sub-types
- Myopathy, lactic acidosis, and sideroblastic anemia 3 trials Sub-types →
- Autosomal recessive sideroblastic anemia 2 trials Sub-types →
- X-linked sideroblastic anemia 1 0 trials
- X-linked sideroblastic anemia with ataxia 0 trials
- Anemia, sideroblastic, 5 0 trials
- Autosomal dominant sideroblastic anemia 0 trials
- Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0 trials
- Severe congenital hypochromic anemia with ringed sideroblasts 0 trials
-
Angioosteohypertrophic syndrome 6 trials
-
Fibromuscular dysplasia 6 trials
5 sub-types
- Fibromuscular dysplasia of the arteries of the extremities 0 trials
- Fibromuscular dysplasia of the cervical and intracranial arteries 0 trials
- Fibromuscular dysplasia of the coronary arteries 0 trials
- Fibromuscular dysplasia of the renal arteries 0 trials
- Fibromuscular dysplasia of the visceral arteries 0 trials
-
Hereditary chronic pancreatitis 6 trials
2 sub-types
- Autosomal recessive hereditary chronic pancreatitis 0 trials
- Tropical pancreatitis 0 trials
-
Laryngeal adductor paralysis 6 trials
-
Sclerosteosis 6 trials
2 sub-types
- Sclerosteosis 1 0 trials
- Sclerosteosis 2 0 trials
-
Uterine anomalies 6 trials
-
Hypotrichosis 5 trials · 6 incl. sub-types
19 sub-types
- Hypotrichosis of eyelid 2 trials
- Basaran Yilmaz syndrome 0 trials
- Marie Unna hereditary hypotrichosis 0 trials Sub-types →
- Congenital hypotrichosis milia 0 trials
- Congenital hypotrichosis with juvenile macular dystrophy 0 trials
- Hypotrichosis 1 0 trials
- Hypotrichosis 10 0 trials
- Hypotrichosis 11 0 trials
- Hypotrichosis 12 0 trials
- Hypotrichosis 13 0 trials
- Hypotrichosis 14 0 trials
- Hypotrichosis 15 0 trials
- Hypotrichosis 16 0 trials
- Hypotrichosis 2 0 trials
- Hypotrichosis 3 0 trials
- Hypotrichosis 6 0 trials
- Hypotrichosis 7 0 trials
- Hypotrichosis 8 0 trials
- Hypotrichosis 9 0 trials
-
Periodontitis, aggressive 4 trials · 6 incl. sub-types
2 sub-types
- Periodontitis, aggressive 1 6 trials
- Periodontitis, aggressive, 2 0 trials
-
Hereditary pulmonary alveolar proteinosis 3 trials · 6 incl. sub-types
8 sub-types
- Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency 3 trials
- SFTPC-related interstitial lung disease 0 trials
- Chronic respiratory distress with surfactant metabolism deficiency 0 trials
- Interstitial lung disease due to ABCA3 deficiency 0 trials
- Surfactant metabolism dysfunction, pulmonary, 1 0 trials
- Surfactant metabolism dysfunction, pulmonary, 2 0 trials
- Surfactant metabolism dysfunction, pulmonary, 4 0 trials
- Surfactant metabolism dysfunction, pulmonary, 5 0 trials
-
DICER1-related tumor predisposition 1 trial · 6 incl. sub-types
2 sub-types
-
Hereditary gastric cancer 1 trial · 6 incl. sub-types
-
Leukoencephalopathy, hereditary diffuse, with spheroids 1 trial · 6 incl. sub-types
2 sub-types
-
CSF1R-related disorder 0 trials · 6 incl. sub-types
2 sub-types
-
Primary failure of tooth eruption 5 trials
-
Progesterone resistance 5 trials
-
Pulmonic stenosis 5 trials
-
Cornelia de Lange syndrome 4 trials · 5 incl. sub-types
6 sub-types
- Cornelia de Lange syndrome 1 1 trial
- Cornelia de Lange syndrome 2 0 trials
- Cornelia de Lange syndrome 3 0 trials
- Cornelia de Lange syndrome 4 0 trials
- Cornelia de Lange syndrome 5 0 trials
- Cornelia de Lange syndrome 6 0 trials
-
Hydatidiform mole 3 trials · 5 incl. sub-types
5 sub-types
- Complete hydatidiform mole 1 trial · 2 incl. sub-types Sub-types →
- Hydatidiform mole, recurrent, 3 0 trials
- Hydatidiform mole, recurrent, 4 0 trials
- Invasive hydatidiform mole 0 trials
- Partial hydatidiform mole 0 trials
-
COL4A1/A2-related disorder 2 trials · 5 incl. sub-types
3 sub-types
- COL4A1-related disorder 1 trial · 4 incl. sub-types Sub-types →
- Brain small vessel disease 2A, autosomal dominant 1 trial
- Hemorrhage, intracerebral, susceptibility to 1 trial
-
Hereditary Wilms tumor 1 trial · 5 incl. sub-types
7 sub-types
- Wilms tumor 1 4 trials
- Wilms tumor 2 0 trials
- Wilms tumor 3 0 trials
- Wilms tumor 4 0 trials
- Wilms tumor 5 0 trials
- Wilms tumor 6 0 trials
- Wilms tumor 7 0 trials
-
Central hypoventilation syndrome, congenital 0 trials · 5 incl. sub-types
-
Congenital diarrhea 0 trials · 5 incl. sub-types
12 sub-types
- Congenital secretory diarrhea 0 trials · 5 incl. sub-types Sub-types →
- Congenital diarrhea 6 0 trials
- Congenital diarrhea 7 with exudative enteropathy 0 trials
- Congenital malabsorptive diarrhea 4 0 trials
- Congenital sodium diarrhea 0 trials Sub-types →
- Diarrhea 10, protein-losing enteropathy type 0 trials
- Diarrhea 11, malabsorptive, congenital 0 trials
- Diarrhea 12, with microvillus atrophy 0 trials
- Diarrhea 13 0 trials
- Diarrhea 14, congenital 0 trials
- Diarrhea 15, congenital 0 trials
- Diarrhea 9 0 trials
-
Hereditary narcolepsy 0 trials · 5 incl. sub-types
3 sub-types
- Narcolepsy 1 5 trials
- Narcolepsy 3 0 trials
- Narcolepsy 7 0 trials
-
Oculoauriculovertebral spectrum with radial defects 0 trials · 5 incl. sub-types
1 sub-type
- Craniofacial microsomia 5 trials Sub-types →
-
WHIM syndrome 4 trials
2 sub-types
- WHIM syndrome 1 4 trials
- WHIM syndrome 2 0 trials
-
Alopecia universalis 4 trials
-
Bile acid malabsorption, primary, 1 4 trials
-
Diastema, dental medial 4 trials
-
3 sub-types
-
Hernia, double inguinal 4 trials
-
Hyperreflexia 4 trials
-
Parathyroid gland carcinoma 4 trials
-
Urinary bladder, atony of 4 trials
-
Volvulus of midgut 4 trials
1 sub-type
-
CTNNB1-related neurodevelopmental disorder and/or vitreoretinopathy 3 trials · 4 incl. sub-types
2 sub-types
-
Prostate cancer, hereditary 1 trial · 4 incl. sub-types
18 sub-types
- Prostate cancer, hereditary, 7 3 trials
- Familial prostate carcinoma 0 trials
- Prostate cancer, hereditary, 1 0 trials
- Prostate cancer, hereditary, 10 0 trials
- Prostate cancer, hereditary, 11 0 trials
- Prostate cancer, hereditary, 12 0 trials
- Prostate cancer, hereditary, 13 0 trials
- Prostate cancer, hereditary, 14 0 trials
- Prostate cancer, hereditary, 15 0 trials
- Prostate cancer, hereditary, 2 0 trials
- Prostate cancer, hereditary, 3 0 trials
- Prostate cancer, hereditary, 4 0 trials
- Prostate cancer, hereditary, 5 0 trials
- Prostate cancer, hereditary, 6 0 trials
- Prostate cancer, hereditary, 8 0 trials
- Prostate cancer, hereditary, 9 0 trials
- Prostate cancer, hereditary, X-linked 1 0 trials
- Prostate cancer, hereditary, X-linked 2 0 trials
-
7q11.23 microduplication syndrome 3 trials
1 sub-type
-
3 sub-types
-
Protrusio acetabuli 3 trials
-
2 sub-types
-
Delayed puberty, self-limited 3 trials
-
Ear malformation 3 trials
1 sub-type
- Auriculocondylar syndrome 0 trials Sub-types →
-
Fibrinolytic defect 3 trials
-
Genu valgum, st. Helena familial 3 trials
-
Hematuria, benign familial 3 trials
2 sub-types
- Hematuria, benign familial, 1 3 trials
- Hematuria, benign familial, 2 0 trials
-
Pigment dispersion syndrome 3 trials
-
Popliteal cyst 3 trials
-
Portal hypertension, noncirrhotic 3 trials
2 sub-types
- Portal hypertension, noncirrhotic, 1 0 trials
- Portal hypertension, noncirrhotic, 2 0 trials
-
Spatial visualization, aptitude for 3 trials
-
Striae distensae, familial 3 trials
-
Tooth ankylosis 3 trials
-
Epithelial-stromal TGFBI dystrophy 1 trial · 3 incl. sub-types
8 sub-types
- Epithelial basement membrane dystrophy 2 trials
- Thiel-Behnke corneal dystrophy 1 trial
- Reis-Bucklers corneal dystrophy 0 trials
- Corneal dystrophy, lattice type 3A 0 trials
- Corneal granular dystrophy 0 trials
- Granular corneal dystrophy type I 0 trials
- Granular corneal dystrophy type II 0 trials
- Lattice corneal dystrophy type I 0 trials
-
AP-4 deficiency syndrome 0 trials · 3 incl. sub-types
4 sub-types
- Hereditary spastic paraplegia 50 3 trials
- Hereditary spastic paraplegia 47 1 trial
- Hereditary spastic paraplegia 51 1 trial
- Hereditary spastic paraplegia 52 1 trial
-
Pitt-Hopkins or Pitt-Hopkins-like syndrome 0 trials · 3 incl. sub-types
2 sub-types
- Pitt-Hopkins syndrome 3 trials
- Pitt-Hopkins-like syndrome 0 trials Sub-types →
-
Distal arthrogryposis 0 trials · 3 incl. sub-types
23 sub-types
- Freeman-Sheldon syndrome 1 trial Sub-types →
- Congenital contractural arachnodactyly 1 trial
- Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A 1 trial
- ACTC1-related distal arthrogryposis with congenital heart disease 0 trials
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- Gordon syndrome 0 trials
- Sheldon-hall syndrome 0 trials Sub-types →
- Arthrogryposis, distal, IIa 11 0 trials
- Arthrogryposis, distal, type 12 0 trials
- Arthrogryposis, distal, type 1C 0 trials
- Arthrogryposis, distal, type 2B4 0 trials
- Arthrogryposis, distal, type 2E 0 trials
- Arthrogryposis, distal, with impaired proprioception and touch 0 trials
- Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome 0 trials
- Arthrogryposis-ectodermal dysplasia-other anomalies syndrome 0 trials
- Arthrogryposis-like hand anomaly-sensorineural deafness syndrome 0 trials
- Arthrogryposis-severe scoliosis syndrome 0 trials
- Autism spectrum disorder - epilepsy - arthrogryposis syndrome 0 trials
- Digitotalar dysmorphism 0 trials Sub-types →
- Distal arthrogryposis Moore weaver type 0 trials
- Distal arthrogryposis type 10 0 trials
- Distal arthrogryposis type 5D 0 trials
- Trismus-pseudocamptodactyly syndrome 0 trials
-
Lethal congenital contracture syndrome 0 trials · 3 incl. sub-types
11 sub-types
- Lethal congenital contracture syndrome 2 3 trials
- NEK9-related lethal skeletal dysplasia 0 trials
- Fetal akinesia-cerebral and retinal hemorrhage syndrome 0 trials
- Lethal congenital contracture syndrome 1 0 trials
- Lethal congenital contracture syndrome 11 0 trials
- Lethal congenital contracture syndrome 3 0 trials
- Lethal congenital contracture syndrome 4 0 trials
- Lethal congenital contracture syndrome 6 0 trials
- Lethal congenital contracture syndrome 7 0 trials
- Lethal congenital contracture syndrome 8 0 trials
- Lethal congenital contracture syndrome 9 0 trials
-
Achoo syndrome 2 trials
-
Kabuki syndrome 2 trials
2 sub-types
- Kabuki syndrome 1 0 trials
- Kabuki syndrome 2 0 trials
-
Kasabach-Merritt syndrome 2 trials
-
Pseudofolliculitis barbae 2 trials
-
Young syndrome 2 trials
-
Alcohol sensitivity, acute 2 trials
-
Anisomastia 2 trials
-
Arthropathy, erosive 2 trials
-
Atrichia with papular lesions 2 trials
-
Bone Paget disease 2 trials
5 sub-types
- Paget disease of bone 2, early-onset 0 trials
- Paget disease of bone 3 0 trials
- Paget disease of bone 6 0 trials
- Juvenile Paget disease 0 trials
- Paget disease of bone 4 0 trials
-
Breath-holding Spells 2 trials
-
Capillary infantile hemangioma 2 trials
-
Cardiac valvular defect 2 trials
2 sub-types
- Cardiac valvular defect, developmental 0 trials
- Cardiac valvular dysplasia 2 0 trials
-
Celiac trunk compression syndrome 2 trials
-
Cystic disease of lung 2 trials
-
Expansile bone lesions 2 trials
-
Familial thrombocytosis 2 trials
3 sub-types
- Thrombocythemia 1 0 trials
- Thrombocythemia 2 0 trials
- Thrombocythemia 3 0 trials
-
Grouped pigmentation of the retina 2 trials
-
Histiocytoma, Angiomatoid fibrous 2 trials
-
Inosine triphosphatase deficiency 2 trials
-
Insect Stings, hypersensitivity to 2 trials
-
Insulin-resistance syndrome type A 2 trials
-
Intussusception 2 trials
-
Kyphoscoliosis 1 2 trials
-
2 sub-types
- Moyamoya disease 5 0 trials
- Aortic aneurysm, familial thoracic 6 0 trials
-
Muscular hypertonia, lethal 2 trials
-
Nose, anomalous shape of 2 trials
-
Platelet aggregation, spontaneous 2 trials
-
5 sub-types
- Pigmented nodular adrenocortical disease, primary, 1 1 trial
- Isolated primary pigmented nodular adrenocortical disease 0 trials
- Pigmented nodular adrenocortical disease, primary, 2 0 trials
- Pigmented nodular adrenocortical disease, primary, 3 0 trials
- Pigmented nodular adrenocortical disease, primary, 4 0 trials
-
Ragweed sensitivity 2 trials
-
Teeth, supernumerary 2 trials
-
Androgen insensitivity syndrome 1 trial · 2 incl. sub-types
2 sub-types
-
Arthrogryposis multiplex congenita 1 trial · 2 incl. sub-types
24 sub-types
- Arthrogryposis multiplex congenita 2, neurogenic type 0 trials · 1 incl. sub-types Sub-types →
- MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome 0 trials
- Marden-Walker syndrome 0 trials
- Wieacker-Wolff syndrome (spectrum) 0 trials Sub-types →
- Adducted thumbs-arthrogryposis syndrome, Christian type 0 trials
- Arthrogryposis due to muscular dystrophy 0 trials
- Arthrogryposis multiplex congenita 3, myogenic type 0 trials
- Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum 0 trials
- Arthrogryposis multiplex congenita 5 0 trials
- Arthrogryposis multiplex congenita 6 0 trials
- Arthrogryposis multiplex congenita 7, X-linked 0 trials
- Arthrogryposis multiplex congenita-whistling face syndrome 0 trials
- Arthrogryposis-hyperkeratosis syndrome, lethal form 0 trials
- Arthrogryposis-like syndrome 0 trials
- Autosomal recessive myogenic arthrogryposis multiplex congenita 0 trials
- Fetal akinesia deformation sequence 0 trials Sub-types →
- Hypomyelination neuropathy-arthrogryposis syndrome 0 trials Sub-types →
- Infantile-onset X-linked spinal muscular atrophy 0 trials
- Lethal arthrogryposis-anterior horn cell disease syndrome 0 trials
- Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome 0 trials
- Microphthalmia microtia fetal akinesia 0 trials
- Multiple pterygium-malignant hyperthermia syndrome 0 trials
- Prenatal-onset spinal muscular atrophy with congenital bone fractures 0 trials Sub-types →
- Van den Ende-Gupta syndrome 0 trials
-
Congenital pseudoarthrosis of the limbs 1 trial · 2 incl. sub-types
5 sub-types
-
Dyskinesia with orofacial involvement 1 trial · 2 incl. sub-types
2 sub-types
-
POLR3A-related disorder 0 trials · 2 incl. sub-types
-
Autoimmune disease, multisystem, infantile-onset 0 trials · 2 incl. sub-types
-
Cornea plana 0 trials · 2 incl. sub-types
2 sub-types
- Cornea plana 1, autosomal dominant 2 trials
- Cornea plana 2 0 trials
-
Familial abdominal aortic aneurysm 0 trials · 2 incl. sub-types
4 sub-types
- Aortic aneurysm, familial abdominal, 1 2 trials
- Aortic aneurysm, familial abdominal, 2 0 trials
- Aortic aneurysm, familial abdominal, 3 0 trials
- Aortic aneurysm, familial abdominal, 4 0 trials
-
Familial hyperaldosteronism 0 trials · 2 incl. sub-types
5 sub-types
-
Hereditary gingival fibromatosis 0 trials · 2 incl. sub-types
6 sub-types
- Fibromatosis, gingival, 2 2 trials
- Fibromatosis, gingival, 1 0 trials
- Fibromatosis, gingival, 3 0 trials
- Fibromatosis, gingival, 4 0 trials
- Fibromatosis, gingival, 5 0 trials
- Fibromatosis, gingival, 6 0 trials
-
Inherited cutis laxa 0 trials · 2 incl. sub-types
14 sub-types
- Arterial tortuosity syndrome 1 trial
- Autosomal recessive cutis laxa type 1 1 trial Sub-types →
- Occipital horn syndrome 1 trial
- ALDH18A1-related de Barsy syndrome 0 trials
- PYCR1-related de Barsy syndrome 0 trials
- RIN2 syndrome 0 trials
- Arterial tortuosity-bone fragility syndrome 0 trials
- Autosomal dominant cutis laxa 0 trials Sub-types →
- Autosomal recessive cutis laxa type 2 0 trials Sub-types →
- Autosomal recessive cutis laxa type 2, classic type 0 trials
- Craniofaciofrontodigital syndrome 0 trials
- Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies 0 trials
- Cutis laxa, autosomal recessive, type 2E 0 trials
- Geroderma osteodysplastica 0 trials
-
Islet cell adenomatosis 0 trials · 2 incl. sub-types
1 sub-type
- Congenital isolated hyperinsulinism 0 trials · 2 incl. sub-types Sub-types →
-
A20 haploinsufficiency 1 trial
-
Axenfeld-Rieger syndrome 1 trial
3 sub-types
- Axenfeld-Rieger syndrome type 3 1 trial
- Axenfeld-Rieger syndrome type 1 0 trials
- Axenfeld-Rieger syndrome type 2 0 trials
-
BENTA disease 1 trial
-
CFTR-related disorder 1 trial
1 sub-type
-
Caroli syndrome 1 trial
-
Caronte 1 trial
-
Chopra-Amiel-Gordon syndrome 1 trial
-
Coffin-Siris syndrome 1 trial
11 sub-types
- Coffin-Siris syndrome 1 0 trials
- Coffin-Siris syndrome 10 0 trials
- Coffin-Siris syndrome 11 0 trials
- Coffin-Siris syndrome 12 0 trials
- Coffin-Siris syndrome 5 0 trials
- Coffin-Siris syndrome 7 0 trials
- Coffin-Siris syndrome 8 0 trials
- Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism 0 trials
- Intellectual disability, autosomal dominant 14 0 trials
- Intellectual disability, autosomal dominant 15 0 trials
- Intellectual disability, autosomal dominant 16 0 trials
-
DHDDS-CDG 1 trial
1 sub-type
- Retinitis pigmentosa 59 0 trials
-
Koolen-de Vries syndrome 1 trial
2 sub-types
-
L-ferritin deficiency 1 trial
-
Mazabraud syndrome 1 trial
-
Potocki-Lupski syndrome 1 trial
-
RNU4ATAC spectrum disorder 1 trial
3 sub-types
- Lowry-Wood syndrome 1 trial
- Roifman syndrome 1 trial
- Microcephalic osteodysplastic primordial dwarfism type I 1 trial
-
Rombo syndrome 1 trial
-
Shashi-Pena syndrome 1 trial
-
Snijders Blok-Campeau syndrome 1 trial
-
Taqi polymorphism 1 trial
-
Yao syndrome 1 trial
-
Aganglionosis, total intestinal 1 trial
-
Anisocoria 1 trial
-
Arcus senilis 1 trial
-
5 sub-types
- Choroidal dystrophy, central areolar 2 0 trials
- Choroidal dystrophy, central areolar, 1 0 trials
- Choroidal dystrophy, central areolar, 3 0 trials
- Partial central choroid dystrophy 0 trials
- Total central choroidal atrophy 0 trials
-
3 sub-types
-
Coxa vara 1 trial
-
Dysautonomia-like disorder 1 trial
-
Eosinophilia, familial 1 trial
-
Esophagitis, eosinophilic, 1 1 trial
-
Familial melanoma 1 trial
1 sub-type
-
Fleck corneal dystrophy 1 trial
-
Focal dermal hypoplasia 1 trial
-
Foveal hypoplasia 1 trial
4 sub-types
-
Frontonasal dysplasia 1 trial
9 sub-types
- Pai syndrome 0 trials
- Acromelic frontonasal dysostosis 0 trials
- Craniofrontonasal dysplasia-Poland anomaly syndrome 0 trials
- Frontofacionasal dysplasia 0 trials
- Frontonasal dysplasia - severe microphthalmia - severe facial clefting syndrome 0 trials
- Frontonasal dysplasia with alopecia and genital anomaly 0 trials
- Frontorhiny 0 trials
- Oculoauriculofrontonasal syndrome 0 trials
- Six2-related frontonasal dysplasia 0 trials
-
Graying of hair, precocious 1 trial
-
2 sub-types
-
Hyperpigmentation of eyelid 1 trial
-
Ichthyosis prematurity syndrome 1 trial
-
Levator-medial rectus synkinesis 1 trial
-
Lumbar stenosis, familial 1 trial
-
Megalodactyly 1 trial
-
Myeloperoxidase deficiency 1 trial
-
Nasal alar collapse, bilateral 1 trial
-
Neutropenia, chronic familial 1 trial
-
Nocturnal enuresis, 2 1 trial
-
Pernicious anemia 1 trial
-
Platelet membrane fluidity 1 trial
-
4 sub-types
-
Premature centromere division 1 trial
-
Prolactin deficiency, isolated 1 trial
-
Pyropoikilocytosis, hereditary 1 trial
-
Tarsal coalition 1 trial
-
Taurodontism 1 trial
-
Trichomegaly 1 trial
1 sub-type
- Familial isolated trichomegaly 0 trials
-
Tune deafness 1 trial
-
Visceral heterotaxy 1 trial
19 sub-types
- Dextrocardia 1 trial
- Situs inversus 1 trial Sub-types →
- Heterotaxy, visceral, 1, X-linked 0 trials
- Heterotaxy, visceral, 10, autosomal, with male infertility 0 trials
- Heterotaxy, visceral, 11, autosomal, with male infertility 0 trials
- Heterotaxy, visceral, 12, autosomal 0 trials
- Heterotaxy, visceral, 13, autosomal 0 trials
- Heterotaxy, visceral, 14, autosomal 0 trials
- Heterotaxy, visceral, 2, autosomal 0 trials
- Heterotaxy, visceral, 3, autosomal 0 trials
- Heterotaxy, visceral, 4, autosomal 0 trials
- Heterotaxy, visceral, 5, autosomal 0 trials
- Heterotaxy, visceral, 6, autosomal 0 trials
- Heterotaxy, visceral, 7, autosomal 0 trials
- Heterotaxy, visceral, 8, autosomal 0 trials
- Heterotaxy, visceral, 9, autosomal, with male infertility 0 trials
- Laterality defects, autosomal dominant 0 trials
- Levocardia 0 trials
- Right atrial isomerism 0 trials
-
ACAN-related short stature spectrum 0 trials · 1 incl. sub-types
-
CACNA1C-related disorder 0 trials · 1 incl. sub-types
4 sub-types
-
ELANE-related neutropenia 0 trials · 1 incl. sub-types
2 sub-types
-
Mendelian encephalopathy 0 trials · 1 incl. sub-types
19 sub-types
- Familial acute necrotizing encephalopathy 1 trial
- Bonnemann-Meinecke-Reich syndrome 0 trials
- Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 0 trials
- Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome 0 trials
- Encephalitis/encephalopathy, mild, with reversible myelin vacuolization 0 trials
- Encephalopathy due to defective mitochondrial and peroxisomal fission 2 0 trials
- Encephalopathy, axonal, with necrotizing myopathy, cardiomyopathy, and cataracts 0 trials
- Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 0 trials
- Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 0 trials
- Encephalopathy, porphyria-related 0 trials
- Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 0 trials Sub-types →
- Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 0 trials
- Encephalopathy, progressive, with amyotrophy and optic atrophy 0 trials
- Encephalopathy, recurrent, of childhood 0 trials
- Ethylmalonic encephalopathy 0 trials
- Familial encephalopathy with neuroserpin inclusion bodies 0 trials
- Severe neonatal-onset encephalopathy with microcephaly 0 trials
- Severe neurodegenerative syndrome with lipodystrophy 0 trials
- Spongiform encephalopathy with neuropsychiatric features 0 trials
-
NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types
3 sub-types
- Thyroid cancer, nonmedullary, 1 1 trial
- Brain-lung-thyroid syndrome 0 trials
- Hereditary progressive chorea without dementia 0 trials
-
PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder 0 trials · 1 incl. sub-types
-
TOR1AIP1-related nuclear envelopathy 0 trials · 1 incl. sub-types
2 sub-types
- TOR1AIP1-related myopathy 0 trials · 1 incl. sub-types Sub-types →
- TOR1AIP1-related multisystem disorder 0 trials
-
WFS1-related disorder 0 trials · 1 incl. sub-types
3 sub-types
- Wolfram syndrome 1 1 trial
- Wolfram-like syndrome 0 trials
- Autosomal dominant nonsyndromic hearing loss 6 0 trials
-
Y-linked disease 0 trials · 1 incl. sub-types
2 sub-types
- Retinitis pigmentosa Y-linked 1 trial
- Nonsyndromic deafness, Y-linked 0 trials Sub-types →
-
Acrofacial dysostosis 0 trials · 1 incl. sub-types
14 sub-types
- Postaxial acrofacial dysostosis 1 trial
- Patterson-Stevenson-Fontaine syndrome 0 trials
- SF3B4-related acrofacial dysostosis 0 trials Sub-types →
- Acrocraniofacial dysostosis 0 trials
- Acrofacial dysostosis Cincinnati type 0 trials
- Acrofacial dysostosis Preis type 0 trials
- Acrofacial dysostosis Rodriguez type 0 trials
- Acrofacial dysostosis, Catania type 0 trials
- Acrofacial dysostosis, Kennedy-Teebi type 0 trials
- Acrofacial dysostosis, Palagonia type 0 trials
- Acrofacial dysostosis, Weyers type 0 trials
- Acrofrontofacionasal dysostosis 0 trials Sub-types →
- Acromelic frontonasal dysostosis 0 trials
- Mandibulofacial dysostosis-microcephaly syndrome 0 trials
-
Contractures, pterygia, and variable skeletal fusions syndrome 0 trials · 1 incl. sub-types
-
Epilepsy, early-onset 0 trials · 1 incl. sub-types
-
Familial vesicoureteral reflux 0 trials · 1 incl. sub-types
9 sub-types
- Vesicoureteral reflux 3 1 trial
- Vesicoureteral reflux 1 0 trials
- Vesicoureteral reflux 2 0 trials
- Vesicoureteral reflux 4 0 trials
- Vesicoureteral reflux 5 0 trials
- Vesicoureteral reflux 6 0 trials
- Vesicoureteral reflux 7 0 trials
- Vesicoureteral reflux 8 0 trials
- Vesicoureteral reflux, X-linked 0 trials
-
Gastrointestinal defect and immunodeficiency syndrome 0 trials · 1 incl. sub-types
2 sub-types
-
Growth hormone insensitivity syndrome with immune dysregulation 0 trials · 1 incl. sub-types
-
Hereditary gallbladder disorder 0 trials · 1 incl. sub-types
3 sub-types
- Gallbladder disease 1 1 trial
- Gallbladder disease 2 0 trials
- Gallbladder disease 3 0 trials
-
Hypothyroidism, congenital, nongoitrous 0 trials · 1 incl. sub-types
9 sub-types
- Hypothyroidism due to TSH receptor mutations 1 trial
- Isolated thyroid-stimulating hormone deficiency 1 trial
- Congenital nongoitrous hypothyroidism 3 0 trials
- Congenital nongoitrous hypothyroidism 6 0 trials
- Hypothyroidism, congenital, nongoitrous, 2 0 trials
- Hypothyroidism, congenital, nongoitrous, 5 0 trials
- Hypothyroidism, congenital, nongoitrous, 7 0 trials
- Hypothyroidism, congenital, nongoitrous, 8 0 trials
- Hypothyroidism, congenital, nongoitrous, 9 0 trials
-
Infantile liver failure 0 trials · 1 incl. sub-types
4 sub-types
-
Isolated congenital breast hypoplasia/aplasia 0 trials · 1 incl. sub-types
3 sub-types
- Amastia 1 trial
- Breasts and/or nipples, aplasia or hypoplasia of, 1 0 trials
- Breasts and/or nipples, aplasia or hypoplasia of, 2 0 trials
-
Isolated microphthalmia 0 trials · 1 incl. sub-types
10 sub-types
- Microphthalmia, isolated, with coloboma 0 trials · 1 incl. sub-types Sub-types →
- Isolated microphthalmia 1 0 trials
- Isolated microphthalmia 2 0 trials Sub-types →
- Isolated microphthalmia 3 0 trials
- Isolated microphthalmia 4 0 trials
- Isolated microphthalmia 5 0 trials
- Isolated microphthalmia 6 0 trials
- Isolated microphthalmia 7 0 trials
- Isolated microphthalmia 8 0 trials
- Microphthalmia, isolated, with cataract 1 0 trials
-
Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 0 trials · 1 incl. sub-types
-
Pancreatic agenesis 0 trials · 1 incl. sub-types
4 sub-types
- Pancreatic agenesis 1 1 trial
- Pancreas, dorsal, agenesis of 0 trials
- Pancreatic agenesis 2 0 trials
- Pancreatic agenesis 3 0 trials
-
Split hand-foot malformation 0 trials · 1 incl. sub-types
6 sub-types
- Split hand-foot malformation 3 1 trial
- Split hand-foot malformation 1 0 trials
- Split hand-foot malformation 2 0 trials
- Split hand-foot malformation 4 0 trials
- Split hand-foot malformation 5 0 trials
- Split hand-foot malformation 6 0 trials
-
3MC syndrome 0 trials
3 sub-types
- 3MC syndrome 1 0 trials
- 3MC syndrome 2 0 trials
- 3MC syndrome 3 0 trials
-
46,XX sex reversal 1 0 trials
-
46,xx sex reversal 5 0 trials
-
6-phosphogluconolactonase deficiency 0 trials
-
ACCES syndrome 0 trials
-
2 sub-types
- ACD-related long telomere syndrome 0 trials
- ACD-related short telomere syndrome 0 trials Sub-types →
-
AKT3-related overgrowth spectrum 0 trials
1 sub-type
-
Abruzzo-Erickson syndrome 0 trials
-
Achard syndrome 0 trials
-
Adams-Oliver syndrome 0 trials
6 sub-types
- Adams-Oliver syndrome 1 0 trials
- Adams-Oliver syndrome 2 0 trials
- Adams-Oliver syndrome 3 0 trials
- Adams-Oliver syndrome 4 0 trials
- Adams-Oliver syndrome 5 0 trials
- Adams-Oliver syndrome 6 0 trials
-
Alazami-Yuan syndrome 0 trials
-
Alfadhel syndrome 0 trials
-
Alkuraya-Kucinskas syndrome 0 trials
-
Armfield syndrome 0 trials
-
Atelis syndrome 0 trials
2 sub-types
- Atelis syndrome 1 0 trials
- Atelis syndrome 2 0 trials
-
Athrombia, essential 0 trials
-
Ayme-Gripp syndrome 0 trials
-
BAFopathy 0 trials
15 sub-types
- ACTL6A-related BAFopathy 0 trials
- Baraitser-Winter syndrome 1 0 trials
- Coffin-Siris syndrome 1 0 trials
- Coffin-Siris syndrome 5 0 trials
- Coffin-Siris syndrome 6 0 trials
- Coffin-Siris syndrome 8 0 trials
- Dias-Logan syndrome 0 trials
- PBRM1-related BAFopathy 0 trials
- SMARCC1-associated developmental dysgenesis syndrome 0 trials
- Intellectual developmental disorder with severe speech and ambulation defects 0 trials
- Intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities 0 trials
- Intellectual disability, autosomal dominant 14 0 trials
- Intellectual disability, autosomal dominant 15 0 trials
- Intellectual disability, autosomal dominant 16 0 trials
- Intellectual disability-sparse hair-brachydactyly syndrome 0 trials
-
BMP4-related ocular growth disorder 0 trials
1 sub-type
-
Bamforth-Lazarus syndrome 0 trials
-
Baralle-Macken syndrome 0 trials
-
Basilicata-Akhtar syndrome 0 trials
-
Beck-Fahrner syndrome 0 trials
-
Birbeck granule deficiency 0 trials
-
Boudin-Mortier syndrome 0 trials
-
Brachymetatarsus 4 0 trials
-
Braddock-Carey syndrome 0 trials
2 sub-types
- Braddock-Carey syndrome 1 0 trials
- Braddock-carey syndrome 2 0 trials
-
2 sub-types
-
Buratti-Harel syndrome 0 trials
-
CEBALID syndrome 0 trials
-
CHAND syndrome 0 trials
-
CLAPO syndrome 0 trials
-
3 sub-types
- Cataract 16 multiple types 0 trials Sub-types →
- Dilated cardiomyopathy 1II 0 trials
- Myofibrillar myopathy 2 0 trials
-
Camptosynpolydactyly, complex 0 trials
-
Car factor deficiency 0 trials
-
Carey-Fineman-Ziter syndrome 0 trials
2 sub-types
- Carey-Fineman-Ziter syndrome 1 0 trials
- Carey-Fineman-Ziter syndrome 2 0 trials
-
Catifa syndrome 0 trials
-
Chitayat syndrome 0 trials
-
Chondronectin 0 trials
-
Christianson syndrome 0 trials
-
Chudley-McCullough syndrome 0 trials
-
Cohen-Gibson syndrome 0 trials
-
Crane-Heise syndrome 0 trials
-
DEGCAGS syndrome 0 trials
-
DNA, low-repetitive sequences of 0 trials
-
DNA, satellite, 3 0 trials
-
DOORS syndrome 0 trials
-
Darwinian tubercle of pinna 0 trials
-
Dauwerse-Peters syndrome 0 trials
-
Devriendt syndrome 0 trials
-
Diamond-Blackfan anemia-like 0 trials
-
Diets-Jongmans syndrome 0 trials
-
Dohle bodies and leukemia 0 trials
-
Dursun syndrome 0 trials
-
EDICT syndrome 0 trials
-
EN1-related dorsoventral syndrome 0 trials
2 sub-types
- ENDOVE syndrome, limb-brain type 0 trials
- ENDOVE syndrome, limb-only type 0 trials
-
2 sub-types
- Capillary malformation-arteriovenous malformation 2 0 trials
- Lymphatic malformation 7 0 trials
-
Elsahy-Waters syndrome 0 trials
-
Emanuel syndrome 0 trials
-
Eosinophilopenia 0 trials
-
FG syndrome 0 trials
6 sub-types
- Aarskog-Scott syndrome, X-linked 0 trials
- FG syndrome 1 0 trials
- FG syndrome 2 0 trials
- FG syndrome 3 0 trials
- FG syndrome 4 0 trials
- FG syndrome 5 0 trials
-
FICUS syndrome 0 trials
-
FRAXD syndrome 0 trials
-
FRAXF syndrome 0 trials
-
Fanconi-like syndrome 0 trials
1 sub-type
-
Faundes-Banka syndrome 0 trials
-
Fliedner-Zweier syndrome 0 trials
-
Floating-Harbor syndrome 0 trials
-
Fowler syndrome 0 trials
-
Fraser-like syndrome 0 trials
-
Freesia Flowers, inability to smell 0 trials
-
GATA1-Related X-Linked Cytopenia 0 trials
-
GCGR-related hyperglucagonemia 0 trials
-
GOMBO syndrome 0 trials
-
GRACILE syndrome 0 trials
-
Gabriele de Vries syndrome 0 trials
-
Gamstorp-Wohlfart syndrome 0 trials
-
Giacheti syndrome 0 trials
-
Glucoglycinuria 0 trials
-
Goldberg-Shprintzen syndrome 0 trials
-
Grant syndrome 0 trials
-
Guillouet-Gordon syndrome 0 trials
-
Guttmacher syndrome 0 trials
-
Halothane hepatitis 0 trials
-
Hengel-Maroofian-Schols syndrome 0 trials
-
Heyn-Sproul-Jackson syndrome 0 trials
-
Hhhh syndrome 0 trials
-
Hooft disease 0 trials
-
Houge-Janssens syndrome 0 trials
4 sub-types
- Houge-Janssens syndrome 1 0 trials
- Houge-Janssens syndrome 2 0 trials
- Houge-Janssens syndrome 3 0 trials
- Houge-Janssens syndrome 4 0 trials
-
Hoxha-Aliu syndrome 0 trials
-
Hunter-Macdonald syndrome 0 trials
-
Huppke-Brendel syndrome 0 trials
-
ICHAD syndrome 0 trials
-
IVIC syndrome 0 trials
-
Imagawa-Matsumoto syndrome 0 trials
-
Jaberi-Elahi syndrome 0 trials
-
Jalili syndrome 0 trials
-
Jawad syndrome 0 trials
-
Juberg-Hayward syndrome 0 trials
-
Jumping Frenchmen of Maine 0 trials
-
Karsch-Neugebauer syndrome 0 trials
-
Kaya-Barakat-Masson syndrome 0 trials
-
Keipert syndrome 0 trials
-
Khan-Khan-Katsanis syndrome 0 trials
-
Kifafa seizure disorder 0 trials
-
Kleefstra syndrome 0 trials
3 sub-types
- Kleefstra syndrome 1 0 trials Sub-types →
- Kleefstra syndrome 2 0 trials
- Kleefstra syndrome due to a point mutation 0 trials
-
Kohlschutter-Tonz syndrome-like 0 trials
-
Kury-Isidor syndrome 0 trials
-
Kyrle disease 0 trials
-
LTBP2-related ocular dysgenesis 0 trials
3 sub-types
-
Lamb-Shaffer syndrome 0 trials
-
Lambotte syndrome 0 trials
-
Lessel-Kreienkamp syndrome 0 trials
-
Leydig cell hypoplasia, type 1 0 trials
2 sub-types
-
Li-Campeau syndrome 0 trials
-
Li-Ghorbani-Weisz-Hubshman syndrome 0 trials
-
Liang-Wang syndrome 0 trials
-
Liberfarb syndrome 0 trials
-
Lisch epithelial corneal dystrophy 0 trials
-
Long-Olsen-Distelmaier syndrome 0 trials
-
Lopes-Maciel-Rodan syndrome 0 trials
-
Lui-Jee-Baron syndrome 0 trials
-
Luo-Schoch-Yamamoto syndrome 0 trials
-
Luscan-Lumish syndrome 0 trials
-
MECOM-associated syndrome 0 trials
1 sub-type
-
MIRAGE syndrome 0 trials
-
MOMO syndrome 0 trials
-
MORM syndrome 0 trials
-
MTOR-related overgrowth spectrum 0 trials
-
Malan overgrowth syndrome 0 trials
-
Mammastatin 0 trials
-
Marinesco-Sjogren-like syndrome 0 trials
-
Martinez-Frias syndrome 0 trials
-
Meacham syndrome 0 trials
-
Meckel diverticulum 0 trials
-
Meesmann corneal dystrophy 0 trials
2 sub-types
- Corneal dystrophy, Meesmann, 1 0 trials
- Corneal dystrophy, Meesmann, 2 0 trials
-
Meester-Loeys syndrome 0 trials
-
Megarbane syndrome 0 trials
-
Megarbane-Jalkh syndrome 0 trials
-
Melhem-Fahl syndrome 0 trials
-
Menke-Hennekam syndrome 0 trials
2 sub-types
- Menke-Hennekam syndrome 1 0 trials
- Menke-Hennekam syndrome 2 0 trials
-
Monophalangy of great toe 0 trials
-
Moynahan syndrome 0 trials
-
Mullegama-Klein-Martinez syndrome 0 trials
-
Mungan syndrome 0 trials
-
N-acetylaspartate deficiency 0 trials
-
NDUFB11-related disorders 0 trials
2 sub-types
-
4 sub-types
- 46,XX sex reversal 4 0 trials
- 46,XY sex reversal 3 0 trials
- Premature ovarian failure 7 0 trials
- Spermatogenic failure 8 0 trials
-
Nance-Horan syndrome 0 trials
-
Nguyen syndrome 0 trials
-
Nizon-Isidor syndrome 0 trials
-
O'Donnell-Luria-Rodan syndrome 0 trials
-
Okt4 epitope deficiency 0 trials
-
Opitz G/BBB syndrome 0 trials
1 sub-type
- X-linked Opitz G/BBB syndrome 0 trials
-
Opticocochleodentate degeneration 0 trials
-
PI4KA-related disorder 0 trials
-
2 sub-types
- SHORT syndrome 0 trials
- Immunodeficiency 36 with lymphoproliferation 0 trials
-
POLR1C-related disorder 0 trials
2 sub-types
- Treacher Collins syndrome 3 0 trials
- Hypomyelinating leukodystrophy 11 0 trials
-
POLR3B-related disorder 0 trials
-
PR interval, variation in 0 trials
-
Paine syndrome 0 trials
-
Pan-Chung-Bellen syndrome 0 trials
-
Paramolar tubercle of bolk 0 trials
-
Parotidomegaly, hereditary bilateral 0 trials
-
Partington-Anderson syndrome 0 trials
-
Passovoy factor defect 0 trials
-
Pechet factor deficiency 0 trials
-
Perlman syndrome 0 trials
-
Pilotto syndrome 0 trials
-
Polyosteolysis-hyperostosis syndrome 0 trials
-
Prepapillary vascular loops 0 trials
-
Primrose syndrome 0 trials
-
Pseudoatrophoderma colli 0 trials
-
Pseudopili annulati 0 trials
-
Pseudouridinuria and mental defect 0 trials
-
Rabin-Pappas syndrome 0 trials
-
Rabson-Mendenhall syndrome 0 trials
-
Radio-Tartaglia syndrome 0 trials
-
Rahman syndrome 0 trials
-
Ramon syndrome 0 trials
-
Rauch-Steindl syndrome 0 trials
-
Reese retinal dysplasia 0 trials
-
Reynolds syndrome 0 trials
-
Robin sequence-oligodactyly syndrome 0 trials
-
Robinow-Sorauf syndrome 0 trials
-
Roussy-Levy syndrome 0 trials
-
Rowley-Rosenberg syndrome 0 trials
-
SEC61A1 deficiency 0 trials
2 sub-types
-
STAD syndrome 0 trials
-
SYCE1-related gametogenic failure 0 trials
2 sub-types
- Premature ovarian failure 12 0 trials
- Spermatogenic failure 15 0 trials
-
Sabinas brittle hair syndrome 0 trials
-
Sakoda complex 0 trials
-
Santos syndrome 0 trials
-
Schnyder corneal dystrophy 0 trials
-
Sener syndrome 0 trials
-
Short stature, Dauber-Argente type 0 trials
-
Shukla-Vernon syndrome 0 trials
-
Siddiqi syndrome 0 trials
-
Sifrim-Hitz-Weiss syndrome 0 trials
-
Skraban-Deardorff syndrome 0 trials
-
Somatomedin, embryonic 0 trials
-
Spondylospinal thoracic dysostosis 0 trials
-
Stevenson-Carey syndrome 0 trials
-
Stuve-Wiedemann syndrome 0 trials
2 sub-types
- Stuve-Wiedemann syndrome 2 0 trials
- Stüve-Wiedemann syndrome 1 0 trials
-
Suleiman-El-Hattab syndrome 0 trials
-
Sweeney-Cox syndrome 0 trials
-
T-cell Subgroups, non-HLA-linked 0 trials
-
T-substance anomaly 0 trials
-
5 sub-types
-
TPM4-related platelet disorder 0 trials
-
TRAF3 haploinsufficiency 0 trials
-
Tan-Almurshedi syndrome 0 trials
-
Tayoun-Maawali syndrome 0 trials
-
Teebi hypertelorism syndrome 0 trials
2 sub-types
- Teebi hypertelorism syndrome 1 0 trials
- Teebi hypertelorism syndrome 2 0 trials
-
Tenorio syndrome 0 trials
-
Tented eyebrows 0 trials
-
4 sub-types
-
Thai symphalangism syndrome 0 trials
-
Tn polyagglutination syndrome 0 trials
-
Tolchin-Le Caignec syndrome 0 trials
-
Tonoki syndrome 0 trials
-
Tristichiasis 0 trials
-
Tryptophanuria with dwarfism 0 trials
-
Tuftsin deficiency 0 trials
-
Tyrosinosis 0 trials
-
Undritz anomaly 0 trials
-
Upington disease 0 trials
-
Usher syndrome, type 1M 0 trials
-
VISS syndrome 0 trials
-
Valinemia 0 trials
-
Ververi-Brady syndrome 0 trials
2 sub-types
- Ververi-Brady syndrome 1 0 trials
- Ververi-Brady syndrome 2 0 trials
-
Vissers-Bodmer syndrome 0 trials
-
Warsaw breakage syndrome 0 trials
-
Webb-Dattani syndrome 0 trials
-
White-Kernohan syndrome 0 trials
-
Wiedemann-Steiner syndrome 0 trials
-
Wolfram syndrome 2 0 trials
-
Woronets trait 0 trials
-
X inactivation, familial skewed 0 trials
2 sub-types
- X inactivation, familial skewed, 1 0 trials
- X inactivation, familial skewed, 2 0 trials
-
Yuksel-Vogel-Bauer syndrome 0 trials
-
ZTTK syndrome 0 trials
-
Zaki syndrome 0 trials
-
Zimmermann-Laband syndrome 0 trials
3 sub-types
- Zimmermann-Laband syndrome 1 0 trials
- Zimmermann-Laband syndrome 2 0 trials
- Zimmermann-Laband syndrome 3 0 trials
-
Ablepharon macrostomia syndrome 0 trials
-
Acetyl-coa carboxylase deficiency 0 trials
-
Acetylation, slow 0 trials
-
Achalasia, familial esophageal 0 trials
-
Acroleukopathy, symmetric 0 trials
-
Acromial dimples 0 trials
-
Acute insulin response 0 trials
-
Advanced sleep phase syndrome 0 trials
4 sub-types
- Advance sleep phase syndrome, familial, 4 0 trials
- Advanced sleep phase syndrome 1 0 trials
- Advanced sleep phase syndrome 2 0 trials
- Advanced sleep phase syndrome 3 0 trials
-
Agenesis of cerebral white matter 0 trials
-
Agnathia-otocephaly complex 0 trials
-
Alar cleft, isolated 0 trials
-
4 sub-types
-
Amenorrhea-galactorrhea syndrome 0 trials
-
Amyloidosis, cutaneous bullous 0 trials
-
Amyotonia congenita 0 trials
-
Amyotrophic dystonic paraplegia 0 trials
-
Anal sphincter dysplasia 0 trials
-
Anal sphincter myopathy, internal 0 trials
-
2 sub-types
-
Anhaptoglobinemia 0 trials
-
Aniridia-absent patella syndrome 0 trials
-
Annular erythema 0 trials
-
Anonychia-ectrodactyly 0 trials
-
Anosmia for isobutyric acid 0 trials
-
Apraxia of eyelid opening 0 trials
-
Ariboflavinosis 0 trials
1 sub-type
- Maternal riboflavin deficiency 0 trials
-
Arms, malformation of 0 trials
-
Arteries, anomalies of 0 trials
-
Arteriosclerosis, severe juvenile 0 trials
-
Aspirin resistance 0 trials
-
Asymmetric short stature syndrome 0 trials
-
Ataxia, deafness, and cardiomyopathy 0 trials
-
Atonic-astatic syndrome of Foerster 0 trials
-
Aurocephalosyndactyly 0 trials
-
Autosomal dominant wooly hair 0 trials
-
Azotemia, familial 0 trials
-
Baculum, congenital absence of 0 trials
-
Beta-amino acids, renal transport of 0 trials
-
Bile acid conjugation defect 1 0 trials
-
Bile acid malabsorption, primary, 2 0 trials
-
Bipartite talus 0 trials
-
Bladder diverticulum 0 trials
1 sub-type
- Stone in bladder diverticulum 0 trials
-
Blepharochalasis, superior 0 trials
-
Blue nevi, familial multiple 0 trials
-
Bone pain, periodic 0 trials
-
Brachial palsy, familial congenital 0 trials
-
Brachydactyly 0 trials
22 sub-types
- Ballard syndrome 0 trials
- Berk-Tabatznik syndrome 0 trials
- Cooks syndrome 0 trials
- Osebold-Remondini syndrome 0 trials
- Brachydactyly type A1 0 trials
- Brachydactyly type A1A 0 trials
- Brachydactyly type A1B 0 trials
- Brachydactyly type A1C 0 trials
- Brachydactyly type A1D 0 trials
- Brachydactyly type A2 0 trials
- Brachydactyly type A3 0 trials
- Brachydactyly type A4 0 trials
- Brachydactyly type A5 0 trials
- Brachydactyly type A7 0 trials
- Brachydactyly type B 0 trials Sub-types →
- Brachydactyly type C 0 trials
- Brachydactyly type D 0 trials
- Brachydactyly type E 0 trials Sub-types →
- Brachydactyly-arterial hypertension syndrome 0 trials
- Camptobrachydactyly 0 trials
- Non-syndromic brachydactyly 0 trials Sub-types →
- Preaxial digit brachydactyly-webbed fingers 0 trials
-
Brachymesomelia-renal syndrome 0 trials
-
Brain malformation renal syndrome 0 trials
-
Branchiootic syndrome 0 trials
3 sub-types
- Branchiootic syndrome 1 0 trials
- Branchiootic syndrome 2 0 trials
- Branchiootic syndrome 3 0 trials
-
Broad terminal phalanges, familial 0 trials
-
Bronchiectasis and nasal polyposis 0 trials
-
Bullous dystrophy, macular type 0 trials
-
Butyrylesterase 1 0 trials
-
Camera-Marugo-Cohen syndrome 0 trials
-
Camptodactyly syndrome, Guadalajara 0 trials
3 sub-types
-
Camptodactyly-ichthyosis syndrome 0 trials
-
Carboxypeptidase N deficiency 0 trials
-
Cardiac-urogenital syndrome 0 trials
-
Cardioacrofacial dysplasia 0 trials
2 sub-types
- Cardioacrofacial dysplasia 1 0 trials
- Cardioacrofacial dysplasia 2 0 trials
-
Carnitine deficiency, myopathic 0 trials
-
Carpal displacement 0 trials
-
Caudal duplication 0 trials
-
Central incisors, absence of 0 trials
-
Cephalin lipidosis 0 trials
-
Cerebelloparenchymal disorder 0 trials
2 sub-types
- Myoclonic cerebellar dyssynergia 0 trials
- Spinocerebellar ataxia type 17 0 trials
-
Cerebral angiopathy, dysphoric 0 trials
-
Cervical rib disease 0 trials
-
Cervical vertebrae, agenesis of 0 trials
-
Cervical vertebral Bridge 0 trials
-
Cervical vertebral dysplasia 0 trials
-
Chloramphenicol toxicity 0 trials
-
Cholesteatoma, congenital 0 trials
-
Cholesterol pneumonia 0 trials
-
Choroidal osteoma, bilateral 0 trials
-
Chromosome 16 inversion, 0.45-Mb 0 trials
-
Chromosome 18 pericentric inversion 0 trials
-
Chromosome 1p35 deletion syndrome 0 trials
-
Chronic mast cell leukemia 0 trials
-
Circumvallate placenta syndrome 0 trials
-
Citrulline transport defect 0 trials
-
Cocoon syndrome 0 trials
-
Colloid cysts of third ventricle 0 trials
-
Coloboma, ocular, autosomal dominant 0 trials
2 sub-types
- Coloboma of choroid and retina 0 trials
- Coloboma of iris 0 trials
-
Combined low LDL and fibrinogen 0 trials
-
Comedones, familial Dyskeratotic 0 trials
-
Commissural lip pits 0 trials
-
Complement factor b deficiency 0 trials
-
Cone-rod dystrophy and hearing loss 0 trials
2 sub-types
- Cone-rod dystrophy and hearing loss 1 0 trials
- Cone-rod dystrophy and hearing loss 2 0 trials
-
Congenital analbuminemia 0 trials
-
Congenital stromal corneal dystrophy 0 trials
-
Congenital vertical talus 0 trials
2 sub-types
- Congenital vertical talus, bilateral 0 trials
- Congenital vertical talus, unilateral 0 trials
-
Coumarin resistance 0 trials
-
Cranial nerves, recurrent paresis of 0 trials
-
Cranioacrofacial syndrome 0 trials
-
Craniofacial-deafness-hand syndrome 0 trials
-
Craniofaciocardiohepatic syndrome 0 trials
-
Craniolenticulosutural dysplasia 0 trials
-
Craniorhiny 0 trials
-
Craniosynostosis-scoliosis syndrome 0 trials
-
Crumpled helices and small mouth 0 trials
-
Cryofibrinogenemia, familial primary 0 trials
-
Cryptotia, familial 0 trials
-
Curved nail of fourth toe 0 trials
-
Cyanosis and hepatic disease 0 trials
-
Cyanosis, transient neonatal 0 trials
1 sub-type
- Hemoglobinopathy Toms River 0 trials
-
Cysteine Peptiduria 0 trials
-
De Sanctis-Cacchione syndrome 0 trials
-
Deafness, mid-tone neural 0 trials
-
Deafness-vitiligo-achalasia syndrome 0 trials
-
Deeah syndrome 0 trials
-
Dens evaginatus 0 trials
-
Dental radicular dysplasia 0 trials
-
Dentin dysplasia type I 0 trials
2 sub-types
- Atypical dentin dysplasia due to SMOC2 deficiency 0 trials
- Dentin dysplasia, type IB 0 trials
-
Dentin dysplasia type II 0 trials
-
Dentinogenesis imperfecta type 2 0 trials
1 sub-type
-
Dentinogenesis imperfecta type 3 0 trials
-
Dermal Ridges, patternless 0 trials
-
Developmental delay with sleep apnea 0 trials
-
Diaminopentanuria 0 trials
-
2 sub-types
-
Dilution, pigmentary 0 trials
-
Distal monosomy 10p 0 trials
1 sub-type
- 10p13-p14 deletion syndrome 0 trials
-
Distal osteosclerosis 0 trials
-
Distal symphalangism 0 trials
-
Double fingernail of fifth finger 0 trials
-
Double nail for fifth toe 0 trials
-
Dwarfism with tall vertebrae 0 trials
-
Dwarfism, Levi type 0 trials
-
Dysmyelination with jaundice 0 trials
-
Dysostosis multiplex, Ain-Naz type 0 trials
-
Dystelephalangy 0 trials
-
Dystonia with Ringbinden 0 trials
-
Dystonia with cerebellar atrophy 0 trials
-
Ear antitragus, tag at base of 0 trials
-
Ear exostoses 0 trials
-
Ear folding 0 trials
-
Ear pits, posterior helical 0 trials
-
Ectopia lentis et pupillae 0 trials
-
Ectopia pupillae 0 trials
-
Ectrodactyly-cleft palate syndrome 0 trials
-
Emphysema, hereditary pulmonary 0 trials
-
Encephalomalacia, multilocular 0 trials
-
Enuresis, nocturnal, 1 0 trials
-
Epidermoid cysts 0 trials
-
Epiphyseal dysplasia, Baumann type 0 trials
-
Episodic muscle weakness, X-linked 0 trials
-
Erythema nodosum, familial 0 trials
-
Erythema of acral regions 0 trials
-
Esophageal ring, lower 0 trials
-
Esophagitis, eosinophilic, 2 0 trials
-
Estrogen resistance syndrome 0 trials
-
Ethanolaminosis 0 trials
-
Exchondrosis of pinna, posterior 0 trials
-
Exostosis, Dupuytren subungual 0 trials
-
Facial spasm 0 trials
-
Faciocardiomelic syndrome 0 trials
-
Faciothoracogenital syndrome 0 trials
-
Familial caudal dysgenesis 0 trials
1 sub-type
- Sirenomelia 0 trials
-
Familial cavitary optic disk anomaly 0 trials
-
Familial cervical artery dissection 0 trials
-
Familial gestational hyperthyroidism 0 trials
-
Familial glucocorticoid deficiency 0 trials
6 sub-types
- Adrenocortical unresponsiveness to ACTH with postreceptor defect 0 trials
- Glucocorticoid deficiency 1 0 trials
- Glucocorticoid deficiency 2 0 trials
- Glucocorticoid deficiency 3 0 trials
- Glucocorticoid deficiency 4 0 trials
- Glucocorticoid deficiency 5 0 trials
-
Familial lipochrome histiocytosis 0 trials
-
Familial monosomy 7 syndrome 0 trials
2 sub-types
-
Familial parathyroid adenoma 0 trials
-
Familial partial paralysis 0 trials
-
Familial supernumerary nipples 0 trials
-
Familial visceral myopathy 0 trials
2 sub-types
- Visceral myopathy 1 0 trials
- Visceral myopathy 2 0 trials
-
Fever, familial lifelong persistent 0 trials
-
Fibromuscular dysplasia, multifocal 0 trials
-
Fibrosclerosis, multifocal 0 trials
-
Flushing of ears and somnolence 0 trials
-
Focal epithelial hyperplasia 0 trials
-
Forsythe-wakeling syndrome 0 trials
-
Fragile site 10Q23 0 trials
-
Frontoocular syndrome 0 trials
-
Fructose and galactose intolerance 0 trials
-
Fucosidase regulator 0 trials
-
Fucosyltransferase 6 deficiency 0 trials
-
Fused mandibular incisors 0 trials
-
Gastric mucosal hypertrophy 0 trials
-
Gastric volvulus, intrathoracic 0 trials
-
Giant neutrophil leukocytes 0 trials
-
Glomuvenous malformation 0 trials
-
Glucocorticoid therapy, response to 0 trials
-
Gluteal muscles, absence of 0 trials
-
Gonadal agenesis 0 trials
-
Granddad syndrome 0 trials
-
Grange syndrome 0 trials
-
Granulomas, congenital cerebral 0 trials
-
Granulosis rubra nasi 0 trials
-
Guanylate cyclase 2E 0 trials
-
Guanylate kinase 3 0 trials
-
Hairy ears, Y-linked 0 trials
-
Hairy nose tip 0 trials
-
Hairy palms and soles 0 trials
-
Hand clasping pattern 0 trials
-
Heart-hand syndrome 0 trials
6 sub-types
- Carney complex - trismus - pseudocamptodactyly syndrome 0 trials
- Holt-Oram syndrome 0 trials Sub-types →
- Brachydactyly-long thumb syndrome 0 trials
- Heart-hand syndrome type 2 0 trials
- Heart-hand syndrome, Slovenian type 0 trials
- Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome 0 trials
-
Hemifacial myohyperplasia 0 trials
-
Hemopoietic proliferation 0 trials
-
Hepatic adenomas, familial 0 trials
-
Hereditary fallopian tube carcinoma 0 trials
-
Hereditary neutrophilia 0 trials
-
Heterochromia iridis 0 trials
-
Histiocytic dermatoarthritis 0 trials
-
Humero-radio-ulnar synostosis 0 trials
2 sub-types
-
Humeroradial synostosis 0 trials
4 sub-types
-
Humerus trochlea aplasia 0 trials
-
Hyaluronan metabolism, defect 1N 0 trials
-
Hydroxyprolinemia 0 trials
-
Hymen, imperforate 0 trials
-
Hyperbiliverdinemia 0 trials
-
Hypercalciuria, absorptive, 2 0 trials
-
Hyperglycinuria 0 trials
-
Hyperheparinemia 0 trials
-
Hyperimmunoglobulin G1(A1) syndrome 0 trials
-
Hyperleucine-Isoleucinemia 0 trials
-
Hyperlysinuria with hyperammonemia 0 trials
-
Hyperopia, high 0 trials
-
Hyperostosis cranialis interna 0 trials
-
Hyperproglucagonemia 0 trials
-
Hyperproinsulinemia 0 trials
-
Hypersulfaturia 0 trials
-
Hypertrophia musculorum vera 0 trials
-
Hypertrophic neuropathy and cataract 0 trials
-
Hypoglycemia, leucine-induced 0 trials
-
Hypokalemic tubulopathy and deafness 0 trials
-
Hypophosphatemic bone disease 0 trials
-
Ichthyosis and male hypogonadism 0 trials
-
Ichthyosis-cheek-eyebrow syndrome 0 trials
-
Immunodeficiency 28 0 trials
-
Immunodeficiency 37 0 trials
1 sub-type
-
Immunodeficiency 39 0 trials
-
Immunodeficiency 47 0 trials
-
Immunoglobulin M, level of 0 trials
-
Incisors, lower central, absence of 0 trials
-
Incisors, rotation of upper central 0 trials
-
Incisors, shovel-shaped 0 trials
-
6 sub-types
- Intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome 0 trials
- Pyloric stenosis, infantile hypertrophic, 1 0 trials
- Pyloric stenosis, infantile hypertrophic, 2 0 trials
- Pyloric stenosis, infantile hypertrophic, 3 0 trials
- Pyloric stenosis, infantile hypertrophic, 4 0 trials
- Pyloric stenosis, infantile hypertrophic, 5 0 trials
-
Inherited isolated nail anomaly 0 trials
9 sub-types
- Isolated congenital anonychia 0 trials Sub-types →
- Isolated congenital digital clubbing 0 trials
- Leukonychia totalis 0 trials
- Nonsyndromic congenital nail disorder 1 0 trials
- Nonsyndromic congenital nail disorder 2 0 trials
- Nonsyndromic congenital nail disorder 3 0 trials
- Nonsyndromic congenital nail disorder 5 0 trials
- Nonsyndromic congenital nail disorder 7 0 trials
- Nonsyndromic congenital nail disorder 8 0 trials
-
Inherited oocyte maturation defect 0 trials
24 sub-types
- Female infertility due to zona pellucida defect 0 trials
- Oocyte maturation defect 10 0 trials
- Oocyte maturation defect 11 0 trials
- Oocyte maturation defect 12 0 trials
- Oocyte maturation defect 13 0 trials
- Oocyte maturation defect 14 0 trials
- Oocyte maturation defect 2 0 trials
- Oocyte maturation defect 3 0 trials
- Oocyte maturation defect 4 0 trials
- Oocyte maturation defect 5 0 trials
- Oocyte maturation defect 6 0 trials
- Oocyte maturation defect 7 0 trials
- Oocyte maturation defect 8 0 trials
- Oocyte maturation defect 9 0 trials
- Oocyte/zygote/embryo maturation arrest 16 0 trials
- Oocyte/zygote/embryo maturation arrest 17 0 trials
- Oocyte/zygote/embryo maturation arrest 18 0 trials
- Oocyte/zygote/embryo maturation arrest 19 0 trials
- Oocyte/zygote/embryo maturation arrest 20 0 trials
- Oocyte/zygote/embryo maturation arrest 21 0 trials
- Oocyte/zygote/embryo maturation arrest 22 0 trials
- Oocyte/zygote/embryo maturation arrest 23 0 trials
- Oocyte/zygote/embryo maturation arrest 24 0 trials
- Oocyte/zygote/embryo maturation arrest 25 0 trials
-
Intellectual disability, FRA12A type 0 trials
-
Interferon antiviral depressor 0 trials
-
Iris pattern 0 trials
-
Iris pigment epithelium anomalies 0 trials
-
Iris pigment layer, cleavage of 0 trials
-
Ischio-vertebral syndrome 0 trials
-
Isolated aniridia 0 trials
3 sub-types
- Aniridia 1 0 trials
- Aniridia 2 0 trials
- Aniridia 3 0 trials
-
Isolated cryptophthalmia 0 trials
3 sub-types
- Complete cryptophthalmia 0 trials
- Congenital symblepharon 0 trials
- Partial cryptophthalmia 0 trials
-
Isolated hyperferritinemia 0 trials
-
Isovaleric acid, inability to smell 0 trials
-
1 sub-type
- Congenital nonhemolytic jaundice 0 trials
-
Keloid formation 0 trials
-
Keratitis fugax hereditaria 0 trials
-
Keratoconus posticus circumscriptus 0 trials
-
Keratoderma hereditarium mutilans 0 trials
-
Keratosis, familial actinic 0 trials
-
Knuckle pads 0 trials
-
Labia minora, incomplete adhesion of 0 trials
-
Lactic acidosis, chronic adult form 0 trials
-
Lessel-kubisch syndrome 0 trials
-
Lethal faciocardiomelic dysplasia 0 trials
-
Lethal recessive chondrodysplasia 0 trials
-
Lip, hamartomatous 0 trials
-
Lipoprotein types--Lt system 0 trials
-
Lipoprotein, variant of beta 0 trials
-
Lithium transport 0 trials
-
Liver disease, severe congenital 0 trials
-
Lysine malabsorption syndrome 0 trials
-
Macrocephaly, benign familial 0 trials
-
1 sub-type
-
Macrocytosis, familial 0 trials
-
Macrosomia adiposa congenita 0 trials
-
Magnesium, elevated red cell 0 trials
-
Malocclusion and short stature 0 trials
-
Mammary-digital-nail syndrome 0 trials
-
Marfanoid hypermobility syndrome 0 trials
-
Maxillofacial dysostosis 0 trials
-
Mediosternal depigmentation line 0 trials
-
Megabladder, congenital 0 trials
-
5 sub-types
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 3 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 0 trials
-
Megaepiphyseal dwarfism 0 trials
-
Megalencephaly with dysmyelination 0 trials
-
Megalencephaly-polydactyly syndrome 0 trials
-
Megalocornea 0 trials
1 sub-type
- Isolated congenital megalocornea 0 trials
-
Melanoma tumor antigen Gp90 0 trials
-
Mesomelic dysplasia, camera type 0 trials
-
Metachondromatosis 0 trials
-
Metachromasia of fibroblasts 0 trials
-
Metatarsus varus, type 1 0 trials
-
Methionine malabsorption syndrome 0 trials
-
2 sub-types
-
2 sub-types
-
2 sub-types
-
Microcephaly-micromelia syndrome 0 trials
-
Microspherophakia with hernia 0 trials
-
Milia, multiple eruptive 0 trials
-
Monosodium glutamate sensitivity 0 trials
-
Mucocutaneous ulceration, chronic 0 trials
-
Multiple fibroadenoma of the breast 0 trials
-
Multiple synostoses syndrome 0 trials
4 sub-types
- Multiple synostoses syndrome 1 0 trials
- Multiple synostoses syndrome 2 0 trials
- Multiple synostoses syndrome 3 0 trials
- Multiple synostoses syndrome 4 0 trials
-
Muscle cramps, familial 0 trials
-
Musk, inability to smell 0 trials
-
Myelinated optic nerve fibers 0 trials
-
Myeloid tumor suppressor 0 trials
-
Myelolymphatic insufficiency 0 trials
-
Nanophthalmia 0 trials
4 sub-types
- Nanophthalmos 1 0 trials
- Nanophthalmos 2 0 trials
- Nanophthalmos 3 0 trials
- Nanophthalmos 4 0 trials
-
Nasal bones, absence of 0 trials
-
Nasal groove, familial transverse 0 trials
-
Neurocardiofaciodigital syndrome 0 trials
-
Neurooculorenal syndrome 0 trials
-
Nevus anemicus 0 trials
-
Nevus flammeus of nape of neck 0 trials
-
Nipples inverted 0 trials
-
Nondisjunction 0 trials
-
Nuclear ribonucleic acid 0 trials
-
Obesity and hypopigmentation 0 trials
-
Occipital hair, white lock of 0 trials
-
Oculomaxillofacial dysostosis 0 trials
1 sub-type
- Tessier number 4 facial cleft 0 trials
-
Oculomotor-abducens synkinesis 0 trials
-
Oculorenocerebellar syndrome 0 trials
-
Oculotrichoanal syndrome 0 trials
-
Oculovertebral syndrome 0 trials
-
Odontoid hypoplasia 0 trials
-
Omphalocele, X-linked 0 trials
-
Omphalocele, autosomal 0 trials
-
Ophthalmomandibulomelic dysplasia 0 trials
-
Ophthalmoplegia, familial static 0 trials
-
Oral sensibility, disturbance of 0 trials
-
Orofaciodigital syndrome 0 trials
19 sub-types
- Orofaciodigital syndrome 16 0 trials
- Orofaciodigital syndrome 17 0 trials
- Orofaciodigital syndrome 18 0 trials
- Orofaciodigital syndrome 19 0 trials
- Orofaciodigital syndrome 20 0 trials
- Orofaciodigital syndrome 21 0 trials
- Orofaciodigital syndrome III 0 trials
- Orofaciodigital syndrome IV 0 trials
- Orofaciodigital syndrome IX 0 trials
- Orofaciodigital syndrome V 0 trials
- Orofaciodigital syndrome VII 0 trials
- Orofaciodigital syndrome VIII 0 trials
- Orofaciodigital syndrome X 0 trials
- Orofaciodigital syndrome XI 0 trials
- Orofaciodigital syndrome XV 0 trials
- Orofaciodigital syndrome type 12 0 trials
- Orofaciodigital syndrome type 14 0 trials
- Orofaciodigital syndrome type 6 0 trials
- Orofaciodigital syndrome type II 0 trials
-
4 sub-types
- Charlie M syndrome 0 trials
- Hypoglossia-hypodactyly syndrome 0 trials
- Glossopalatine ankylosis 0 trials
- Isolated congenital hypoglossia/aglossia 0 trials Sub-types →
-
Ossicular malformations, familial 0 trials
-
Ossified ear cartilages 0 trials
-
Osteoma of cranial vault, familial 0 trials
-
Osteoma of middle ear 0 trials
-
Osteootohepatoenteric syndrome 0 trials
-
Otofaciocervical syndrome 0 trials
2 sub-types
- Otofaciocervical syndrome 1 0 trials
- Otofaciocervical syndrome 2 0 trials
-
Otofacioosseous-gonadal syndrome 0 trials
-
Otoonychoperoneal syndrome 0 trials
-
Pachydermodactyly, familial 0 trials
-
Palant cleft palate syndrome 0 trials
-
Palmaris longus muscle, absence of 0 trials
-
Pancreatic lymphoma, familial 0 trials
-
Papillomatosis, florid, of nipple 0 trials
-
Parotitis, juvenile recurrent 0 trials
-
Patella aplasia/hypoplasia 0 trials
2 sub-types
- Patella aplasia/hypoplasia, bilateral 0 trials
- Patella aplasia/hypoplasia, unilateral 0 trials
-
Patent ductus venosus 0 trials
-
Pellagra-like syndrome 0 trials
-
Peripapillary atrophy, beta type 0 trials
-
Peripheral cone dystrophy 0 trials
-
Peroneal nerve, accessory deep 0 trials
-
Peroneus tertius muscle, absence of 0 trials
-
Peroxidase, salivary 0 trials
-
Phenformin 4-hydroxylation 0 trials
-
Phlebectasia of lips 0 trials
-
Phosphatase, acid, of tissues 0 trials
-
Phosphoglucomutase 4 0 trials
-
Phosphoglycoprotein 1 0 trials
-
Phosphohydroxylysinuria 0 trials
-
Pigmented purpuric eruption 0 trials
-
Plasma fibronectin deficiency 0 trials
-
Platelet adenylate cyclase activity 0 trials
-
Platelet disorder, undefined 0 trials
-
Platelet factor 3 deficiency 0 trials
-
Platelet signal processing defect 0 trials
-
Polycystic bone disease 0 trials
-
Polydactyly-macrocephaly syndrome 0 trials
-
Polyhydramnios, chronic idiopathic 0 trials
-
Polymyoclonus, infantile 0 trials
-
Polysaccharide, storage of unusual 0 trials
-
Postaxial tetramelic oligodactyly 0 trials
-
Posterior column ataxia 0 trials
-
Preauricular fistulae, congenital 0 trials
-
Premature chromatid separation trait 0 trials
-
Presenile dementia, Kraepelin type 0 trials
-
Priapism, familial idiopathic 0 trials
-
Properdin deficiency, X-linked 0 trials
-
Protein Z deficiency 0 trials
-
Proteinuria, chronic benign 0 trials
-
Proteolytic capacity of plasma 0 trials
-
Protocadherin 3 0 trials
-
Pruritus, hereditary localized 0 trials
-
Pseudoarthrogryposis 0 trials
-
Pseudohyperaldosteronism type 2 0 trials
-
Pseudomonilethrix 0 trials
-
Pterygium colli, isolated 0 trials
-
Pubic bone dysplasia 0 trials
-
Pulmonary alveolar microlithiasis 0 trials
-
Pulmonary venoocclusive disease 0 trials
2 sub-types
- Pulmonary venoocclusive disease 1 0 trials
- Pulmonary venoocclusive disease 2 0 trials
-
Pulmonic stenosis and deafness 0 trials
-
Pupillary membrane, persistence of 0 trials
-
Purpura simplex 0 trials
-
Pyloric atresia 0 trials
-
Radial ray deficiency, X-linked 0 trials
-
Radiculoneuropathy, fatal neonatal 0 trials
-
Radio-renal syndrome 0 trials
-
Raindrop hypopigmentation 0 trials
-
Recombinant 8 syndrome 0 trials
-
Red cell permeability defect 0 trials
-
Renal and mullerian duct hypoplasia 0 trials
-
Renal-hepatic-pancreatic dysplasia 0 trials
2 sub-types
- Renal-hepatic-pancreatic dysplasia 1 0 trials
- Renal-hepatic-pancreatic dysplasia 2 0 trials
-
Restrictive dermopathy 0 trials
2 sub-types
- Restrictive dermopathy 1 0 trials
- Restrictive dermopathy 2 0 trials
-
Reticuloendotheliosis, X-linked 0 trials
-
Retinal degeneration and epilepsy 0 trials
-
Retinal venous beading 0 trials
-
Retinitis pigmentosa 89 0 trials
-
Rhabdomyosarcoma, embryonal, 2 0 trials
-
Rhiny 0 trials
-
Ribbing disease 0 trials
-
Ring dermoid of cornea 0 trials
-
Salivary duct calculi 0 trials
-
Sandestig-stefanova syndrome 0 trials
-
Sella turcica, bridged 0 trials
-
Senile plaque formation 0 trials
-
Serpinopathy 0 trials
-
Sex-linked disease 0 trials
-
Short stature due to GHSR deficiency 0 trials
-
2 sub-types
- Brachydactyly type A1 0 trials
- Short stature with nonspecific skeletal abnormalities 1 0 trials
-
Short stature, Brussels type 0 trials
-
Short stature-obesity syndrome 0 trials
-
Snijders blok-fisher syndrome 0 trials
-
Spastic paraplegia, mitochondrial 0 trials
-
Specific granule deficiency 0 trials
2 sub-types
- Specific granule deficiency 1 0 trials
- Specific granule deficiency 2 0 trials
-
Sperm protamine P4 0 trials
-
Sperm-specific antigen 1 0 trials
-
Spinal dysplasia, Anhalt type 0 trials
-
Splenoportal vascular anomalies 0 trials
-
Split lower lip 0 trials
-
Storm syndrome 0 trials
-
Subaortic stenosis, membranous 0 trials
-
Succinic acidemia 0 trials
-
Sudden cardiac failure, infantile 0 trials
-
Suppressor of tumorigenicity 3 0 trials
-
Surface antigen, glycoprotein 75 0 trials
-
Surface polypeptides, anonymous 0 trials
-
Symphalangism of toes 0 trials
-
Symphalangism, C. S. Lewis type 0 trials
-
Syndesmodysplasic dwarfism 0 trials
-
Syngnathia multiple anomalies 0 trials
-
Syngnathia-cleft palate syndrome 0 trials
-
Syringomas, multiple 0 trials
-
Talonavicular coalition 0 trials
-
Tear protein, anodal 0 trials
-
Teeth present at birth 0 trials
-
Teeth, fused 0 trials
-
Teeth, odd shapes of 0 trials
-
Temtamy syndrome 0 trials
-
Testes, rudimentary 0 trials
-
Testicular microlithiasis 0 trials
-
2 sub-types
- Tetraamelia syndrome 1 0 trials
- Tetraamelia syndrome 2 0 trials
-
Tetralogy of fallot and glaucoma 0 trials
-
Tetramelic monodactyly 0 trials
-
Tetrasomy 18p 0 trials
-
Thoracic dysostosis, isolated 0 trials
-
Thumb deformity 0 trials
-
Thumb, distal hyperextensibility of 0 trials
-
Thumbs, congenital Clasped 0 trials
-
Thymic aplasia with fetal death 0 trials
-
Thymoma, familial 0 trials
-
Thyroid hormone metabolism, abnormal 0 trials
3 sub-types
- Thyroid hormone metabolism, abnormal 1 0 trials
- Thyroid hormone metabolism, abnormal, 2 0 trials
- Thyroid hormone metabolism, abnormal, 3 0 trials
-
Tibial aplasia-ectrodactyly syndrome 0 trials
3 sub-types
-
Tibial torsion, bilateral medial 0 trials
-
Tiglic acidemia 0 trials
-
Toe, fifth, number of phalanges 1N 0 trials
-
Toe, misshapen 0 trials
-
Toe, rotated fifth 0 trials
-
Toes, space between first and second 0 trials
-
Trichilemmal cyst 0 trials
-
Trichoscyphodysplasia 0 trials
-
Trisomy 18-like syndrome 0 trials
-
Trypsinogen deficiency 0 trials
-
Tubulin, beta 0 trials
-
Turnpenny-fry syndrome 0 trials
-
Ulnar hypoplasia-split foot syndrome 0 trials
-
Umbilicus, familial flat 0 trials
-
Uncombable hair syndrome 1 0 trials
-
Uncombable hair syndrome 2 0 trials
-
Uncombable hair syndrome 3 0 trials
-
Unique green phenomenon 0 trials
-
Ureter, bifid or double 0 trials
-
Ureterocele 0 trials
-
Urogenital adysplasia 0 trials
-
Vacuolar Neuromyopathy 0 trials
-
Van Bogaert-Hozay syndrome 0 trials
-
Van Maldergem syndrome 0 trials
2 sub-types
- Van Maldergem syndrome 1 0 trials
- Van Maldergem syndrome 2 0 trials
-
Varicella, severe recurrent 0 trials
-
Vascular helix of umbilical cord 0 trials
-
Vascular hyalinosis 0 trials
-
Ventriculomegaly and arthrogryposis 0 trials
-
Venular insufficiency, systemic 0 trials
-
Visceral neuropathy, familial 0 trials
2 sub-types
-
Vitamin D-dependent rickets, type 3 0 trials
-
Warburg-cinotti syndrome 0 trials
-
Widow's peak syndrome 0 trials
-
Woolly hair-skin fragility syndrome 0 trials
-
Wooly hair, autosomal recessive 3 0 trials
-
Xylosidase deficiency 0 trials
-
Yakut short stature syndrome 0 trials
-
Zinc deficiency, transient neonatal 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 3489 trials in this tab.
-
Rewriting the code: a One-Time gene fix for a rare immune disease?
Cure By invitation onlyThis trial tests a one-time gene therapy for WHIM syndrome, a rare inherited immune disorder that causes severe infections. Doctors collect a person's own blood stem cells, use base editing to correct the faulty CXCR4 gene, and return the edited cells to the body. The goal is to …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Cure
Last updated Sep 21, 2026 16:00 UTC
-
Could a Half-Matched donor cure a rare immune disease?
Cure OngoingThis early-phase trial tests whether a bone marrow transplant from a partially matched relative can safely cure chronic granulomatous disease (CGD), a condition that causes severe infections and inflammation. Four people aged 4 to 65 with CGD and no perfect donor will receive che…
Early phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Missing Iron-Carrying protein replaced in rare blood disorder
Cure OngoingAtransferrinemia is a rare inherited condition in which the body cannot make enough transferrin, a protein that moves iron through the blood. Without it, iron builds up in organs and red blood cells cannot form properly. Researchers are testing intravenous infusions of apotransfe…
Phase 2 • Sponsor: Prothya Biosolutions • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a Precision-Engineered transplant rebuild immunity in babies born without it?
Cure OngoingInfants with severe combined immunodeficiency (SCID) lack working immune cells and face life-threatening infections. A matched sibling donor transplant is the standard cure, but most babies do not have one. This trial tests a refined transplant using a parent or other partially m…
Phase 1/2 • Sponsor: St. Jude Children's Research Hospital • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a One-Time gene therapy fix the root cause of rett syndrome?
Cure By invitation onlyRett syndrome is a rare genetic disorder that mostly affects girls and stems from mutations in the MECP2 gene. This trial tests GCB-002, an experimental gene therapy given as a single injection into the spinal fluid, in 6 to 9 girls aged 2 to 10 who have a confirmed MECP2 mutatio…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
One-Time gene therapy for fatal childhood brain disease: does it last?
Cure OngoingResearchers are following 64 people with cerebral adrenoleukodystrophy (CALD) for 15 years after they received a one-time gene therapy called eli-cel in earlier studies. The therapy uses the patient's own stem cells, modified to carry a working copy of the gene that is faulty in …
Sponsor: Genetix Biotherapeutics Inc. • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
One-Shot gene therapy aims to restore movement in children with SMA
Cure By invitation onlyResearchers test GCB-001, a gene therapy given as a single injection into the spinal fluid, in children aged 2 to 12 with type 2 spinal muscular atrophy who can sit alone but cannot walk. The trial checks safety and whether the treatment improves motor skills over 12 months. It i…
Sponsor: Genecombio Ltd. • Aim: Cure
Last updated Sep 13, 2026 00:00 UTC
-
Can a calming drug make cord blood transplants safer?
Cure PausedResearchers are testing whether adding abatacept to standard immune-suppressing drugs can prevent severe graft-versus-host disease after a double umbilical cord blood transplant. The trial enrolls people with blood cancers such as leukemia, lymphoma, and myelodysplastic syndromes…
Phase 2 • Sponsor: Leland Metheny • Aim: Cure
Last updated Sep 12, 2026 00:00 UTC
-
Can a milder transplant cure sickle cell and thalassemia in adults?
Cure OngoingResearchers are testing a stem cell transplant that uses low-dose radiation and two immune-suppressing drugs instead of high-dose chemotherapy. The goal is to cure severe sickle cell disease and beta-thalassemia in adults up to age 65 who have a matched sibling donor. Participant…
Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Cure
Last updated Sep 11, 2026 00:00 UTC
-
New combo aims to cure hodgkin lymphoma without harsh chemo or transplant
Cure OngoingThis study tests whether combining the drug pembrolizumab with a precise form of radiation can cure people with early-stage Hodgkin lymphoma that has returned or not responded to initial treatment. About 22 participants will receive this combination, with the goal of avoiding the…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Cure
Last updated Sep 04, 2026 00:00 UTC
-
Can a softer transplant cure sickle cell disease?
Cure OngoingThis trial tests a stem cell transplant method that uses lower doses of chemotherapy and radiation, aiming to reduce side effects while still replacing the faulty blood cells that cause sickle cell disease. Children and young adults up to age 25 with severe sickle cell disease ca…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Cure
Last updated Sep 03, 2026 00:00 UTC
-
Stick to a schedule to beat Pre-Diabetes?
Disease control OngoingThis study tests whether keeping a consistent daily routine—like eating and sleeping at the same times—can improve blood sugar control and reduce body fat in people with pre-diabetes. Researchers will enroll 34 adults and ask half to follow a fixed schedule for 12 weeks. The goal…
Sponsor: Columbia University • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New drug SAT-3247 tested for long-term muscle protection in duchenne MD
Disease control By invitation onlyThis study looks at the long-term safety and effects of a drug called SAT-3247 in 10 people with Duchenne muscular dystrophy who were in a previous trial. Participants take the drug by mouth five days a week for about 11 months. Researchers will check for side effects and measure…
Phase 2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New enzyme therapy aims to reach the brain in hunter syndrome
Disease control OngoingResearchers are testing a new enzyme replacement therapy called GNR-055 in people with Hunter syndrome (MPS II), a rare inherited disorder that causes harmful sugar molecules to build up in the body. The trial enrolls about 32 patients, including those who have never had enzyme t…
Phase 2/3 • Sponsor: AO GENERIUM • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
Modified vitamin a pill tested against inherited blindness
Disease control OngoingResearchers are testing whether a daily pill called ALK-001 can slow the progression of Stargardt disease, a rare inherited condition that causes vision loss in children and young adults. The trial enrolls people aged 8 and older who have a clinical diagnosis of Stargardt disease…
Phase 2 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New pill could tame tough psoriasis
Disease control OngoingThis phase 3 trial tests an oral drug called JNJ-77242113 in 774 adults with moderate to severe plaque psoriasis. Participants receive either the new drug, a placebo, or an active comparator (deucravacitinib) to see how well it clears skin lesions. The main goal is to measure imp…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
Could keytruda tame tough prostate cancers?
Disease control OngoingThis phase 2 study tests pembrolizumab (Keytruda) in 40 men with metastatic castration-resistant prostate cancer that has specific genetic flaws (mismatch repair deficiency or CDK12 inactivation). The goal is to see if the drug can shrink tumors or slow the cancer. Researchers wi…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New hope for kids with tough cancers: targeted drug attacks gene flaw
Disease control OngoingThis study tests a drug called ulixertinib in children and teens whose advanced cancers have a specific genetic change in the MAPK pathway. The goal is to see if the drug can shrink or control the tumor. About 20 participants with various solid tumors, lymphomas, or related disor…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New combo shows promise for tough kidney cancers
Disease control OngoingThis study tests two drugs, nivolumab and cabozantinib, together in 60 people with advanced or metastatic non-clear cell kidney cancer. The goal is to see how well the combination shrinks tumors. Participants take cabozantinib daily and receive nivolumab infusions every two weeks…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
Vitamin a derivative eyed to halt inherited blindness
Disease control OngoingResearchers are testing a daily oral drug called ALK-001 in people aged 8 to 70 with Stargardt disease, an inherited condition that causes progressive vision loss. The trial compares ALK-001 to a placebo over 24 months to see if the drug is safe and can slow damage to the retina.…
Phase 2 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New hope for kids with tough brain tumors: targeted drug shows promise
Disease control OngoingThis study tests a drug called selumetinib in children and young adults with low grade glioma that has come back or not responded to other treatments. The drug works by blocking certain enzymes that help tumor cells grow. The goal is to find the best dose and see if it can shrink…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
Could a common diabetes drug help manage cystic Fibrosis-Related diabetes?
Disease control OngoingThis pilot study tests the safety and feasibility of empagliflozin (Jardiance) in 8 overweight or obese adults with cystic fibrosis-related diabetes (CFRD) who are already on insulin. Participants will receive either the drug or a placebo in a crossover design. The goal is to gat…
Phase 2/3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New pill targets genetic form of polycystic kidney disease
Disease control OngoingThis study tests an experimental drug called VX-407 in 24 adults with autosomal dominant polycystic kidney disease (ADPKD) who have specific changes in the PKD1 gene. The goal is to see if the drug can slow kidney growth and is safe. Participants take VX-407 tablets by mouth and …
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
Immunotherapy drug blinatumomab aims to boost leukemia survival in major trial
Disease control OngoingThis Phase III trial is testing whether adding the immunotherapy drug blinatumomab to standard chemotherapy helps adults with a newly diagnosed type of acute lymphoblastic leukemia (ALL) live longer and stay cancer-free longer. About 488 participants are randomly assigned to rece…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
New drug aims to stop brain bleeds in rare disease
Disease control OngoingThis study tests an experimental drug called ALN-APP in 200 adults with cerebral amyloid angiopathy (CAA), a condition that causes bleeding in the brain. The drug is given via spinal injection and aims to slow disease progression and reduce new brain bleeds. Participants will be …
Phase 2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug cocktail takes on glioblastoma in early trial
Disease control OngoingThis early-stage study tests whether adding an experimental drug called OKN-007 to standard chemoradiotherapy is safe and tolerable for people with newly diagnosed glioblastoma, a fast-growing brain cancer. About 27 participants will receive the combination after surgery. The mai…
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can special glasses stop Kids' eyesight from getting worse?
Disease control OngoingThis study tests whether new spectacle lenses can safely slow the progression of myopia (nearsightedness) in children. About 249 kids will wear either the novel lenses or standard single vision glasses for 36 months. Researchers will measure changes in eye length and prescription…
Sponsor: HOYA Lens Thailand LTD. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Real-World lupus drug study launches in poland
Disease control OngoingThis study follows 100 Polish adults with systemic lupus erythematosus (SLE) who are receiving anifrolumab as part of their routine care. Researchers will track changes in disease activity and overall response over time. The goal is to see how well the drug works outside of contr…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat carcinoid tumors
Disease control OngoingThis Phase II trial tests whether combining lenvatinib and everolimus can shrink or slow advanced carcinoid tumors that cannot be removed by surgery. The study enrolls 36 adults with confirmed unresectable carcinoid tumors. Both drugs are taken orally and work by blocking enzymes…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Immunotherapy combo shows promise in preventing High-Risk uterine cancer return
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (with or without radiation) after surgery can help prevent high-risk endometrial cancer from coming back. About 990 participants who had surgery to remove their uterus and ovaries will r…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker tested for Musician's hand cramps
Disease control OngoingThis study tests deep brain stimulation (DBS) surgery for people with severe focal hand dystonia, including musician's dystonia, that hasn't improved with botulinum toxin. Five participants will have electrodes placed in brain areas that control movement, connected to a stimulato…
Phase 1/2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to slow kidney failure in rare genetic disease
Disease control OngoingThis study tests an experimental drug called BAY 3401016 in 60 adults aged 18 to 45 with Alport syndrome, a rare genetic condition that damages kidneys, hearing, and eyes. The drug works by blocking a protein thought to cause kidney injury, with the goal of slowing the loss of ki…
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to boost growth and health in kids with thalassemia
Disease control OngoingThis study looks at growth problems in children with thalassemia, a blood disorder. Researchers will test a program that includes health education, nutrition plans, exercise, and support to help kids grow better. The goal is to improve height, weight, and overall well-being in 36…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New daily shot could help kids with hemophilia avoid bleeds
Disease control OngoingThis study tests a daily injection called concizumab in children under 12 with hemophilia A or B, with or without inhibitors. The goal is to see if it safely prevents bleeding episodes. Participants receive daily shots under the skin for at least 2 years, and the study tracks how…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New antibody takes aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-stage trial tests a new antibody drug called Hu8F4 in 72 people with advanced blood cancers like leukemia and myelodysplastic syndrome. The goal is to find the safest dose and see if it can slow or stop cancer growth. Researchers will also track how long patients live …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Higher-Dose eye injection shows promise for two leading causes of vision loss
Disease control OngoingThis study tests a higher dose of the drug aflibercept (8 mg) given as an eye injection every 4 weeks to people with wet age-related macular degeneration (nAMD) or diabetic macular edema (DME). The goal is to see if this dosing schedule is safe and works well for those who have a…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New psoriasis drug shows promise for kids in Head-to-Head trial
Disease control OngoingThis study tests a new medicine called bimekizumab against an existing one (ustekinumab) for children and teens aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if bimekizumab works better at clearing skin symptoms. About 168 participants will receive inj…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug shows promise for Crohn's sufferers in Mid-Stage trial
Disease control OngoingThis study tests a new drug called AZD7798 in 120 people with moderate to severe Crohn's disease. The goal is to see if it can reduce symptoms and improve the appearance of the gut lining. Participants are randomly assigned to receive either the drug or a placebo, and neither the…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New lupus drug tested for Long-Term safety in large trial
Disease control By invitation onlyThis study is checking the long-term safety of a drug called dapirolizumab pegol for people with systemic lupus erythematosus (lupus). It involves 760 participants who have already completed earlier studies of the drug. Researchers will monitor side effects over time to see if th…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can Device-Preserved donor lungs boost transplant success?
Disease control By invitation onlyThis registry collects data on lung transplant patients whose donor lungs were preserved and transported using the LUNGguard or BAROguard devices. Researchers track outcomes such as primary graft dysfunction, rejection, survival, ICU and hospital stays, readmissions, and time on …
Sponsor: Paragonix Technologies • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims to deepen remission in early CML
Disease control OngoingThis study tests whether adding ASTX727 to the standard drug dasatinib can better control chronic myeloid leukemia (CML) in newly diagnosed patients. About 70 adults with a specific genetic marker (Philadelphia chromosome) will receive both pills. The goal is to see if the combin…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New gene therapy targets Parkinson's in patients with specific gene flaw
Disease control OngoingThis study tests a new gene therapy called LY3884961 in 32 people with moderate to severe Parkinson's disease who have a specific genetic change (GBA1 mutation). The treatment is given as a single injection into the fluid around the brain and spinal cord. The main goal is to chec…
Phase 1/2 • Sponsor: Prevail Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for lupus skin lesions: drug trial targets stubborn cases
Disease control OngoingThis study tests a drug called litifilimab for people with lupus-related skin disease that didn't get better with standard antimalarial pills. About 450 adults with active skin lesions will receive either the drug or a placebo every 4 weeks for 24 weeks, then everyone gets the dr…
Phase 2/3 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo therapy shows promise for Radioiodine-Resistant thyroid cancer
Disease control OngoingThis phase 2 trial tests a combination of the immunotherapy drug PDR001 with either trametinib or dabrafenib in 19 patients with thyroid cancer that no longer responds to radioiodine treatment. The goal is to see if the combination can shrink tumors. The study is active but no lo…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New cocktail of drugs tested for Tough-to-Treat lymphoma
Disease control OngoingThis phase 2 trial is testing several new drug combinations for people with aggressive B-cell lymphoma that has come back or not responded to standard therapy. About 129 participants will receive one of several experimental combinations, including drugs like ibrutinib and selinex…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for kids with pompe: enzyme combo trial underway
Disease control OngoingThis study tests a new treatment called cipaglucosidase alfa/miglustat in children (0 to under 18 years) with late-onset Pompe disease. The goal is to see if it is safe and how well it works. Participants either have never had enzyme therapy before or have been on it for at least…
Phase 3 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Gene therapy shot aims to tame autoimmune diseases in early trial
Disease control OngoingThis early-phase study tests a single injection of a gene therapy called V001-BCMA for people with autoimmune diseases like lupus that have not responded to standard treatments. The therapy targets and modifies specific immune cells to reduce disease activity. The main goal is to…
Early phase 1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two biologics go head to head in ulcerative colitis
Disease control OngoingResearchers compare two biologic drugs, ustekinumab and infliximab, in adults with moderate to severe ulcerative colitis who have not previously tried biologic therapy. The trial measures how well each drug reduces inflammation, controls symptoms, and improves quality of life, wh…
Sponsor: Helwan University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New study tests everolimus for kidney tumors in TSC patients
Disease control OngoingThis study looks at how safe and effective the drug everolimus is for Taiwanese adults with tuberous sclerosis complex (TSC) who have kidney tumors called angiomyolipomas. Four participants will take the drug and be monitored for side effects and tumor shrinkage. The goal is to c…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New oil therapy could slash Life-Threatening events in kids with rare metabolic disease
Disease control OngoingThis study tests whether triheptanoin, a special oil, can reduce major clinical events (like severe low blood sugar or heart problems) in children with long-chain fatty acid oxidation disorders (LC-FAOD), a rare condition where the body can't break down certain fats for energy. A…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Lifeline for ALK cancer patients: continued access to ceritinib
Disease control OngoingThis study offers continued treatment with the drug ceritinib to people with ALK-positive cancers who were already benefiting from it in a previous Novartis study. The main goal is to track safety and side effects over time. About 233 participants will receive the drug as long as…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for becker MD: new drug shows promise in Long-Term trial
Disease control By invitation onlyThis study looks at the long-term safety and effects of a drug called EDG-5506 (sevasemten) in people with Becker muscular dystrophy, a muscle-weakening disease. About 260 adults and teens who were in earlier EDG-5506 studies will take the drug and be monitored for side effects a…
Phase 2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New eye injection aims to slow genetic blindness
Disease control OngoingThis study tests a new medicine called PYC-001, given as an injection into the eye, for people with a genetic condition that damages the optic nerve (OPA1 optic atrophy). The main goal is to check if the treatment is safe and tolerable. About 18 adults will receive a single dose,…
Phase 1 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for dravet syndrome: phase 3 trial of LP352 aims to cut seizure frequency
Disease control OngoingThis study tests whether the drug LP352 can safely reduce seizures in children and adults with Dravet syndrome, a severe form of epilepsy. About 160 participants will receive either LP352 or a placebo, and researchers will track changes in seizure frequency over several months. T…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can special lenses plus eye drops stop Kids' myopia from getting worse?
Disease control OngoingThis study tests whether combining special glasses (that create optical defocus) with low-dose atropine eye drops can better control myopia (nearsightedness) in children aged 7 to 12. Over 18 months, researchers will measure changes in eye prescription and eye length. The goal is…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a daily injection save your sight? new trial for dry AMD
Disease control OngoingThis phase 3 trial tests whether a daily injection of elamipretide can slow vision loss in people with dry age-related macular degeneration (AMD). About 313 adults aged 55 and older with early dry AMD will receive either the drug or a placebo for 96 weeks. The main goal is to see…
Phase 3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug aims to tame rare bleeding disorder
Disease control OngoingThis study tests a new medicine called ALN-6400 for people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels and frequent nosebleeds. First, healthy volunteers will receive a single dose to check safety. Then, HHT patients will recei…
Phase 1/2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Promising drug may shrink inoperable tumors in kids with rare genetic condition
Disease control OngoingThis study tests a drug called selumetinib in children and young adults (ages 3-18) with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink or slow the growth of these tumors. Participants take the dru…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Crohn's: experimental drug targets gut inflammation
Disease control OngoingThis study tests an experimental drug called RO7790121 in about 21 adults with moderate to severe Crohn's disease who haven't responded well to other treatments. The goal is to see if the drug can reduce gut inflammation and improve symptoms like diarrhea and stomach pain. Partic…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a simple ketone drink reduce the need for surgery in FAP patients?
Disease control By invitation onlyThis study tests whether a daily ketone supplement (BHB) is safe and tolerable for people with Familial Adenomatous Polyposis (FAP), a genetic condition that causes many colon polyps and often leads to surgery. Twenty participants will take the supplement for two weeks to see if …
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hip implant aims to fix cartilage without replacement
Disease control OngoingThis early study is testing a new device called the ReNew Hip Implant in 15 people aged 14 to 64 with hip cartilage damage from conditions like osteoarthritis or hip impingement. The implant is surgically placed to repair the cartilage. Researchers are checking if it is safe and …
Sponsor: Cytex Therapeutics, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug shows promise for Long-Term control of rare immune disorders
Disease control OngoingThis study is testing the long-term safety of a drug called leniolisib in people with primary immunodeficiency disorders linked to PI3K signaling. Participants are 12 people who already took leniolisib in a previous study and may benefit from continuing it. The goal is to see if …
Phase 2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New daily injection could cut bleeding episodes in hemophilia
Disease control OngoingThis study tests a medicine called concizumab for people with hemophilia A or B who do not have inhibitors. The goal is to see if a daily shot under the skin can prevent bleeding episodes safely. About 156 participants, aged 12 and older, will either start concizumab right away o…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Blood test showdown: MCV vs. ferritin in iron overload treatment
Disease control OngoingThis study looks at whether the MCV test (which measures red blood cell size) is as good as or better than the standard ferritin test for guiding phlebotomy (blood removal) therapy in people with hereditary hemochromatosis, a condition causing too much iron absorption. About 622 …
Phase 2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a pill that starves tumors of oxygen help fight advanced cancer?
Disease control OngoingThis early-stage trial is testing an experimental drug called belzutifan in people with advanced solid tumors that have not responded to standard treatments. Belzutifan works by blocking a protein (HIF-2α) that tumors use to survive in low-oxygen conditions. The main goal is to f…
Phase 1 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for tough hodgkin lymphoma: immune drugs tested alone or together
Disease control OngoingThis study tests two immune-boosting drugs, ipilimumab and nivolumab, in people with classic Hodgkin lymphoma that has returned or not responded to prior therapy. The goal is to see if giving these drugs alone or together can shrink tumors. The trial involves 13 adults with measu…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New study tests aggressive BP management to protect heart and kidneys in cancer patients
Disease control OngoingThis phase II trial tests whether intensive blood pressure management (targeting systolic BP below 120 mmHg) is better than standard care (below 140 mmHg) for patients with advanced kidney or thyroid cancer starting anti-angiogenic TKI therapy. The study enrolls 61 participants a…
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for hard-to-treat lung cancer: experimental drug targets MET gene
Disease control OngoingThis study tests an experimental drug called REGN5093 in people with advanced non-small cell lung cancer that has a specific change in the MET gene. The first part finds a safe dose, and the second part checks if the drug can shrink tumors. About 231 participants will take part.
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New stem cell approach aims to cure rare immune disease
Disease control OngoingThis study tests a high-dose stem cell transplant for people with chronic granulomatous disease (CGD), a condition that weakens the immune system. Participants receive donor stem cells along with drugs to prevent rejection and graft-versus-host disease. The goal is to improve tra…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a daily pill boost blood counts in fanconi anemia?
Disease control OngoingFanconi anemia is a genetic condition that can damage bone marrow and lead to low blood cell counts, causing anemia, bleeding, or infections. Researchers are testing whether a daily pill called eltrombopag can improve blood counts in people with this condition. The trial enrolls …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
PET scans guide Nivolumab-Chemo combo in relapsed hodgkin lymphoma
Disease control OngoingResearchers test a treatment plan for adults with Hodgkin lymphoma that has come back or stopped responding to initial therapy. Participants receive nivolumab, an immunotherapy, plus three chemotherapy drugs. PET scans help doctors decide how much treatment each person needs. The…
Phase 1/2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Spinal gene injection aims to slow duchenne in toddlers
Disease control OngoingThis early-stage study tests a single injection of a gene therapy called INS1201, given into the spinal fluid of young boys (ages 2 to 5) with Duchenne muscular dystrophy who can still walk. The main goal is to check if the treatment is safe and to see how it spreads in the body.…
Phase 1 • Sponsor: Insmed Gene Therapy LLC • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Smart scans guide tailored therapy for hodgkin lymphoma patients
Disease control OngoingThis study tests a personalized approach for people with early-stage Hodgkin lymphoma. Doctors use PET scans to decide if standard chemotherapy alone is enough or if adding immunotherapy drugs can improve results. The goal is to boost survival while limiting unnecessary treatment…
Phase 2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New oral drug balinatunfib tested for long-term control of Crohn's and colitis
Disease control OngoingThis study looks at the long-term safety and effectiveness of balinatunfib, an oral tablet, in adults with Crohn's disease or ulcerative colitis. Participants have already completed a one-year treatment in a previous study. The trial will last up to 107 weeks and includes both do…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for Hard-to-Treat seizures: phase 3 trial launches
Disease control OngoingThis study tests an experimental drug called LP352 to see if it can safely reduce seizures in children and adults with developmental and epileptic encephalopathies (DEE), a group of severe epilepsy syndromes. About 320 participants will receive either LP352 or a placebo, and rese…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Parkinson's patients get brain transplants of their own cells
Disease control By invitation onlyThis early-stage trial tests whether transplanting dopamine neurons made from a patient's own stem cells into the brain is safe for Parkinson's disease. Six people aged 55 to 80 with Parkinson's for at least 5 years will receive the cells in a single surgery. The main goal is to …
Phase 1 • Sponsor: Penelope J. Hallett, Ph.D. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immunotherapy boost may wipe out stubborn leukemia cells
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard tyrosine kinase inhibitors (TKIs) can eliminate tiny amounts of leftover leukemia cells in people with chronic myeloid leukemia (CML). About 40 adults with CML who still have detectable cancer marker…
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for duchenne: experimental drug targets genetic glitch
Disease control OngoingThis study tests an experimental drug called NS-089/NCNP-02 (Brogidirsen) in 20 boys with Duchenne muscular dystrophy whose genetic mutation can be fixed by skipping exon 44. The drug is given as a weekly IV infusion and aims to help the body produce a working version of the dyst…
Phase 2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Brain implant shows promise for Hard-to-Treat seizures in rare epilepsy
Disease control OngoingThis study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…
Phase 2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New acne gel put to the test for Year-Long safety
Disease control OngoingThis study is testing whether a new gel applied daily for up to 52 weeks is safe for people with acne. About 400 participants will use the gel on their face and upper body and visit the clinic regularly for checkups. The main goal is to track any side effects, not to measure how …
Phase 3 • Sponsor: PPM Services S.A. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a Two-Drug chemo combo shrink BRCA breast tumors before surgery?
Disease control OngoingResearchers test whether giving mitomycin plus carboplatin before surgery helps people with BRCA1 or BRCA2 mutations and locally advanced triple-negative breast cancer. The trial compares this combination, followed by paclitaxel, against standard chemotherapy. About 30 adults wit…
Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for rare inflammatory disease: pacritinib trial begins
Disease control OngoingThis study tests a drug called pacritinib for people with VEXAS syndrome, a rare genetic disease that causes severe inflammation. About 78 adults will receive either the drug or a placebo to see if it controls symptoms and reduces flare-ups. The goal is to find a safe and effecti…
Phase 2 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug duo aims to control rare lymphoma without chemotherapy
Disease control OngoingThis study tests whether combining zanubrutinib (a targeted pill) with rituximab (an antibody infusion) can shrink or control MALT lymphoma, a slow-growing cancer of the lymph nodes and organs. About 42 adults with newly diagnosed advanced disease or lymphoma that returned after …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Hope for rare disease: new drug shows promise in Long-Term study
Disease control By invitation onlyThis study is for people with PMM2-CDG, a rare genetic disorder, who have already taken the experimental drug GLM101 in a previous trial. The goal is to see if GLM101 is safe and effective over a longer period. Participants will receive weekly infusions of GLM101 at the same dose…
Phase 2 • Sponsor: Glycomine, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Head-to-Head safety check: which Clot-Reversal drug is safer before emergency surgery?
Disease control OngoingThis observational study compares the safety of two drugs, BALFAXAR and KCENTRA, used to reverse the effects of vitamin K antagonist blood thinners (like warfarin) in adults who need urgent surgery or an invasive procedure. The main goal is to see how often blood clots (thromboem…
Sponsor: Octapharma • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New antibody aims to block muscle wasting in rare disease
Disease control OngoingThis Phase 2 trial tests a drug called RO7204239 in 51 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. The drug is an antibody that blocks myostatin, a protein that normally limits muscle growth, to help pres…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill shows promise for rare tumor in japanese patients
Disease control OngoingThis phase 2 study tests the drug nirogacestat in 20 Japanese adults with desmoid tumors that are growing. The goal is to see if the drug can shrink tumors or stop them from getting worse. Participants take nirogacestat as an oral tablet, and researchers will monitor tumor respon…
Phase 2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a supplement duo quiet PCOS-Linked inflammation?
Disease control OngoingResearchers are testing whether a daily combination of myo-inositol and folic acid can lower two markers of inflammation, NLR and CRP, in overweight women aged 25 to 35 with polycystic ovarian syndrome. The trial compares this supplement pair with metformin plus folic acid over t…
Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New antibody cocktail aims to tame ulcerative colitis for good
Disease control By invitation onlyThis study is testing three long-acting antibodies, alone or in combination, in 645 people with ulcerative colitis. The goal is to see if they are safe and can improve bowel inflammation over 48 weeks. Participants are joining from a previous study and may have already seen some …
Phase 2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill could tame lupus flares in major trial
Disease control OngoingThis phase 3 trial tests whether adding cenerimod, a daily pill, to standard lupus treatments can reduce symptoms in adults with moderate-to-severe systemic lupus erythematosus (SLE). About 470 participants will receive either cenerimod or a placebo for 12 months. Researchers wil…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill aims to tame rare immune diseases
Disease control OngoingThis early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for NF1 patients: drug shows promise against inoperable tumors
Disease control OngoingThis study tests a drug called selumetinib in adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink these tumors or slow their growth. Participants take the drug twice daily and are monitored …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug targets Sugar-Coated proteins on cancer cells
Disease control OngoingResearchers are testing an experimental oral drug called PhOx430 in people with advanced solid tumors, including glioblastoma and triple-negative breast cancer. The trial has two parts: first, they give increasing doses to small groups to find a safe dose and watch for side effec…
Phase 1 • Sponsor: Phost'In Therapeutics • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase study tests a combination of two oral drugs, olaparib and ASTX727, in adults with advanced solid tumors that have mutations in genes like BRCA1, BRCA2, PALB2, ATM, or CHEK2. The main goals are to find the safest dose and to check for side effects. About 18 partic…
Phase 1 • Sponsor: Varun Monga, MBBS • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immunotherapy combo aims to boost hodgkin lymphoma response in slow responders
Disease control OngoingThis phase 2 trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can help children and young adults (ages 3-25) with newly diagnosed classical Hodgkin lymphoma who did not respond well to initial chemo. About 340 participants will receive pemb…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New gene therapy aims to fix immune system in rare disease
Disease control By invitation onlyThis study tests a new gene therapy for people with chronic granulomatous disease (CGD), a genetic disorder that weakens the immune system and makes them prone to serious infections. The treatment takes the patient's own blood stem cells, adds a missing gene in the lab, and puts …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug LP352 aims to control seizures in severe epilepsy over the long term
Disease control By invitation onlyThis phase 3 study is testing the long-term safety and effectiveness of LP352 (Bexicaserin) in 324 children and adults with developmental and epileptic encephalopathy (DEE), including Dravet and Lennox-Gastaut syndromes. Participants who completed earlier studies will receive LP3…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Engineered donor cells aim to beat blood cancer without severe side effects
Disease control OngoingThis study tests a new way to treat children and young adults with high-risk blood cancers like leukemia and lymphoma. Doctors take blood cells from a family donor, remove certain T cells that can cause a harmful immune reaction, and then transplant the modified cells. The goal i…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New lupus pill shows promise in major trial
Disease control OngoingThis Phase 3 study tests whether adding cenerimod to standard lupus treatments can better control moderate-to-severe lupus symptoms. About 451 adults will receive either cenerimod or a placebo for 12 months. The main goal is to see if more people improve on a lupus disease activi…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug combo shows promise in controlling Early-Stage leukemia
Disease control OngoingThis study tests a combination of two drugs, dasatinib and venetoclax, in people with early chronic phase chronic myeloid leukemia (CML). The goal is to see if the combination can better control the disease by blocking enzymes that help cancer cells grow. About 155 participants w…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Triple-Target CAR T-Cells take on tough lymphomas
Disease control By invitation onlyThis early-phase trial is testing a new type of immunotherapy called tri-specific CAR T-cells that target three proteins (CD19, CD20, CD22) on cancer cells. It is for adults with B-cell lymphomas that have come back or not responded to standard treatments. The study will enroll 1…
Phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for ulcerative colitis: phase 3 trial of afimkibart underway
Disease control OngoingThis Phase 3 trial tests whether the drug Afimkibart can help people with moderate-to-severe ulcerative colitis achieve remission. About 400 adults who have not responded well to other treatments will receive either Afimkibart or a placebo. The study measures remission at 12 and …
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Nasal spray shows promise against deadly brain cancer
Disease control OngoingThis study tests a nasal spray drug called NEO100 (perillyl alcohol) in people with aggressive brain tumors (grade III or IV gliomas) that have come back or worsened. The trial has two phases: first to find the safest dose, then to see if it helps patients live longer. About 49 p…
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug aims to cut sickle cell pain crises in half
Disease control OngoingThis phase 3 study tests two doses of crizanlizumab against a placebo in 255 adolescents and adults with sickle cell disease who have frequent pain crises. The goal is to see if the drug can reduce the number of severe pain episodes that require a hospital or clinic visit. Partic…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug shows promise for rare blood cancer
Disease control OngoingThis phase 2 study tests acalabrutinib, a targeted drug, in 107 people with Waldenström macroglobulinemia, a rare blood cancer. The goal is to see how well the drug shrinks tumors and controls the disease. Participants either had prior treatment or are new to therapy and cannot t…
Phase 2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Immunotherapy before surgery shows promise for certain colorectal cancers
Disease control OngoingThis trial is testing whether giving the immunotherapy drug pembrolizumab before surgery can improve outcomes for people with high-risk stage 2 or stage 3 colorectal cancer that has a specific genetic feature called mismatch repair deficiency. About 88 participants will receive p…
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Real-World check: is talzenna safe for advanced breast cancer?
Disease control CancelledThis study will track 600 people in Korea with advanced breast cancer who are already being prescribed Talzenna. Researchers will watch for side effects and see how well the drug works in everyday medical practice, not in a strict research setting. The goal is to confirm the drug…
Sponsor: Pfizer • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New MRI technique could revolutionize cystic fibrosis care
Disease control OngoingThis study tests a special MRI technique that uses inhaled gas to create detailed images of lung function in people with cystic fibrosis. Researchers want to see how a new triple-combination therapy changes lung ventilation over time. The study involves 64 participants and aims t…
Phase 4 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New laser method could make glaucoma treatment easier
Disease control By invitation onlyThis study tests if a new, automated laser treatment (DSLT) works as well as the standard laser treatment (SLT) for lowering eye pressure in people with open-angle glaucoma. About 51 adults will receive one of the two treatments and be followed for 12 months. The goal is to see i…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Twice-Daily hormone pill match standard care for CAH?
Disease control CancelledResearchers are testing whether Chronocort, a modified-release hydrocortisone taken twice daily, controls hormones as well as standard glucocorticoid therapy in people aged 16 and over with congenital adrenal hyperplasia. The trial assigns participants to either Chronocort or the…
Phase 3 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Eye drops face off to halt Kids' worsening nearsightedness
Disease control OngoingResearchers compare two strengths of atropine eye drops, 0.05% and 0.5%, in Dutch children aged 6 to 11 with progressive nearsightedness. About 550 children use the drops for three years, then researchers follow them for two more years. The goal is to see which strength better sl…
Phase 3 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Dialysis upgrade could protect bones in kidney patients
Disease control OngoingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can better manage bone and mineral problems common in people with end-stage kidney disease. Thirty adults on maintenance dialysis will try both the new and standard filters for three months each. R…
Sponsor: Gazi University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Cornea transplant showdown: which surgery gives sharper sight?
Disease control OngoingThis study compares two types of cornea transplant surgery—DSAEK and DMEK—in 220 adults with corneal swelling or Fuchs' dystrophy. The goal is to see which procedure leads to better vision and patient satisfaction one year after surgery. Participants will be randomly assigned to …
Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New epilepsy drug XEN1101 tested for long-term seizure control
Disease control By invitation onlyThis study tests the long-term safety and effectiveness of XEN1101 (azetukalner) in 880 adults with focal or tonic-clonic seizures. Participants who completed earlier studies will take XEN1101 capsules for up to 6 years. Researchers will track side effects and changes in monthly …
Phase 3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug cocktail shows promise for tough childhood brain cancers
Disease control OngoingThis trial is testing whether adding hydroxychloroquine to two targeted cancer drugs (dabrafenib and trametinib) can help children and young adults with certain brain tumors that have come back or not responded to treatment. The study includes patients with specific genetic chang…
Phase 1/2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can early PET scans guide a gentler, more effective attack on hodgkin lymphoma?
Disease control OngoingThis phase 2 trial tests whether adjusting treatment based on a very early PET scan can improve outcomes and reduce side effects for people with advanced Hodgkin lymphoma. Participants receive brentuximab vedotin plus chemotherapy, with the regimen modified according to how well …
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill could tame severe ulcerative colitis Flare-Ups
Disease control OngoingThis study tests an experimental drug called SAR441566 in about 204 adults with moderate-to-severe ulcerative colitis, a chronic bowel disease causing inflammation and symptoms like diarrhea and bleeding. Participants will receive either the drug or a placebo for up to 52 weeks t…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New bone graft material could improve spine surgery outcomes
Disease control OngoingThis study is testing a material called Orthoss®, made from granules, to help bones in the spine fuse together after surgery. The trial includes 65 adults with lower back problems like slipped discs or narrowing of the spine canal. Doctors will check if the bones fuse properly an…
Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a Drug-Radiation combo outsmart Treatment-Resistant colorectal cancer?
Disease control CancelledThis phase 2 trial is testing whether combining an experimental drug called S-531011 with a precise radiation technique known as RadScopal can help control metastatic colorectal cancer that has not responded to prior treatments. The study enrolls about 30 adults with advanced dis…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New implant could replace eye drops after corneal surgery
Disease control By invitation onlyThis study tests whether a tiny steroid-releasing implant (Dextenza) placed in the tear duct works as well as standard steroid eye drops after corneal crosslinking surgery for keratoconus. About 20 people aged 13 and older with progressive keratoconus will receive either the impl…
Phase 1/2 • Sponsor: Maanasa Indaram, MD • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New stem cell transplant trial aims to control tough lymphoma
Disease control OngoingThis study tests a stem cell transplant to control peripheral T-cell lymphoma in people whose cancer has not responded to standard treatments. Participants receive a donor's stem cells after chemotherapy or antibody therapy to prepare their body. The goal is to see if this approa…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New lupus drug tested for Long-Term safety in 680 patients
Disease control By invitation onlyThis study looks at the long-term safety of cenerimod in adults with moderate-to-severe lupus. About 680 participants who were in a previous study will take cenerimod for up to 3 years, along with their usual lupus medications. Researchers will track side effects and see how well…
Phase 3 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control OngoingThis study tests an experimental oral drug called GS-5290 (tilpisertib fosmecarbil) in 176 adults with moderate to severe ulcerative colitis. Participants are randomly assigned to receive either the drug or a placebo for 12 weeks. The main goal is to see if the drug can improve s…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New lupus drug shows promise in Long-Term safety trial
Disease control By invitation onlyThis study looks at the long-term safety of a drug called litifilimab for people with active lupus. About 864 adults who finished earlier studies will continue taking the drug for up to 3 years, along with their usual treatments. The goal is to see how safe it is and how well it …
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New eye injection aims to slow vision loss from Age-Related macular degeneration
Disease control OngoingThis study tests the safety of a drug called ASP3021 (avacincaptad pegol) for people in Japan with geographic atrophy, an advanced form of age-related macular degeneration that causes vision loss. Twenty participants will receive monthly injections into the affected eye for 12 mo…
Phase 4 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Myopia glasses may keep working even after kids take them off
Disease control OngoingResearchers are studying whether the benefit of a special spectacle lens for slowing nearsightedness lasts after children stop wearing it. The trial follows 91 children who took part in an earlier three-year study, where some wore the innovative lenses and others wore regular sin…
Sponsor: Essilor International • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could an antibody slow Parkinson's? new trial hopes to find out
Disease control OngoingThis study tests an experimental drug called prasinezumab in 316 people with early Parkinson's disease. The drug is an antibody designed to target and remove clumps of a protein linked to Parkinson's. Participants receive either the drug or a placebo for 52 weeks, with an option …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for Crohn's: experimental drug aims to heal the gut
Disease control OngoingThis study tests an experimental drug called SAR441566 in 260 adults with moderate to severe Crohn's disease. Participants will receive different doses of the drug or a placebo for up to 52 weeks to see if it reduces gut inflammation and improves symptoms. The goal is to find a s…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug could cut transfusions for rare blood disorder
Disease control OngoingThis phase 2 trial tests luspatercept (Reblozyl) in adults and adolescents with alpha-thalassemia, a genetic blood disorder that causes anemia. The goal is to see if the drug can reduce the need for blood transfusions and raise hemoglobin levels. About 189 participants will recei…
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Gene therapy hope for duchenne boys in first human test
Disease control OngoingThis early-stage trial tests a single dose of a gene therapy called JWK007 in 3 boys aged 5-10 with Duchenne muscular dystrophy. The main goal is to check safety and tolerability, while also looking at whether it helps muscle function. It is a very small, first-in-human study, so…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can tailoring bypass length improve weight loss surgery results?
Disease control By invitation onlyResearchers are studying how the length of bypassed intestine during gastric bypass affects weight loss, complications, and metabolic changes in people with severe obesity. Participants will have different lengths of intestine bypassed and will provide blood and stool samples bef…
Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Gene therapy shot could end frequent eye injections for wet AMD
Disease control OngoingThis early-stage trial tests a one-time gene therapy injection (NG101) for wet age-related macular degeneration. The therapy uses a harmless virus to deliver a gene that makes a drug inside the eye, aiming to reduce the need for repeated anti-VEGF injections. About 20 adults aged…
Phase 1/2 • Sponsor: Elisigen, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Ketogenic diet vs mediterranean diet: which better reshapes metabolism?
Disease control OngoingResearchers compare a very low calorie ketogenic diet with a Mediterranean-style low-calorie diet in 40 adults who have type 2 diabetes, obesity, and non-alcoholic fatty liver disease. Participants follow one of the two diets for several weeks. The study measures changes in weigh…
Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could skipping Face-Down recovery be safe for macular hole surgery?
Disease control OngoingThis trial tests whether people with large macular holes (over 400 micrometres) can heal without the usual face-down positioning after surgery. All participants undergo a procedure called inverted flap vitrectomy with gas tamponade, and half are asked to avoid face-down posturing…
Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New combo shows promise for rare adrenal cancers
Disease control OngoingThis study tests whether adding olaparib to the standard chemotherapy temozolomide helps control advanced pheochromocytoma or paraganglioma—rare neuroendocrine tumors that have spread or can't be removed surgically. About 46 adults with these cancers will be randomly assigned to …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug bitopertin offers hope for sunlight pain relief in rare blood disorders
Disease control By invitation onlyThis long-term study tests the safety and effectiveness of bitopertin (DISC-1459) in people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain from sunlight exposure. About 230 participants who previously took bitoper…
Phase 2/3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Brain implant that learns: new hope for Parkinson's?
Disease control OngoingThis study tests an adaptive deep brain stimulation (aDBS) system that automatically adjusts stimulation based on real-time brain signals. It aims to improve symptom control for 62 people with Parkinson's disease in China who already have a compatible brain implant. The main goal…
Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could dead donors provide Life-Saving bone marrow?
Disease control OngoingThis early study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. Twelve patients will receive the transplant along with chemotherapy or radiation. The main goal is to see if the new ma…
Phase 1/2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New triple therapy shows promise for cystic fibrosis in Long-Term trial
Disease control OngoingThis study tests a triple-combination drug (VX-121/TEZ/D-IVA) for people with cystic fibrosis, a genetic condition that affects the lungs and digestion. The goal is to see if the treatment is safe and works well over a long period. About 822 participants who completed earlier stu…
Phase 3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Trikafta's long-term safety tested in cystic fibrosis patients with rare mutations
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug combination Trikafta (elexacaftor/tezacaftor/ivacaftor) in people with cystic fibrosis who have certain non-F508del gene mutations. About 297 participants who completed a prior study will continue taking the m…
Phase 3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Lung cancer hope: drug combo aims to boost survival in Early-Stage disease
Disease control OngoingThis phase 3 trial tests whether adding pembrolizumab (an immunotherapy) and olaparib (a targeted drug) to standard chemotherapy and radiation can help people with limited-stage small cell lung cancer live longer. About 672 participants will receive either the drug combo or a pla…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug Mim8 shows promise for Long-Term bleeding prevention in hemophilia a
Disease control OngoingThis study tests Mim8, a drug that helps blood clot by mimicking a missing protein, in people with hemophilia A (with or without inhibitors). Over 450 participants will receive injections for up to 5.5 years to see if it safely prevents bleeding episodes. The goal is to provide a…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for Drug-Resistant stomach cancer? sorafenib trial underway
Disease control OngoingThis phase 2 trial tests the drug sorafenib in 38 patients with gastrointestinal stromal tumor (GIST) that has worsened despite treatment with imatinib and sunitinib. Sorafenib works by blocking enzymes that help tumors grow and by cutting off blood supply to the cancer. The stud…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill hopes to tame rare blood cancer in japanese patients
Disease control OngoingThis study tests a cancer pill called venetoclax in 14 Japanese adults with a rare blood cancer (Waldenström macroglobulinemia) that has come back or not responded to treatment. Participants take the drug by mouth daily, with doses slowly increased. The main goal is to see how ma…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New oral drug shows promise for rare sun allergy conditions
Disease control OngoingThis study is for people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain and skin reactions to sunlight. The purpose is to check the long-term safety of an oral medication called dersimelagon. About 301 participant…
Phase 3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Hope for rare muscle disease: new drug enters final testing phase
Disease control OngoingThis study tests a drug called BBP-418 (Ribitol) in 81 people aged 12 to 60 with limb girdle muscular dystrophy type 2I (LGMD2I), a genetic condition that causes progressive muscle weakness. Participants receive either the drug or a placebo for 36 months to see if it slows the di…
Phase 3 • Sponsor: ML Bio Solutions, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for angelman syndrome: experimental drug enters Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called GTX-102 (apazunersen) in 60 people with Angelman syndrome, a genetic disorder causing developmental delays and seizures. Participants range from 1 to 65 years old and are grouped by age and genetic type. The goal is to see if the drug …
Phase 2 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New injection aims to tame lupus when standard treatments fail
Disease control OngoingThis early-stage study tests an injection called GC012F in 20 adults with refractory systemic lupus erythematosus (SLE) — a type of lupus that hasn't responded to standard treatments. The goal is to see if the therapy is safe and can reduce disease activity. Participants receive …
Phase 1/2 • Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
SMA drug risdiplam under Long-Term watch: will it hold up?
Disease control OngoingThis study follows 403 adults and children with spinal muscular atrophy who are already taking risdiplam (Evrysdi) as prescribed by their doctor. Researchers will track side effects and how well the drug works over about two years. The goal is to see if risdiplam remains safe and…
Phase 4 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Gene therapy aims to tame rare metabolic disorder
Disease control OngoingThis Phase 3 trial tests a gene therapy called DTX301 for people with late-onset OTC deficiency, a rare genetic disorder that causes dangerous ammonia buildup. The study involves 37 participants and compares the gene therapy to a placebo. The goal is to see if the treatment can h…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New Muscle-Boosting drug combo tested for SMA
Disease control OngoingThis study tests whether adding an experimental drug (RO7204239) to an existing SMA medicine (risdiplam) can help people with spinal muscular atrophy build stronger muscles and move better. The trial includes about 259 children and young adults, ages 2 to 25, who can walk. Resear…
Phase 2/3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug aims to control angelman syndrome long-term
Disease control OngoingThis phase 3 trial tests the long-term safety of GTX-102 (apazunersen) in 255 people with Angelman syndrome, a genetic disorder causing developmental delays and seizures. Participants have already completed an earlier GTX-102 study and will continue receiving the drug. The main g…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Pompe disease patients get continued enzyme therapy in Long-Term safety study
Disease control OngoingThis study follows 17 people with Pompe disease who have already taken part in earlier trials of avalglucosidase alfa (Nexviadyme). It aims to check the drug's long-term safety and effectiveness by giving it every two weeks as an IV infusion. The study will continue until the dru…
Phase 4 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Triple therapy under the microscope: does it transform cystic fibrosis care?
Disease control OngoingResearchers are observing how elexacaftor/tezacaftor/ivacaftor triple combination therapy affects people with cystic fibrosis in routine care. The study follows two groups: children aged 6 to 11 and people aged 12 and older. Over seven years, they measure lung function, inflammat…
Phase 4 • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can focused radiation replace surgery for inherited pancreatic tumors?
Disease control OngoingPeople with MEN1 syndrome inherit a high risk of developing multiple pancreatic neuroendocrine tumors. Surgery is the only curative option but causes major complications. Researchers are testing high-dose, high-precision MR-guided radiotherapy to see if it can shrink these tumors…
Sponsor: J.M. de Laat • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New daily injection could cut bleeding in Tough-to-Treat hemophilia
Disease control OngoingThis study tests a drug called concizumab, given as a daily shot under the skin, to prevent bleeding in people with hemophilia A or B who have inhibitors (antibodies that block standard treatment). About 134 participants either start concizumab right away or continue their usual …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for kids with rare kidney disease: crovalimab trial underway
Disease control OngoingThis phase 3 trial tests crovalimab in 41 children with atypical hemolytic uremic syndrome (aHUS), a rare disease that causes blood clots and kidney damage. The drug is given first through a vein, then as a shot under the skin every four weeks. The goal is to see if it can stop d…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill combo aims to slash cholesterol in High-Risk patients
Disease control OngoingThis Phase 3 study tests whether a daily pill combining obicetrapib and ezetimibe, or obicetrapib alone, can lower LDL (bad) cholesterol more than placebo in 300 people with type 2 diabetes or metabolic syndrome. Participants continue their standard cholesterol medications. The m…
Phase 3 • Sponsor: NewAmsterdam Pharma • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Gene therapy trial targets duchenne in toddlers
Disease control OngoingThis study tests a gene therapy called delandistrogene moxeparvovec in 13 children under age 4 with Duchenne muscular dystrophy. The goal is to see if it is safe and can help produce a key muscle protein. The children will be followed for about 5 years.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Daily Bone-Growth drug tested for taller stature in hypochondroplasia
Disease control By invitation onlyResearchers are studying whether daily injections of vosoritide can safely improve long-term growth in children with hypochondroplasia, a genetic condition that causes short stature. The trial enrolls about 140 children who have already taken vosoritide in earlier studies and who…
Phase 3 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Sound waves open brain barrier to attack deadly tumor
Disease control PausedThis early study tests a combination approach for recurrent glioblastoma, an aggressive brain cancer. The treatment uses focused ultrasound (NaviFUS) to temporarily open the blood-brain barrier, allowing the drug Avastin (bevacizumab) to reach the tumor more effectively. Ten adul…
Phase 1/2 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New enzyme therapy aims to reach the brain in MPS II
Disease control OngoingResearchers are testing tividenofusp alfa (DNL310), an experimental enzyme replacement therapy, against the standard treatment idursulfase in children and young adults with mucopolysaccharidosis type II (MPS II). The study includes participants with and without brain involvement,…
Phase 2/3 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New clotting factor aims to stop bleeding in severe hemophilia a
Disease control OngoingThis phase 3 trial tests a new drug called FRSW107, a lab-made clotting factor VIII fused with a protein that helps it last longer in the body. The study enrolls males aged 12 to 65 with severe hemophilia A who have had at least 150 prior exposure days to factor VIII products. Pa…
Phase 3 • Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Gene fix trial aims to tame rare immune disease
Disease control By invitation onlyThis study tests a gene therapy for people with X-linked chronic granulomatous disease (X-CGD), a genetic condition that weakens the immune system and leads to severe infections. Researchers take the patient's own stem cells, add a working copy of the faulty gene, and return the …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Raspberry diet shows promise for gut health and metabolism
Disease control OngoingThis study looks at whether eating 2 cups of frozen raspberries daily for 8 weeks can improve blood sugar, cholesterol, and gut health in overweight or obese adults with early signs of metabolic syndrome. Researchers want to see if the berries' natural compounds help by changing …
Sponsor: Laval University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
One-Time infusion aims to build cancer killers inside the body
Disease control OngoingThis early study tests a new gene therapy called INT2104 in 10 adults with B-cell cancers that have come back or not responded to treatment. The therapy is given as a single IV infusion and works by instructing the body to create its own cancer-fighting T cells and natural killer…
Phase 1 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for men with Hard-to-Treat prostate cancer?
Disease control OngoingThis phase 3 trial compares a new drug, BMS-986365, against standard treatments (docetaxel or other hormone therapies) in 960 men with metastatic castration-resistant prostate cancer that has stopped responding to hormone therapy. The main goal is to see if the new drug delays ca…
Phase 3 • Sponsor: Celgene • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New vaccine combo aims to slow Alzheimer's by targeting tau tangles
Disease control By invitation onlyThis study tests a vaccine called AADvac1, which targets tau tangles in the brain, a hallmark of Alzheimer's. It will be given alone or with another drug (donanemab) to 450 adults aged 50-80 with very early Alzheimer's. The goal is to see if this approach can reduce tau buildup a…
Phase 2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New mRNA inhalation therapy offers hope for Hard-to-Treat cystic fibrosis
Disease control OngoingThis early-stage trial tests an inhaled mRNA therapy called VX-522, combined with an existing drug (ivacaftor), in 26 adults with cystic fibrosis who have genetic mutations that do not respond to current modulator treatments. The main goals are to check safety and tolerability, a…
Phase 1/2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug cocktail targets rare bone cancer that spreads
Disease control OngoingThis study tests two drug combinations (belinostat plus either guadecitabine or ASTX727) in 19 adults with a rare bone cancer called chondrosarcoma that has spread or cannot be removed surgically. The goal is to see if the drugs can shrink tumors or stop them from growing. Partic…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Eye size may reveal which kids benefit most from myopia lenses
Disease control OngoingThis study tests whether pupil size changes can predict how well peripheral defocus spectacle lenses slow myopia progression in children. Researchers will measure pupil responses and track eye growth over 24 months in 14 kids with progressive myopia. The goal is to see if a simpl…
Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new enzyme therapy tame MPS II over time?
Disease control OngoingThis study tests the long-term safety and effects of JR-141, an enzyme replacement therapy, in people with mucopolysaccharidosis II (MPS II), a rare genetic disorder. Participants who completed an earlier JR-141 trial receive the drug again by IV infusion. Researchers track side …
Phase 2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a short pill course save hand function in advanced MS?
Disease control OngoingThis UK trial tests whether cladribine tablets, taken for just 8-10 days a year over two years, can slow the loss of hand function in people with advanced multiple sclerosis (MS). The study includes 204 participants with significant disability (EDSS 6.5-8.5). Half receive cladrib…
Phase 2/3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a direct brain infusion slow sanfilippo syndrome?
Disease control OngoingThis trial tests an experimental enzyme replacement called GC1130A in children with Sanfilippo syndrome type A, a rare genetic disease that damages the brain. The enzyme is given through a small device placed under the scalp that delivers it directly into the fluid around the bra…
Phase 1 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug hope for rare kidney disease: daratumumab trial launches
Disease control OngoingThis study tests a drug called daratumumab in 40 people with a rare kidney condition called PGNMID, where abnormal proteins damage the kidneys. Participants receive weekly injections for 8 weeks, then every two weeks for another 8 weeks. The goal is to see if the drug can reduce …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a brain implant let paralyzed people control computers with their minds?
Disease control OngoingThis study tests a device called a motor neuroprosthesis, an implantable brain computer interface designed to help people with severe paralysis control digital devices like computers or tablets. The device aims to bypass damaged motor pathways and transmit brain signals directly …
Sponsor: Synchron Medical, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Blueberry powder may tame metabolic syndrome by boosting gut bacteria
Disease control OngoingThis study tests whether taking 50 grams of blueberry powder daily for 8 weeks can improve gut bacteria and metabolic health in overweight or obese adults. Researchers will measure changes in blood sugar, cholesterol, and gut microbes. The goal is to see if blueberries can help m…
Sponsor: Laval University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a weekly infusion reach the brain to fight a rare childhood disease?
Disease control OngoingThis trial tests an experimental drug called JR-441 in children with mucopolysaccharidosis type IIIA (MPS IIIA), a rare genetic condition that harms the brain and body. Researchers give the drug as a weekly intravenous infusion to see if it is safe and tolerable. They also measur…
Phase 1/2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug aims to slow Parkinson's progression in early stages
Disease control OngoingThis phase 2 trial tests whether prasinezumab, given as an IV infusion every 4 weeks, can slow motor decline in people with early Parkinson's disease. The study includes 586 participants who are already on stable Parkinson's medication. Researchers are measuring how long it takes…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could an arthritis drug help kids with duchenne MD? new trial aims to find out
Disease control OngoingThis study tests satralizumab, a drug that calms inflammation, in 30 children aged 8 to 17 with Duchenne muscular dystrophy. The goal is to see if it improves bone density and muscle function. Participants receive injections for several months while continuing standard steroid th…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New study aims to help smokers with HIV kick the habit for good
Disease control OngoingThis study tests whether a smoking cessation medication (varenicline) combined with tools to help people stick with treatment can improve quit rates for smokers living with HIV. About 340 participants will be followed for 6 months to see if they stop smoking, confirmed by breath …
Phase 3 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New clotting factor aims to cut bleeding episodes in severe hemophilia a
Disease control OngoingThis phase 3 trial tests a new drug called FRSW107, a long-lasting version of clotting factor VIII, in people with severe hemophilia A. The study enrolls males aged 12 to 65 who have had at least 150 prior exposure days to factor VIII products. Participants receive regular inject…
Phase 3 • Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection tame hereditary swelling attacks?
Disease control ApprovedThis program provides access to an investigational drug called donidalorsen for people with hereditary angioedema (HAE), a genetic condition that causes sudden, painful swelling in various body parts. The drug is given as a monthly or every-other-month injection under the skin. I…
Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a single injection drug calm the immune attack on kidneys?
Disease control OngoingThis phase 2 trial tests an experimental drug called SGB-9768 in adults with three related kidney diseases: IgA nephropathy, C3 glomerulopathy, and immune complex-mediated membranoproliferative glomerulonephritis. These conditions occur when the immune system deposits proteins in…
Phase 2 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a tiny metal plug fix painful ankle defects?
Disease control OngoingThis trial tests whether a small metal implant, called the Episealer Talus, can relieve pain and improve function in people with a specific type of ankle cartilage damage. The study will enroll 20 adults aged 18 to 65 who have a focal defect on the talus bone and have not improve…
Sponsor: Stefano Zaffagnini • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New pill aims to keep ulcerative colitis in check for a year
Disease control OngoingThis study looks at the safety and effectiveness of Velsipity tablets taken daily for up to 52 weeks by people with moderate to severe ulcerative colitis. About 553 participants will be followed in real-world medical settings. The goal is to see if the drug can help control sympt…
Sponsor: Pfizer • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Lupus drug anifrolumab put to the test in Real-World study
Disease control OngoingThis study follows 551 people with lupus who are starting anifrolumab for the first time. Researchers will track how well the drug controls disease activity, reduces flares, and improves quality of life over time. The goal is to see if the benefits seen in clinical trials hold up…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
AI Doctor's helper: could a smart system improve heart and diabetes care?
Disease control OngoingThis study will test whether an artificial intelligence (AI) system can help community doctors better manage patients who have high blood pressure along with diabetes or high cholesterol. About 6,800 adults will be split into two groups: one where doctors use the AI tool to guide…
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Contact lens showdown: which lens slows Kids' nearsightedness best?
Disease control OngoingThis study compares two special contact lenses (MiSight 1 Day and Abiliti 1-Day) to see which one better slows the worsening of nearsightedness in Chinese children aged 6-12 living in New Zealand. Each child will wear a different lens in each eye for 6 months. The goal is to find…
Phase 3 • Sponsor: Aston University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New eye drug could slash injection frequency for wet AMD patients
Disease control OngoingThis phase 3 trial tests EYP-1901, a new eye injection that may last longer than current treatments for wet age-related macular degeneration (AMD). About 400 participants will receive either EYP-1901 or the standard drug aflibercept. The goal is to see if EYP-1901 can maintain or…
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Gene-Targeting drug could change how we treat high blood pressure
Disease control OngoingThis early-stage study tests a new drug called ADX-850 in 28 people with mild to moderate high blood pressure. The drug uses siRNA technology to target genes involved in blood pressure regulation. The main goal is to check safety and how the drug moves through the body, with a se…
Phase 1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a less invasive reflux surgery match the standard one?
Disease control OngoingThis trial compares two surgical procedures for people with gastroesophageal reflux disease (GERD) and a hiatal hernia. One procedure, called transoral incisionless fundoplication (TIF), is done through the mouth without cuts. The other, laparoscopic Nissen fundoplication (LNF), …
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New lupus drug RO7507062 enters first human safety trial
Disease control OngoingThis early-stage study tests a new drug called RO7507062 in 70 people with systemic lupus erythematosus (SLE). The main goal is to check its safety and how the body processes it. Participants receive the drug as a shot under the skin, and the study will look for side effects and …
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New eye drug aims to cut injection frequency for wet AMD patients
Disease control OngoingThis phase 3 trial tests EYP-1901, a new eye injection that may last longer than current treatments for wet age-related macular degeneration (AMD). About 400 people with wet AMD will receive either EYP-1901 or standard aflibercept injections over 2 years. The main goal is to see …
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a leukemia drug slow Parkinson's disease?
Disease control OngoingResearchers are testing whether radotinib, a drug used for leukemia, can help people with Parkinson's disease. The trial will give the drug or a placebo to about 43 adults aged 40 to 80 who were diagnosed within the past three years. The study measures safety, how the drug moves …
Phase 2 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New cocktail aims to boost remission in rare blood cancer
Disease control OngoingThis phase II trial tests whether adding the targeted drug acalabrutinib to standard chemotherapy (bendamustine and rituximab) improves outcomes for people with untreated Waldenstrom's macroglobulinemia, a rare blood cancer. About 63 participants will receive the three-drug combo…
Phase 2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy trial for rare muscle disease halted after severe side effects
Disease control OngoingThis trial tested a gene therapy called AT132 for X-linked myotubular myopathy (XLMTM), a rare muscle disease present at birth that causes severe breathing problems. The therapy aimed to deliver a healthy copy of the MTM1 gene to improve muscle function. However, the study was st…
Phase 2/3 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could removing certain immune cells prevent a deadly transplant complication?
Disease control OngoingThis study tests whether removing a specific type of immune cell (naive T cells) from donor stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body after a stem cell tr…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a lower dose of a leukemia drug keep the disease in check?
Disease control OngoingThis study tests whether reducing the dose of the cancer drug radotinib can still control chronic myeloid leukemia in its early phase while possibly easing side effects. Adults newly diagnosed with this blood cancer take a lower dose twice daily for up to a year. Researchers meas…
Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a newer drug outperform the standard for chronic myeloid leukemia?
Disease control OngoingThis phase III trial compares two oral drugs, radotinib and imatinib, in adults newly diagnosed with chronic myeloid leukemia in its chronic phase. Researchers want to see if radotinib, taken twice daily, achieves a deeper molecular response at 12 months than imatinib, taken once…
Phase 3 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Children's trial launches for Friedreich's ataxia drug
Disease control OngoingThis study tests omaveloxolone, a drug already approved for adults with Friedreich's ataxia, in children aged 2 to 15. Researchers want to see how the drug moves through children's bodies and whether it is safe. The study involves two parts: a single dose followed by daily dosing…
Phase 1 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
When waters break early, does acting fast beat waiting?
Disease control By invitation onlyThis trial studies women whose water breaks before labor starts, a condition called premature rupture of membranes, at 37 to 42 weeks of pregnancy. Half the participants will have labor induced within 24 hours using a vaginal gel, while the other half will wait up to 24 hours for…
Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Bubble boy disease gets a gene fix: new trial offers hope
Disease control By invitation onlyThis study tests a new gene therapy for X-linked severe combined immunodeficiency (X-SCID), a rare immune disorder. Doctors take a person's own stem cells, fix a faulty gene using a technique called base editing, and return the cells to the body. The goal is to rebuild the immune…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a weekly infusion slow the toll of a rare genetic disease?
Disease control OngoingThis trial tests whether JR-141, an enzyme replacement therapy given as a weekly IV infusion, can safely manage mucopolysaccharidosis type II (MPS II) over the long term. Researchers will follow about 27 people who completed an earlier JR-141 study, tracking side effects, develop…
Phase 2/3 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Bone-Boosting shot tested for first time in humans
Disease control OngoingThis early-stage study tests a new injectable drug called LYN101 in 44 people. First, healthy volunteers get a single dose to check safety. Then, postmenopausal women with low bone mass get multiple doses to see how the drug affects bone turnover markers. The main goal is safety,…
Phase 1 • Sponsor: Shanghai TTM-Bio Technology Co., Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New Huntington's drug enters first human tests
Disease control OngoingThis early-stage study tests a new drug called RG6496 in people who carry the gene for Huntington's disease. The main goal is to check if the drug is safe and how the body handles it. About 40 participants will receive a single dose injected into the spine, with some getting a pl…
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Old asthma drug shows promise for rare genetic disorder
Disease control OngoingThis phase 2 trial tests whether theophylline, a drug used for asthma, can help people with pseudohypoparathyroidism lose weight and improve blood sugar control. The study includes 29 obese participants aged 13 and older. Researchers will measure changes in body mass index and gl…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Sound waves aimed at the brain: a new approach to OCD?
Disease control OngoingThis trial tests whether low intensity focused ultrasound (LIFU), a non-invasive technique that uses sound waves to stimulate deep brain regions, can safely ease symptoms of obsessive-compulsive disorder (OCD). Researchers will target the ventral striatum, an area linked to OCD, …
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a cancer drug stop the body from making extra bone?
Disease control OngoingThis phase 2 trial tests whether saracatinib, an oral drug originally developed for cancer, can prevent new abnormal bone growth in adults with fibrodysplasia ossificans progressiva (FOP), a rare genetic condition where muscle and soft tissue turn into bone. Twenty adults with ac…
Phase 2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill could let Sun-Sensitive patients enjoy the outdoors
Disease control OngoingThis Phase 3 trial tests whether bitopertin, a daily pill, can help people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) spend more time in sunlight without pain. About 183 participants aged 12 and older will take bitopertin or a placebo for 6 months. …
Phase 3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Small study tests plerixafor for gene therapy in sickle cell
Disease control OngoingThis early-phase trial is testing whether the drug plerixafor can safely and effectively collect enough stem cells from people with sickle cell disease for a future gene therapy. Only 5 participants are enrolled, and the main goal is to check for side effects. If it works, it cou…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New 'Sandwich' strategy aims to stop leukemia relapse
Disease control OngoingThis study tests a new treatment plan for adults with B-cell acute lymphoblastic leukemia (B-ALL) who cannot or choose not to have a donor stem cell transplant. The approach uses a 'sandwich' strategy: first, patients receive two types of CAR T-cells (targeting CD22 and CD19), th…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a daily zinc pill tame insulin resistance in polyendocrine ovarian syndrome?
Disease control By invitation onlyThis trial tests whether taking 50 mg of zinc daily for 12 weeks, alongside standard treatment, improves insulin resistance and other features of polyendocrine metabolic ovarian syndrome (PMOS) in women aged 18 to 45. PMOS is a common hormone condition linked to insulin resistanc…
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Gene therapy trial hopes to treat rare muscle disease
Disease control OngoingThis early-stage study tests a gene therapy called AT845 for adults with late-onset Pompe disease, a condition that weakens muscles. The treatment aims to deliver a working copy of the GAA gene to muscle cells. Eleven participants who have been on standard enzyme replacement ther…
Phase 1/2 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a common asthma drug help treat a rare genetic disorder?
Disease control By invitation onlyThis study tests whether theophylline, a drug used for asthma, can help children and young adults with pseudohypoparathyroidism—a rare genetic condition causing early obesity, hormone problems, and short stature. Researchers will check for weight loss, better blood sugar control,…
Phase 2 • Sponsor: Jaclyn Tamaroff • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a brain implant learn to sense OCD distress and respond in real time?
Disease control OngoingThis trial tests an adaptive deep brain stimulation system for people with severe obsessive-compulsive disorder (OCD) that has not improved with standard treatments. The device, implanted in the brain, aims to detect brain signals linked to OCD distress and adjust its stimulation…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hip implant aims to cut repeat surgeries
Disease control OngoingThis study is testing a new hip implant called the OR3O Dual Mobility System in 177 people who need hip replacement surgery. The goal is to see if the implant is safe and lasts longer without needing another surgery. Researchers will follow participants for up to 10 years to chec…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called MK-2870, either alone or with the immunotherapy pembrolizumab, in Japanese patients with advanced solid tumors or a type of lung cancer. The main goal is to check the safety and side effects of these treatments. About 30 people will …
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
One-Time cell therapy could tame tough lupus
Disease control OngoingThis study tests a one-time treatment called rapcabtagene autoleucel, made from a patient's own immune cells, for people with active lupus or lupus kidney disease that hasn't improved with standard therapies. About 179 adults will receive the treatment after a short chemotherapy …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a One-Time immune cell infusion help older leukemia patients avoid harsh chemo?
Disease control OngoingThis early-phase trial tests a personalized cell therapy for adults aged 60 and older with B-cell acute lymphoblastic leukemia (ALL) who are in first remission. Researchers take a patient's own immune cells, modify them in the lab to recognize and attack leukemia cells, and infus…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a single infusion stop GPP flares in their tracks?
Disease control OngoingThis study is testing whether the drug spesolimab can safely and effectively treat repeated flares of generalized pustular psoriasis (GPP), a serious skin condition. Adults with GPP who have had a flare will receive a single intravenous dose of spesolimab, with a possible second …
Phase 4 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Which DBS setting works best for Parkinson's? a trial puts anodic vs cathodic to the test
Disease control OngoingThis trial tests three deep brain stimulation (DBS) settings in people with Parkinson's disease who already have a Boston Scientific Vercise system implanted. The settings are pure anodic, pure cathodic, and a mix of both. Researchers want to see which setting offers the best sym…
Sponsor: University of South Florida • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New eye lens could let you focus without glasses after cataract surgery
Disease control OngoingThis study is testing a new type of intraocular lens (IOL) that can be adjusted after cataract surgery using laser energy, potentially allowing the eye to focus at different distances. Researchers will enroll 85 adults with cataracts in both eyes to check safety and how well the …
Sponsor: Alcon Research • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a collagen patch replace a palate graft for Better-Looking dental implants?
Disease control OngoingThis trial tests whether a collagen matrix can match the standard tissue graft for improving gum shape around a single dental implant in the front upper jaw. Thirty adults with one missing tooth will receive an implant and then either a graft taken from their palate or a collagen…
Sponsor: Damascus University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a single gene therapy calm Parkinson's for years?
Disease control OngoingThis study follows people with Parkinson's disease who previously received AAV-GAD, a gene therapy infused into a brain region that helps control movement. The goal is to check how safe the treatment remains over many years, watching for any drug-related side effects. Researchers…
Phase 1/2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New pill combo aims to crush bad cholesterol
Disease control OngoingThis study tests whether adding a new drug called AZD0780 to the common statin rosuvastatin can lower 'bad' LDL cholesterol more than rosuvastatin alone. About 76 adults with high cholesterol will take either AZD0780 or a placebo pill, plus rosuvastatin, for 12 weeks. Neither par…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
A daily eye drop might slow childhood nearsightedness. a trial puts it to the test.
Disease control OngoingThis phase 3 trial tests whether an experimental eye drop called CTO0308 can slow the progression of myopia, or nearsightedness, in children aged 5 to 12. Participants receive either the active drop or a placebo once daily in each eye for 12 months. Researchers measure changes in…
Phase 3 • Sponsor: Taejoon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Video diet coaching may cut heart risks after spinal cord injury
Disease control OngoingThis trial tests whether nutrition counseling delivered over video calls can help people with spinal cord injury eat healthier and lower their risk of obesity, high cholesterol, and diabetes. Participants, who are at least one year post-injury and overweight, will receive six ses…
Sponsor: Santa Clara Valley Health & Hospital System • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare blood disorder: drug targets overactive immune cells
Disease control OngoingThis phase 2 trial is testing the drug ruxolitinib in people with hypereosinophilic syndrome, a rare condition where the body produces too many eosinophils (a type of white blood cell), causing organ damage. The study aims to see if ruxolitinib can normalize blood cell counts and…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare liver disease: drug shows promise in reducing damage and symptoms
Disease control OngoingThis study tests a new drug called elafibranor in people with primary biliary cholangitis (PBC), a rare liver disease that can lead to scarring and liver failure. Participants either did not get enough help from or could not take the standard medicine. The goal is to see if elafi…
Phase 3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could brain pacemakers slow Alzheimer's? new trial tests DBS
Disease control By invitation onlyThis study tests whether deep brain stimulation (DBS) can improve thinking and memory in people with early Alzheimer's disease. Two participants will have electrodes implanted in a brain area that produces a key chemical for memory. The goal is to see if daily, one-hour stimulati…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Eye implant could replace monthly shots for blinding disease
Disease control OngoingThis study tests a small, refillable implant placed in the eye that slowly releases medication for wet age-related macular degeneration (nAMD). It aims to see if refilling the implant every 24 weeks works as well as getting a standard eye injection every 4 weeks. About 68 Chinese…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for advanced stomach cancer: experimental combo targets HER2-positive tumors
Disease control OngoingThis study tests whether a new drug called zanidatamab, combined with chemotherapy and sometimes another drug (tislelizumab), works better than the current standard treatment for advanced HER2-positive stomach and esophageal cancers. About 920 adults whose cancer has spread or ca…
Phase 3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug shows promise for rare skin disease over nearly 5 years
Disease control OngoingThis study looks at the long-term safety and effectiveness of spesolimab in people with generalized pustular psoriasis (GPP), a rare and severe skin condition. All 131 participants had already taken spesolimab in a previous study and will continue treatment for up to 5 years. Res…
Phase 2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug cocktail shows promise for rare cancers
Disease control OngoingThis phase 2 trial is testing whether a combination of two drugs, talazoparib and temozolomide, can shrink tumors in people with rare cancers that have spread. The study includes 14 participants with advanced rare solid tumors, such as pheochromocytoma or paraganglioma, who have …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New study tests belimumab to tame early lupus
Disease control OngoingThis study is testing the drug belimumab (Benlysta) in 350 adults who were diagnosed with systemic lupus erythematosus (SLE) within the last two years and still have active disease despite standard treatment. The goal is to see if adding belimumab helps more people reach a state …
Phase 4 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New fluid lens could sharpen vision after cataract surgery
Disease control OngoingThis study tests a new type of lens implant for people having cataract surgery. The lens uses fluid to adjust focus, aiming to improve vision compared to a standard fixed-focus lens. About 175 participants will receive either the new lens or a standard one, and their vision and a…
Sponsor: Alcon Research • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a muscle-boosting antibody help people with spinal muscular atrophy over the long haul?
Disease control OngoingThis trial tests the long-term safety and effectiveness of apitegromab, an investigational antibody that blocks myostatin, a protein that limits muscle growth. People with type 2 or type 3 spinal muscular atrophy who completed earlier apitegromab studies can join. Researchers wil…
Phase 3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New study tests video coaching to help older adults shed pounds and prevent disease
Disease control OngoingThis study tests a video-based healthy lifestyle program for adults aged 50 to 74 who are overweight and have conditions like prediabetes, type 2 diabetes, or high blood pressure. Participants use a tablet, scale, and activity tracker at home, and some get extra support from a co…
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug guselkumab aims to tame Crohn's Flare-Ups
Disease control OngoingThis study tests whether guselkumab, given as a shot under the skin, can help people with moderate to severe Crohn's disease achieve remission and heal their gut lining. About 350 adults who have not responded well to other treatments will receive either guselkumab or a placebo. …
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug guselkumab aims to tame Crohn's Flare-Ups
Disease control OngoingThis large study tests whether guselkumab, an injected drug, can control symptoms and heal the gut lining in people with moderate to severe Crohn's disease. About 1,400 participants will receive guselkumab, an existing treatment (ustekinumab), or a placebo. The goal is to see if …
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New pill could tame tough psoriasis
Disease control OngoingThis phase 3 study tests an experimental oral drug, JNJ-77242113, in about 731 adults with moderate to severe plaque psoriasis. Participants receive either the new drug, a placebo, or an active comparator (deucravacitinib) to see how well it clears skin lesions. The main goal is …
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for liver disease: drug shows promise in reducing damage
Disease control OngoingThis study tests a daily pill called elafibranor in about 18 Japanese adults with primary biliary cholangitis (PBC), a rare liver disease that can lead to scarring and liver failure. Participants had not responded well to standard treatment. The main goal is to see if the drug im…
Phase 3 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New pill shows promise for rare, severe psoriasis
Disease control OngoingThis phase 3 trial tests an oral drug called JNJ-77242113 in 19 people with two rare and severe forms of psoriasis: generalized pustular psoriasis and erythrodermic psoriasis. The study measures how many participants see improvement after 16 weeks of treatment. It is an open-labe…
Phase 3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug guselkumab shows promise for ulcerative colitis in large trial
Disease control OngoingThis study tests guselkumab, a drug that targets inflammation, in over 1,000 people with moderate to severe ulcerative colitis. Participants receive either guselkumab or a placebo to see if the drug can improve symptoms and lead to remission. The goal is to find a new treatment o…
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could your own nerves help treat Parkinson's? early trial tests idea
Disease control OngoingThis study is testing whether implanting a small piece of a patient's own nerve tissue into the brain during deep brain stimulation (DBS) surgery is safe and doable for people with Parkinson's disease. The nerve tissue contains cells that produce growth factors, which might help …
Phase 1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could your own nerves help heal Parkinson's? small trial begins
Disease control OngoingThis early-stage trial tests whether implanting a small piece of a patient's own nerve tissue into the brain during deep brain stimulation (DBS) surgery is safe and feasible. Ten people with Parkinson's disease will receive the implant, and researchers will monitor them for a yea…
Phase 1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for anemia patients: drug may cut need for blood transfusions
Disease control OngoingThis study tests a drug called luspatercept in people with anemia caused by myelodysplastic syndromes (MDS) or beta-thalassemia who need regular blood transfusions. The goal is to see if the drug is safe and can reduce the number of transfusions needed. About 85 participants in I…
Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a One-Stop clinic solve the mystery of functional disorders?
Diagnosis OngoingFunctional somatic disorders cause persistent physical symptoms that doctors cannot explain by other diseases. The DISTRESS trial evaluates a new clinic where internal medicine doctors, trained to recognize these disorders, examine patients and provide guidance to their general p…
Sponsor: Regionshospitalet Silkeborg • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Glow-in-the-Dark mouth scans could catch cancer early
Diagnosis OngoingThis study tests whether special lights and cameras can help find early signs of mouth cancer in people at high risk. About 338 participants with precancerous spots or conditions like Fanconi anemia will have their mouths examined with fluorescence imaging, which makes abnormal c…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Can AI learn to spot kidney disease in biopsy images?
Diagnosis OngoingResearchers are building deep learning models that analyze digital images of kidney biopsy tissue to classify kidney diseases such as IgA nephropathy and membranous nephropathy. The study uses pathology images and clinical data from thousands of patients who had kidney biopsies a…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
AI chest X-Rays could catch hidden lung disease in zambia
Diagnosis OngoingThis project tests an integrated approach to lung health in Zambia. Community and primary care clinics screen people with cough, breathlessness or other respiratory symptoms for TB, post-TB lung disease, COPD, silicosis and pneumonia. All participants get a symptom check and a di…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Simple scan mistakes may skew osteoporosis diagnoses
Diagnosis OngoingResearchers at a Turkish hospital are studying how errors in bone density scans (DXA) affect doctors' decisions about osteoporosis. They will review scans from 530 adults, identify common positioning mistakes, correct them, and compare the original and corrected results. The goal…
Sponsor: Ankara Etlik City Hospital • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
AI plus ultrasound could catch heart and lung decline before it turns critical
Diagnosis By invitation onlyResearchers are testing whether artificial intelligence can combine ultrasound images with routine health data to track changes in a person's physiology over time. The study enrolls adults with heart, lung, kidney, or blood vessel conditions, as well as healthy volunteers. The go…
Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Can AI turn routine scans into a bone health check?
Diagnosis OngoingThis trial tests whether an AI tool called DeepBMD can identify people at high risk for osteoporosis using CT scans they've already had for other reasons. Researchers will compare the AI's findings with the standard bone density test (DXA) to see if it's accurate. If it works, th…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Monthly HIV prevention pill could replace daily dose
Prevention OngoingThis large phase 3 trial is testing whether a new oral pill called MK-8527, taken just once a month, can prevent HIV infection as well as the standard daily PrEP pill. About 4,390 people at risk of HIV will be randomly assigned to receive either the monthly pill or daily Truvada …
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Village health workers lead new HIV prevention effort in lesotho
Prevention CancelledThis study tests a new program where trained village health workers use tablet-based tools to provide HIV prevention services, including PrEP and emergency PEP, to people at high risk in rural Lesotho. About 380 participants will be enrolled to see if this approach increases mont…
Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Aspirin shows promise in blocking ovarian cancer for High-Risk women
Prevention OngoingThis study tests whether taking aspirin can prevent ovarian cancer in women with BRCA1 or BRCA2 gene mutations, who are at high risk. About 117 participants will take either aspirin or a placebo daily for up to 2 years before their scheduled risk-reducing surgery. Researchers wil…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can diet and exercise programs cut cancer risk? new study tests lifestyle changes
Prevention OngoingThis study tests different programs to help people at high risk for cancer (such as those with BRCA or Lynch syndrome) or cancer survivors increase their physical activity and eat healthier. The goal is to see which programs work best to reduce cancer risk. About 337 participants…
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can cutting alcohol help stop HIV? vietnam trial tests clinic strategies
Prevention OngoingThis study looks at how to best help HIV clinics in Vietnam offer a short alcohol counseling program to patients who drink heavily. The goal is to reduce risky drinking and lower the chance of spreading HIV. Over 3,200 people living with HIV and clinic staff are taking part to se…
Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
New drug aims to stop dangerous gut infection from returning
Prevention OngoingThis study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infection from coming back after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more pe…
Phase 2/3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Banking on health: savings accounts may cut HIV risk in kenyan men
Prevention OngoingThis study tests whether offering lottery-based rewards for saving money can help Kenyan men reduce behaviors that raise their risk for HIV and other STIs. About 1,500 men aged 18-39 who drink alcohol and have paid for sex in the past will be split into two groups. One group gets…
Sponsor: University of Pennsylvania • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Eye drops may shield the cornea after cataract surgery
Prevention By invitation onlyResearchers are testing whether netarsudil eye drops can protect the cornea in people with Fuchs endothelial corneal dystrophy and glaucoma who have cataract surgery. The study enrolls 50 adults aged 40 to 90. Participants use either netarsudil or a placebo drop daily for four we…
Sponsor: University Hospital Dubrava • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Can a common heart drug stop rhythm problems after a Stroke-Related heart repair?
Prevention OngoingResearchers test whether flecainide, an antiarrhythmic drug, can prevent atrial arrhythmias in adults who have a patent foramen ovale (PFO) closed after a cryptogenic stroke. Participants receive flecainide or standard care for 3 to 6 months. An insertable cardiac monitor records…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Early Gluten-Free diet or probiotics: a new strategy to prevent celiac disease?
Prevention OngoingResearchers are testing whether a gluten-free diet during the first three years of life, or daily probiotic supplements, can prevent celiac disease in children with a high genetic risk. The trial enrolls infants before they start eating gluten and randomly assigns them to one of …
Sponsor: Lund University • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
A simple fix for myopia could change education for millions
Prevention OngoingThis trial tests whether giving free glasses to short-sighted middle school children in rural China helps more of them continue to academic high school. Researchers will randomly assign 111 schools to either provide glasses with teacher support or just give prescriptions. The mai…
Sponsor: Queen's University, Belfast • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
Could exercise be the key to stronger bones in women?
Prevention OngoingThis trial tests whether a year of twice-weekly supervised exercise can improve bone mineral density in women. Researchers will measure bone density and blood markers linked to bone turnover. The goal is to see if regular physical activity can help prevent osteoporosis and relate…
Sponsor: Poznan University of Physical Education • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Could 10 minutes of daily mindfulness shield children from anxiety?
Prevention OngoingThis trial tests whether 5-10 minutes of daily mindfulness and compassion training in school can prevent anxiety and depression in children aged 6-16. About 1,750 pupils will take part, with some classes doing the training for 10 weeks and others not. Researchers will track menta…
Sponsor: Lund University • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
500,000-person study aims to close diabetes screening gaps with tailored outreach
Prevention By invitation onlyThis study tests whether sending personalized screening invitations based on a person's race, ethnicity, and diabetes risk, plus offering phone navigation for those who don't respond, leads to more people getting tested for diabetes compared to generic invitations or usual care. …
Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Brain and body boost: Dual-Task training may ease Parkinson's symptoms
Symptom relief By invitation onlyThis study tests whether adding cognitive training to balance and gait exercises helps people with Parkinson's disease improve their balance, walking, and thinking. Fourteen participants will undergo 12 sessions of combined training. The goal is to see if this approach eases move…
Sponsor: Gazi University • Aim: Symptom relief
Last updated Sep 21, 2026 16:00 UTC
-
Can an arthritis drug help cystic fibrosis lungs?
Symptom relief OngoingResearchers are testing whether anakinra, a drug that blocks inflammation, can improve lung function in people with cystic fibrosis. The trial enrolls about 52 participants aged 12 and older who receive daily injections of anakinra or a placebo for 28 days, then switch to the oth…
Phase 2 • Sponsor: Heidelberg University • Aim: Symptom relief
Last updated Sep 21, 2026 16:00 UTC
-
Spinal cord stimulation put to the test for Parkinson's freezing of gait
Symptom relief OngoingFreezing of gait is a disabling symptom of Parkinson's disease that often does not respond well to current treatments. Researchers are testing whether spinal cord stimulation, a device-based therapy already used for chronic pain, can reduce these freezing episodes. In this trial,…
Phase 2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Symptom relief
Last updated Sep 21, 2026 16:00 UTC
-
Can a vibrating platform steady the wobbly joints of hypermobility?
Symptom relief OngoingResearchers are testing whether adding whole-body vibration to a standard exercise program improves balance and reduces pain in women with hypermobility spectrum disorder. Thirty women aged 18 to 45 who have had musculoskeletal pain for at least three months join either a supervi…
Sponsor: Gökalp Arif Utkugün • Aim: Symptom relief
Last updated Sep 21, 2026 16:00 UTC
-
Hands-On therapy put to the test for spine and jaw pain
Symptom relief By invitation onlyResearchers at Poznan University of Physical Education are studying whether physiotherapy and osteopathic techniques ease pain in the neck, lower back, and jaw. The trial enrolls 300 adults aged 20 to 40 who have a recent episode of neck or lower back pain lasting no more than si…
Sponsor: Poznan University of Physical Education • Aim: Symptom relief
Last updated Sep 21, 2026 16:00 UTC
-
Suture device may get heart patients walking sooner after leg vein procedures
Symptom relief By invitation onlyResearchers are testing whether a suture-based closure device helps patients recover faster after heart procedures that use a large tube placed in the femoral vein. The trial enrolls adults undergoing procedures such as atrial fibrillation ablation, leadless pacemaker insertion, …
Sponsor: Ewha Womans University Mokdong Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a video-based therapy tame tough behaviors in kids with rare genetic disorders?
Symptom relief OngoingThis study tests a virtual behavioral therapy (Functional Behavioral Training) for children aged 2-12 with genetic syndromes like Fragile X, Angelman, or Rett syndrome who have challenging behaviors. The therapy teaches parents how to identify what triggers problem behaviors and …
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Hidden braces aim to straighten tilted back molars
Symptom relief CancelledResearchers at Hanoi Medical University are studying whether small lingual appliances can correct an excessive Curve of Wilson at the lower second molars in people already wearing labial fixed braces. The trial uses a split-mouth design: one side of the mouth receives the auxilia…
Sponsor: Hanoi Medical University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Giving Parkinson's patients a say may boost their Brain's ability to learn movement
Symptom relief OngoingPeople with Parkinson's disease often struggle with motivation and motor learning, which can limit rehabilitation. This trial compares two ways of practicing a joystick task: one group chooses the stories and exercises they practice, while the other follows the same routine witho…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Dental implant showdown: titanium vs nano-carbon frames
Symptom relief OngoingResearchers compare two materials for the framework that supports a full set of replacement teeth on four dental implants in the lower jaw. Ten completely edentulous patients receive either a titanium or a nano-carbon fiber-reinforced CAD/CAM framework. The study tracks gum healt…
Sponsor: Mansoura University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can red light therapy boost your hormones?
Symptom relief CancelledResearchers are testing whether an 8-week course of Joovv infrared light therapy can change hormone levels in healthy adults. The study measures testosterone in men and estrogen, progesterone, and thyroid-stimulating hormone in women, along with general wellness. Participants use…
Sponsor: ProofPilot • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Custom-Shaped nose splint may ease recovery for kids after cleft lip surgery
Symptom relief By invitation onlyChildren who have cleft lip repair or nasal scar release often wear a nasal splint while healing. This trial compares the standard hollow, cone-shaped conformer with a new one shaped to match the inside of the nose. Each child tries both types, switching halfway through, and pare…
Phase 2 • Sponsor: East Tennessee Children's Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a personalized mix of nerve stimulation and therapy rewire the brain for better mental health?
Symptom relief OngoingResearchers are testing a personalized, non-drug treatment for adults with ongoing depression, anxiety, trauma-related symptoms, sleep problems, attention difficulties, or substance-use concerns. Instead of assigning treatment by diagnosis alone, the study selects approaches base…
Sponsor: Tactical Mind Research Coalition, Inc. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Splint showdown: which brace best beats trigger finger?
Symptom relief By invitation onlyResearchers compare two splint designs to see which better eases trigger finger, a condition where a finger catches or locks when bent. Thirty people with trigger finger wear either a metacarpophalangeal joint blocking splint or a relative motion extension splint. The study measu…
Sponsor: Waikato Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a new cycling style help MS patients walk better and feel less tired?
Symptom relief OngoingThis study tests a new type of cycling called eccentric cycling for people with multiple sclerosis. Researchers want to see if it improves muscle strength, walking ability, fatigue, and quality of life better than standard cycling. Sixty adults with MS who can walk independently …
Sponsor: University of Liege • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Vibrating wristband put to the test for Parkinson's relief
Symptom relief OngoingResearchers are exploring whether a wrist-worn device called the Beechband, which delivers intermittent vibrations, can change movement symptoms and everyday experiences for people with Parkinson's disease. About 60 participants will be randomly assigned to wear the device for ei…
Sponsor: University of Exeter • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Eye workouts may steady Parkinson's patients
Symptom relief By invitation onlyThis study tests whether a program of supervised eye exercises can improve physical function, balance, and reduce fear of falling in people with Parkinson's disease. 34 participants will do progressive eye movements and gaze stabilization exercises in a clinic setting. The goal i…
Sponsor: Pardis Specialized Wellness Institute • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New VR device aims to make exercise fun for kids with muscle weakness
Symptom relief OngoingThis early study tests a virtual reality rehabilitation device for children with spinal muscular atrophy (SMA), a genetic condition that causes progressive muscle weakness. The device uses games, muscle sensors, and a grip-strength ball to make home exercises more engaging. Resea…
Sponsor: University of Oxford • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can yoga calm anxious minds and sharpen focus?
Symptom relief By invitation onlyResearchers at the University of Illinois at Chicago are studying which parts of a yoga practice affect anxiety, mood, and thinking in highly anxious college women. About 60 participants complete four sessions that include yoga postures, breathwork, meditation, or watching a yoga…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
New hope for Parkinson's pain: drug trial targets tough-to-treat discomfort
Symptom relief OngoingThis study tests whether a drug called crisugabalin can safely reduce pain in people with Parkinson's disease who have a type of pain called nociplastic pain. About 166 adults will take either the drug or a placebo twice a day for 12 weeks. Researchers will measure pain levels an…
Phase 4 • Sponsor: Guangdong Provincial People's Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a liver drug help people see color? tiny trial launched
Symptom relief PausedThis early-phase trial tests whether an FDA-approved drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare form of color blindness caused by mutations in the ATF6 gene. Only 2 participants are enrolled, and they will take PBA three times daily while t…
Early phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can better sleep ease Crohn's symptoms? new study investigates
Symptom relief OngoingThis study looks at whether treating insomnia can help people with Crohn's disease feel better, including reducing pain and inflammation. About 83 adults with mild to moderate Crohn's and insomnia will receive a remote sleep treatment. The main goal is to see if the approach is p…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Tailored therapy for kids with OCD: a new hope?
Symptom relief OngoingThis study at Johns Hopkins tests whether using personalized mobile health assessments can improve cognitive-behavioral therapy (CBT) for children aged 8-17 with obsessive-compulsive disorder (OCD). 30 participants will receive either standard CBT or CBT guided by their own sympt…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
App plus therapist sessions may help WTC responders with PTSD
Symptom relief By invitation onlyThis study tests whether a mobile app called PTSD Coach, with or without brief clinician support, can reduce PTSD, anxiety, depression, and sleep problems in World Trade Center responders living in Florida. About 120 English- or Spanish-speaking responders will be randomly assign…
Sponsor: Florida International University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a Nine-Week group program help blood cancer patients grow through trauma?
Symptom relief OngoingResearchers in Greece are testing a nine-session group program called TRANSFORM for people who have finished treatment for blood cancers such as leukemia, lymphoma, and myeloma. The program combines teaching, reflection, coping exercises, and mindfulness to see whether it can spa…
Sponsor: University of West Attica • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could a simple drink help clear confusion in hospitalized seniors?
Symptom relief OngoingThis study tests a proprietary amino acid drink given twice daily for up to 4 days to older adults (60+) hospitalized with infections who have delirium. 20 participants get the drink, 20 get standard care, and 20 non-delirious controls are observed. The goal is to see if the drin…
Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a phone app and a health worker ease depression in rural HIV care?
Symptom relief OngoingResearchers are adapting a mobile health program that pairs the PositiveLinks app with video counseling from a community health worker. The study enrolls 60 people in Florida who have HIV and mild to moderate anxiety or depression. Participants receive either the enhanced counsel…
Sponsor: University of Florida • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can learning positive emotions stop burnout for violence prevention staff?
Symptom relief OngoingThis study tests a program called FOREST that teaches positive emotion skills to staff working in gun violence prevention. The goal is to reduce burnout, anxiety, and depression, and improve well-being and job retention. One hundred employees from UCAN in Chicago will take part o…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can VR and a tiny ear ZAP ease shoulder pain and anxiety?
Symptom relief CancelledThis study combines virtual reality with a gentle electrical pulse on the ear (called taVNS) to help people with chronic shoulder pain who are waiting for surgery. The goal is to see if this drug-free approach can reduce pain, anxiety, and depression. Only 10 people will take par…
Sponsor: East Kent Hospitals University NHS Foundation Trust • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a home Brain-Training program ease Parkinson's memory woes?
Symptom relief OngoingThis pilot study tests whether a home-based program called HOBSCOTCH, originally designed for epilepsy, can be adapted for people with Parkinson's disease. Ten participants will work one-on-one with a coach in nine virtual sessions to learn problem-solving strategies and memory a…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can hula dancing ease Parkinson's symptoms?
Symptom relief By invitation onlyResearchers at the University of Hawaii are studying whether a weekly hula class can improve quality of life, well-being, balance, and motor symptoms in people with Parkinson's disease. The trial enrolls 40 adults with idiopathic Parkinson's disease who can attend in-person sessi…
Sponsor: University of Hawaii • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a daily pill quiet the spinning of vertigo?
Symptom relief CancelledResearchers are testing an experimental oral tablet called APSLXR in people with Meniere's disease or vertigo of vestibular origin. The main goal is to check whether the drug is safe when taken once a day for 60 days. A small group will also have blood tests to see how the body p…
Phase 1 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can brain stimulation be tuned to improve sleep in Parkinson's?
Symptom relief OngoingThis trial tests whether adjusting deep brain stimulation (DBS) settings specifically for sleep can improve sleep quality in people with Parkinson's disease. Participants already use an adaptive DBS system that responds to brain signals. Researchers will compare three different s…
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
AI-Powered online therapy aims to ease depression and anxiety
Symptom relief OngoingThis study tests whether an online problem-solving therapy, matched to a person's specific symptoms using machine learning, can reduce depression and anxiety better than usual care. About 380 adults with moderate symptoms will take part. The goal is to create a precise, scalable …
Sponsor: Wuhan Mental Health Centre • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Magic mushroom compound tested for OCD in early trial
Symptom relief OngoingThis early-phase study at Johns Hopkins University is testing whether psilocybin, the active compound in magic mushrooms, can safely help people with obsessive-compulsive disorder (OCD). Thirty-five adults with moderate to severe OCD who have already tried other treatments will r…
Early phase 1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Exercise may ease IBD symptoms in children, new study hopes to prove
Symptom relief OngoingThis study explores whether physical activity and fitness can reduce inflammation and improve quality of life in children aged 6 to 17 with Crohn's disease or ulcerative colitis. Researchers will track 100 participants over time and test a 12-week supervised exercise program. The…
Sponsor: Universidad Complutense de Madrid • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can a simple care program boost mood in epilepsy patients?
Symptom relief OngoingThis study tests whether a 24-week collaborative care program can improve quality of life for adults with epilepsy who also have anxiety or depression. The program includes regular check-in calls and expert recommendations from a psychiatrist and neurologist. Researchers will com…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Laughing gas takes on the needle: could a simple breath ease one of Medicine's most uncomfortable procedures?
Symptom relief OngoingThis study investigates whether breathing a 50:50 mix of nitrous oxide (laughing gas) and oxygen can reduce pain and anxiety during insertion of a central venous catheter, a common but uncomfortable procedure. Adults aged 18 to 65 who have never used nitrous oxide will be randoml…
Sponsor: Institute for Oncology and Radiology of Serbia • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can gentle touch therapy calm Parkinson's tremors?
Symptom relief By invitation onlyThis trial tests whether CranioSacral therapy, a gentle manual therapy applied to the feet, diaphragm, neck, and skull, can reduce tremors and improve movement precision in people with Parkinson's disease. Five participants will receive 90-minute sessions twice a month for three …
Sponsor: Zia, Al Raza • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Personalized brain maps could make Parkinson's stimulation more precise
Symptom relief By invitation onlyThis study tests whether using advanced brain imaging to guide deep brain stimulation (DBS) can better control tremor in people with Parkinson's disease while avoiding side effects like involuntary movements. Twenty adults who already have DBS implants will have their stimulation…
Sponsor: Duke University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Oxygen chamber treatment tested for long COVID fatigue relief
Symptom relief OngoingThis study is testing whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can improve symptoms like fatigue and brain fog in people with post-COVID syndrome. About 40 adults with long COVID will receive the treatment. The main goal is to see if a la…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can online family therapy ease childhood anxiety and OCD?
Symptom relief OngoingThis study compares two low-intensity family treatments for children aged 7-13 with anxiety or obsessive-compulsive disorder (OCD): internet-delivered cognitive behavioral therapy (CBT) and a parent-led reading program. Both are delivered via telehealth and compared to a relaxati…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Spinal zaps and exercise may boost walking after injury
Symptom relief OngoingThis study tests whether combining motor skill training with a non-invasive spinal stimulation can improve walking, balance, and strength while reducing muscle spasticity in people with incomplete spinal cord injury. Twenty-eight participants will do a series of standing exercise…
Sponsor: Shepherd Center, Atlanta GA • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New coaching program aims to help young cancer survivors connect with friends
Symptom relief OngoingThis study tests a communication coaching program for adolescent and young adult cancer survivors (ages 18-35) who have finished treatment at least a year ago. Participants complete online sessions and AI coaching to improve how they talk with peers. The goal is to see if the pro…
Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Promising drug may ease painful genital psoriasis
Symptom relief OngoingThis study tests an injected drug called tildrakizumab for people with moderate to severe genital psoriasis. About 206 adults will receive either the drug or a placebo to see if it clears skin and reduces itching. The goal is to improve comfort and quality of life in this sensiti…
Phase 3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Power training shows promise for Parkinson's slowness
Symptom relief OngoingThis study looked at whether a special exercise program focusing on muscle power (moving quickly) could help people with Parkinson's disease who have slow movements (bradykinesia). Twenty-two adults with Parkinson's were split into two groups: one did standard exercises, and the …
Sponsor: Federal University of Health Science of Porto Alegre • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Coloring and music may calm cancer screening fears
Symptom relief By invitation onlyThis trial tests whether a 20-minute session of mandala coloring while listening to slow instrumental music can reduce cancer fear and anxiety in women undergoing cancer screening. Women aged 30 to 65 attending a screening center will be randomly assigned to either the coloring a…
Sponsor: Agri Ibrahim Cecen University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Gut bacteria may hold clues to dozens of diseases
Knowledge-focused PausedResearchers are sequencing the gut microbiomes of people with a wide range of conditions, from autism and Alzheimer's to Crohn's disease and multiple sclerosis, to see whether bacterial patterns differ by disease. The study also enrolls healthy participants for comparison. By mat…
Sponsor: ProgenaBiome • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Sickle cell clues to diabetes risk hidden in DNA
Knowledge-focused OngoingResearchers at the University of Illinois at Chicago are studying how the bodies of adults with sickle cell disease handle glucose, cholesterol, and triglycerides, and why some of them develop diabetes. The study enrolls 75 adults over 35 with major sickle cell genotypes. Partici…
Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Massive study digs into why some kids outgrow food allergies
Knowledge-focused By invitation onlyThis research study aims to understand why some people develop food allergies and others outgrow them. Researchers at Children's Hospital of Philadelphia will collect blood samples from 5,300 people (ages 1 month to 65 years) with and without food allergies to study immune cells …
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Why do some people with severe obesity develop kidney disease?
Knowledge-focused OngoingResearchers are following 480 adults with severe obesity in Guadeloupe and French Polynesia for five years. The study checks whether having metabolic syndrome, a cluster of conditions like high blood pressure and high blood sugar, raises the risk of chronic kidney disease, heart …
Sponsor: Clinique • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Heart drug entresto may double as diabetes treatment, small study hints
Knowledge-focused CancelledThis study tests whether a heart failure medication called Entresto (sacubitril/valsartan) can boost a natural hormone that helps control blood sugar after meals. Researchers will give the drug or a comparison drug (valsartan) to 25 adults with type 2 diabetes or prediabetes and …
Phase 3 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Dystonia study seeks to map Disease's Real-World toll
Knowledge-focused OngoingThis study watches 200 people with isolated dystonia (affecting more than one body part) to see how the condition changes over time. Researchers will collect information on symptoms, daily activities, pain, and social life using standard rating scales. No experimental treatment i…
Sponsor: Vima Therapeutics • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Tiny hearts, tiny kidneys: new study monitors oxygen in preterm infants
Knowledge-focused OngoingThis study looks at oxygen levels in the kidneys of premature babies born before 32 weeks who have a heart condition called patent ductus arteriosus (PDA). Researchers want to see how kidney oxygen relates to the severity of the heart condition and whether it can predict kidney i…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Can a One-Page guide spark better End-of-Life talks for dementia patients?
Knowledge-focused OngoingThis study tests a short guide called the 'Jumpstart Guide' to help doctors have better conversations with dementia patients and their families about healthcare goals. Over 1,800 patients and their caregivers are taking part. Researchers will compare whether those whose doctors u…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Can phone coaching help hispanic seniors beat sedentary habits?
Knowledge-focused OngoingThis study enrolls 130 Hispanic adults aged 55+ without dementia to see if a 12-week phone-based coaching program helps them become more active. Participants are randomly assigned to either the coaching program or a general brain health education group. The goal is to see if the …
Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Can brain recordings make DBS safer for thinking and memory?
Knowledge-focused OngoingThis study tracks brain activity in 160 Parkinson's patients who have or will receive deep brain stimulation (DBS). Researchers record signals from the brain during memory tasks, with the stimulator on and off, to find patterns linked to cognitive side effects. The goal is to ide…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Scientists track eye disease progression over five years
Knowledge-focused OngoingThis study follows 110 people who previously took part in the AREDS or AREDS2 trials to see how age-related macular degeneration (AMD) and cataracts change over time. Participants get a yearly eye exam, including vision tests and eye photos, and may give a blood sample. The goal …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
Knowledge-focused OngoingResearchers are running an international registry to follow adults who had an ischemic stroke or transient ischemic attack and also have a patent foramen ovale, a small opening between the upper chambers of the heart. The registry collects real-world information on how these pati…
Sponsor: Luciano A. Sposato • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
10-Year NF1 study aims to unlock secrets of rare genetic disorder
Knowledge-focused OngoingThis natural history study follows 259 children, adolescents, and adults with Neurofibromatosis Type 1 (NF1) for up to 10 years. Researchers will track tumor growth, monitor quality of life, and perform genetic testing to better understand how the disease changes over time. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Pompe disease study aims to clear path for gene therapy
Knowledge-focused OngoingThis study looks at people with late-onset Pompe disease to measure antibodies against a virus used in gene therapy and against the standard enzyme replacement therapy. It also checks for biomarkers in blood and urine. About 119 teenagers and adults will give samples over 2 years…
Sponsor: Astellas Gene Therapies • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New tools aim to speed up FSHD drug trials
Knowledge-focused OngoingThis study involves 324 adults with facioscapulohumeral muscular dystrophy (FSHD) across 14 international sites. Researchers are testing two new measurement tools—a functional test called FSHD-COM and a muscle-impedance device—to better track disease progression. The goal is to i…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Blood samples sought to unlock secrets of sickle cell disease
Knowledge-focused By invitation onlyThis study collects blood and other samples from people with sickle cell disease and healthy volunteers to help researchers understand how inflammation affects blood vessels. Up to 2,000 adults aged 18 and older will take part. The samples will be used in lab tests to support fut…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Austrian study maps how lung, heart, and metabolic health interact
Knowledge-focused OngoingThe Austrian LEAD study follows a large group of people to understand how lung, heart, and metabolic health change over time. Researchers measure lung function with spirometry and track body composition and metabolic markers. By observing this group, they aim to learn how these c…
Sponsor: Ludwig Boltzmann Institute for Lung Health • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a new questionnaire capture life with hereditary amyloidosis?
Knowledge-focused CancelledResearchers in Argentina are developing and testing a self-administered questionnaire to measure how hereditary transthyretin amyloidosis affects patients' physical, emotional, and social quality of life. The study includes input from neurologists, a cardiologist, a psychologist,…
Sponsor: Hospital General de Niños Pedro de Elizalde • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists dig into tissue samples to unravel lung scarring mystery
Knowledge-focused OngoingThis study collects and analyzes blood, DNA, and tissue samples from 315 adults with pulmonary fibrosis, their relatives, and healthy volunteers. The goal is to learn more about the disease's causes, not to test a new treatment. Researchers hope the findings will guide future the…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Could an algorithm replace the eye chart? a trial puts software-guided refraction to the test.
Knowledge-focused OngoingThis study tests whether a software program called the Vision Trainer can guide eyeglass prescriptions as accurately as the traditional manual method performed by trained examiners. Adults with myopia (nearsightedness) will have their prescriptions determined both ways, and the r…
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unravel mysteries of rare genetic diseases
Knowledge-focused By invitation onlyThis study aims to identify genetic, biochemical, and clinical factors linked to disease severity in people with Gaucher disease and other lysosomal storage disorders. Researchers will evaluate up to 1,000 participants, including patients, carriers, and healthy controls, to bette…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Eye disease progression under the microscope: 3-Year study launched
Knowledge-focused OngoingThis study follows 400 people with intermediate age-related macular degeneration (AMD) for about 3 years. Researchers watch how the disease advances to more severe stages and test if measuring the loss of light-sensing cells in the eye can be a useful way to track the disease. No…
Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Tiny study probes Mitapivat's inner workings in sickle cell
Knowledge-focused OngoingThis observational study will examine how the drug mitapivat changes red blood cells in 6 people with sickle cell disease. Researchers will measure oxygen binding and cell survival markers from blood samples and muscle oxygen tests. The goal is to understand the drug's effects, n…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New program aims to boost genetic testing in cancer families
Knowledge-focused OngoingThis study looks at whether a website and a genetic family navigator can help more relatives of people with hereditary cancer get genetic testing. About 205 participants will use the online hub and work with a navigator to learn about their cancer risk. The goal is to see if this…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for hidden genes behind family blood cancer clusters
Knowledge-focused OngoingThis long-term study looks at people and families with a higher chance of developing blood or lymph node cancers like leukemia or lymphoma. Researchers collect medical histories, genetic samples, and sometimes perform exams to find inherited genes or environmental triggers. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Researchers hunt for muscle clues in rare dystrophy
Knowledge-focused OngoingThis pilot study looks at biomarkers in the blood of people with fragile sarcolemmal muscular dystrophy, a condition that makes muscle membranes weak. Researchers will collect blood samples at rest and after exercise during four 5-day hospital stays. The goal is to better underst…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Which Mini-Implant size works best? new study aims to find out
Knowledge-focused OngoingThis study tests two different diameters (1.6mm and 2mm) of mini-implants placed in the upper jaw to support orthodontic tooth movement. Twenty people receiving braces will get one size on each side of their mouth. Researchers will measure how stable the implants are, how much pa…
Sponsor: University of Baghdad • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track families to uncover Cancer's hidden causes
Knowledge-focused OngoingThis study looks at people and families who have a high risk of cancer to learn what genes and environmental factors might increase that risk. Over 5,000 participants are followed over time with questionnaires, medical records, and optional genetic testing. No treatment is given,…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Tongue-Tie surgery in infancy: do feeding, speech, and sleep problems return later?
Knowledge-focused By invitation onlyResearchers at the University of Alberta are following 500 children who had a tongue-tie release as infants to see how often they later develop feeding, speech, dental, or sleep and breathing problems that need further evaluation. Tongue tie is a shortened band under the tongue t…
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches massive sample collection to unlock disease secrets
Knowledge-focused By invitation onlyThis study collects blood, bone marrow, urine, and tissue samples from up to 6,000 people with solid tumors, blood cancers, or non-cancerous blood disorders, as well as from their healthy family members who are stem cell donors. The samples are stored and used in research to bett…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
No-Needle glucose monitor could spot pregnancy risks early
Knowledge-focused CancelledThis pilot study is testing a device called LabClasp that measures blood sugar without needles. Researchers want to see if regular, non-invasive glucose checks can help predict gestational diabetes and preeclampsia in pregnant women. The study plans to enroll 100 women with at le…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
500-Person study aims to crack the code of personalized weight loss
Knowledge-focused By invitation onlyThis study follows 500 obese adults to see how different factors like diet, exercise, stress, and sleep affect weight loss. Researchers collect blood tests, measurements, and questionnaires at the start and during follow-up. The goal is to find patterns that could lead to more pe…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can a wearable track your bladder health? new study aims to find out
Knowledge-focused OngoingThis study explores whether wearable bladder devices can help monitor and treat bladder problems in postpartum women and men after prostate surgery. Researchers will test a wearable ultrasound and an intravaginal exerciser to see if they provide useful data for patients and thera…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Spanish databases used to map a rare liver disease
Knowledge-focused OngoingPrimary biliary cholangitis is a rare liver disease that slowly damages the bile ducts and can lead to cirrhosis or a liver transplant. Researchers are studying anonymised health records from about 3,000 adults in four Spanish databases to estimate how many people have the diseas…
Sponsor: Fundacio Privada Mon Clinic Barcelona • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can wearable sensors and walking tests reliably track nerve damage?
Knowledge-focused OngoingResearchers are checking whether tests of muscle strength, walking, balance, and fine motor skills give consistent results in people with polyneuropathy. About 520 adults with various forms of nerve damage, plus healthy volunteers, take part. Participants complete physical tests,…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study hopes to outsmart pancreatic cancer by gathering clues
Knowledge-focused OngoingThis study collects health information and test results from 317 people at high risk for pancreatic cancer, including those with cysts, genetic syndromes, or other risk factors. Researchers aim to build a database to find better ways to detect the disease early or prevent it. No …
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study tracks rare disease SCA7 to uncover clues for future treatments
Knowledge-focused OngoingThis study follows 25 people with spinocerebellar ataxia type 7 (SCA7) for up to 5 years to learn how the disease changes vision, coordination, and thinking. Participants will have yearly eye exams, brain scans, and neurological tests. No treatment is given; the goal is to gather…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
2000 volunteers needed to test Next-Gen MRI scans
Knowledge-focused OngoingThis study aims to test new MRI sequences in 2000 adults (patients and healthy volunteers) to see if they can produce better images than current methods. Participants will undergo additional scans during their regular MRI. The goal is to improve diagnostic capabilities without di…
Phase 4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Thousands tracked after carpal tunnel surgery: does new device deliver?
Knowledge-focused OngoingThis study is tracking 2000 adults with carpal tunnel syndrome who are having surgery to release the nerve. The surgery uses a special device called UltraGuideCTR, which is guided by ultrasound. Researchers are collecting real-world data on symptoms and hand function for up to 24…
Sponsor: Sonex Health, Inc. • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New study peers inside lungs to uncover cystic fibrosis damage
Knowledge-focused OngoingThis study aims to understand how small blood vessels in the lungs change as cystic fibrosis (CF) lung disease progresses. Researchers will use imaging to measure blood vessel volume in 86 people with CF aged 5-21. The goal is to learn more about the disease, not to test a new tr…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Sweetener showdown: erythritol vs. aspartame on blood clot risk
Knowledge-focused OngoingThis study looks at how the common sweetener erythritol affects blood clotting and blood vessel health compared to aspartame. Twenty-four adults with a BMI of 27 or higher will drink beverages sweetened with each sweetener for two weeks. Researchers will measure markers of platel…
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Researchers track rare thyroid cancer to uncover its secrets
Knowledge-focused OngoingThis study follows children and adults with medullary thyroid cancer (MTC), often linked to a genetic condition called MEN2. Researchers will track how the cancer grows and affects health over time using regular check-ups, blood tests, and imaging. No treatment is given, but part…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Sound waves may replace X-Rays for dental implant timing
Knowledge-focused OngoingThis study at the University of Michigan is testing whether ultrasound can monitor bone graft healing after tooth extraction, potentially replacing more invasive scans. About 140 adults needing a tooth extraction and bone graft for a future dental implant will have their healing …
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Dialysis showdown: which method protects heart and bones best?
Knowledge-focused OngoingThis study looks at how different types of dialysis affect heart health, bone metabolism, inflammation, and quality of life in people with end-stage kidney disease. Researchers will compare patients on hemodialysis, continuous ambulatory peritoneal dialysis, and automated periton…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Swedish survey asks: what shapes daily life with chiari malformation?
Knowledge-focused By invitation onlyResearchers at Karolinska Institutet are surveying adults in Sweden who have Chiari malformation type 1, a condition where part of the brain pushes into the spinal canal. The study asks how these patients rate their health-related quality of life compared with the general Swedish…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
University health survey aims to uncover hidden struggles of students and staff
Knowledge-focused OngoingThis study is a health check for students at Constructor University Bremen and employees at HAW-Hamburg. Researchers will use surveys and interviews to measure loneliness, anxiety, stress, and health habits. The goal is to understand what affects wellbeing and find ways to suppor…
Sponsor: Jacobs University Bremen gGmbH • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
One bite of gluten: scientists track the immune alarm in celiac disease
Knowledge-focused By invitation onlyResearchers at Boston Children's Hospital are studying how the immune system reacts after a single oral dose of gluten powder. The study includes people with celiac disease and healthy controls, all of whom follow a gluten-free diet before the test. By measuring blood levels of i…
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
New registry tracks SMA in chinese kids to unlock Real-World insights
Knowledge-focused OngoingThis study is a registry that collects information on up to 600 children in China with spinal muscular atrophy (SMA). It aims to describe how the disease progresses and how treatments are used in everyday medical practice. The study does not test a new drug but gathers data to be…
Sponsor: Biogen • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Lupus care under the microscope: new registry tracks Real-World treatment in kazakhstan
Knowledge-focused OngoingThis study is a registry that will follow about 500 adults with lupus (SLE) in Kazakhstan to see how the disease behaves and how doctors treat it in everyday practice. Researchers will look at disease activity, organ damage, and which medications are used. No new treatments are b…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Balloon in the aorta: a new hope for cardiac arrest?
Knowledge-focused OngoingThis study tests whether a balloon device, called REBOA, can be safely used by emergency teams outside a hospital to improve blood flow in people whose heart has stopped (cardiac arrest). The balloon is inserted into the main artery and inflated to redirect blood to the heart and…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
100,000 volunteers join digital brain health study to catch dementia early
Knowledge-focused By invitation onlyThis observational study will enroll 100,000 people over age 45 to track early signs of Alzheimer's and Parkinson's using smartphone-based tests, genetic data, and brain scans. Researchers aim to develop better ways to identify who is at risk before symptoms worsen. Participants …
Sponsor: Greece 2021 Committee • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Hidden brain damage in young sickle cell patients: new study aims to find answers
Knowledge-focused OngoingThis study looks at how common strokes and silent brain injuries are in young adults (ages 16-25) with sickle cell anemia, especially in Nigeria where the disease is widespread. Researchers will use brain scans and blood tests to check for damage and identify risk factors like hi…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Drain or no drain? new study aims to improve Kids' neck surgery recovery
Knowledge-focused By invitation onlyThis study looks at children having surgery to remove a common neck lump called a thyroglossal duct cyst. Some kids will have a small drain placed during surgery, and some will not. The goal is to see if using a drain reduces problems like infection, fluid buildup, or the need fo…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
A chest belt that maps the lungs could help breathing machines fit better
Knowledge-focused By invitation onlyResearchers at the Royal Free Hospital are testing whether electrical impedance tomography (EIT), a radiation-free imaging method that uses a chest belt and low-level electrical currents, can help clinicians adjust breathing machines for people with chronic respiratory failure. T…
Sponsor: Royal Free Hospital NHS Foundation Trust • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Braces breakthrough? study tests which wire moves teeth faster
Knowledge-focused By invitation onlyThis study compares stainless steel and titanium-molybdenum alloy wires for moving canine teeth in people with braces. Sixteen participants will have one type of wire on each side of their upper jaw to see which works better. The goal is to find out which wire moves teeth more ef…
Sponsor: Tanzila Rafique • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
New cage for neck surgery under observation – no treatment given
Knowledge-focused OngoingThis study watches 24 adults who are getting standard neck fusion surgery with a special device called the BEE HA cage. The goal is to see how well the cage helps with pain and function over time. No new treatment is tested—just careful tracking of normal surgery results.
Sponsor: Invibio Ltd • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Blood test could spot hidden tumors in NF1 patients
Knowledge-focused By invitation onlyThis study aims to find blood-based biomarkers that signal the presence and size of plexiform neurofibromas in people with Neurofibromatosis type 1 (NF1). Researchers will collect blood samples and use whole-body MRI to compare biomarker levels in 200 participants with different …
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Gene study aims to unlock secrets of kidney disease
Knowledge-focused OngoingThis study looks at 401 people with autosomal dominant polycystic kidney disease (ADPKD) to see how different versions of the PKD1 gene relate to patient traits like age at diagnosis and body size. Researchers are not testing any treatment—they are simply gathering information to…
Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Massive study aims to unlock secrets of childhood nerve and muscle diseases
Knowledge-focused OngoingThis long-term study looks at children and adults with inherited nerve and muscle disorders that start early in life, like muscular dystrophy. Researchers will track symptoms over time and collect genetic samples from affected individuals, their family members, and healthy volunt…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
New study aims to unlock the secrets of a rising lung disease
Knowledge-focused OngoingThis study follows 320 Chinese adults with non-cystic fibrosis bronchiectasis (a chronic lung condition causing cough and infections) and some healthy volunteers for 12 months. Researchers will collect lung function tests, blood samples, and imaging to identify biomarkers and dis…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Researchers watch and learn: PH1 study tracks 207 patients over time
Knowledge-focused OngoingThis study follows 207 people with primary hyperoxaluria type 1 (PH1), a rare kidney disease, to see how the condition progresses over time. Researchers are also checking the long-term safety and real-world effectiveness of the drug lumasiran. Participants are not given any new t…
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New study aims to uncover hidden heart risks in women
Knowledge-focused OngoingThis pilot study is testing whether it's possible to run a larger study that focuses on heart disease in women. Researchers will gather information from 176 women aged 25-55 in Ontario who have had certain female-specific health issues like pre-eclampsia, gestational diabetes, or…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Gut fungi linked to lung trouble in HIV patients
Knowledge-focused OngoingThis study looks at whether fungi moving from the gut into the blood can cause inflammation and worsen lung function in people with HIV. Researchers will measure a fungal marker called BDG in blood and urine, and track lung health over three years. The goal is to better understan…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can imaging and monitoring unlock the hidden dangers of mitral valve prolapse?
Knowledge-focused OngoingThis study enrolls adults aged 60 and older who are already participating in a larger trial comparing two ways to repair a leaky mitral valve. Researchers will use heart MRI scans, wearable heart monitors, and tissue samples to look for scarring in the heart muscle and abnormal h…
Sponsor: Annetine Gelijns • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Parkinson's drug may impact gum disease risk
Knowledge-focused OngoingThis study looks at whether the Parkinson's drug Levodopa-Benserazide affects gum health and inflammation. Researchers will measure gum health and saliva markers in 136 people, including Parkinson's patients with and without gum disease, and healthy controls. The goal is to under…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New registry aims to unlock secrets of rare bone disease HPP
Knowledge-focused By invitation onlyThis long-term study follows over 1,500 people of all ages with hypophosphatasia (HPP), a rare bone disease. Researchers will collect information on how the disease progresses, its impact on daily life, and the long-term safety and effectiveness of the treatment asfotase alfa. Th…
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New study aims to sharpen tools for tracking becker muscular dystrophy
Knowledge-focused OngoingThis 24-month observational study will follow 80 people with Becker muscular dystrophy (BMD) to better understand how the disease progresses. Researchers will measure muscle strength, walking speed, breathing, and heart function using standard tests. The goal is to identify which…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Florida launches brain disease biobank to fuel future discoveries
Knowledge-focused OngoingThis study is creating a statewide collection of blood samples and medical information from people with various brain blood vessel diseases, such as stroke and dementia. The goal is to build a resource that scientists can use in future research to better understand and potentiall…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
A Baby's fidgets may reveal brain health: study tests early warning signs
Knowledge-focused OngoingResearchers are studying the natural fidgety movements of infants to see if these movements can help predict cerebral palsy and other developmental issues. They will follow 350 babies, including healthy full-term infants and those at higher risk due to medical conditions, trackin…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New study tracks early signs of pompe disease in newborns
Knowledge-focused OngoingThis study follows 20 newborns and children diagnosed with late-onset Pompe disease through newborn screening. Researchers will track their health for up to 4.5 years to document early muscle and joint symptoms, biomarkers, and quality of life. The goal is to learn when to start …
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can we predict who will have memory issues after brain surgery for Parkinson's?
Knowledge-focused OngoingThis study follows 30 people with Parkinson's disease who are scheduled to receive deep brain stimulation (DBS). Researchers will test whether brain scans, thinking tests, and other measures can predict who might experience cognitive decline after surgery. Participants complete t…
Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Diet soda showdown: stevia vs. aspartame – which is better for your gut?
Knowledge-focused OngoingThis study looked at 41 healthy adults who regularly drink sugary sodas. Researchers replaced their sugary drinks with either stevia-sweetened or aspartame-sweetened beverages for 10 weeks. The goal was to see how these alternatives affect metabolism and gut bacteria. The results…
Sponsor: Laval University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Could a spin class recharge the Parkinson's brain?
Knowledge-focused OngoingThis study asks whether exercise can improve how the brain produces and uses energy in people with Parkinson's disease. Researchers will scan participants' brains before and after a six-month program of supervised aerobic cycling, comparing them to a group doing stretching or yog…
Sponsor: Pacific Parkinson's Research Centre • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New study analyzes Odevixibat's impact on rare liver disease outcomes
Knowledge-focused OngoingThis study looks at a rare liver disease called PFIC, which causes severe itching and liver damage. Researchers compare patients who took the drug odevixibat to those who did not, using data from past studies and a patient registry. The goal is to see if odevixibat helps avoid li…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
HIV patients over 75: are too many pills harming healthy aging?
Knowledge-focused PausedThis study looks at people with HIV who are 75 or older and take at least five medications regularly. Researchers want to understand how this 'polypharmacy' affects healthy aging and quality of life. They will interview participants and review their medical records to count medic…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Watching the brain and body during OCD triggers: a window into the disorder
Knowledge-focused OngoingResearchers at Baylor College of Medicine are studying how brain activity and visible behaviors, like head movements, facial expressions, and voice tone, change during tasks that trigger OCD symptoms. Adults with OCD and healthy volunteers will complete tasks that provoke distres…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Massive Real-World study tracks roche eye drugs in 6,000 patients
Knowledge-focused OngoingThis study is collecting long-term, real-world data from about 6,000 adults being treated with Roche eye medications (Faricimab or the Port Delivery System with Ranibizumab) for conditions like wet age-related macular degeneration and diabetic macular edema. The goal is to unders…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
50,000 samples to unlock secrets of hereditary tumors
Knowledge-focused CancelledThis study will collect blood and tumor tissue from up to 50,000 adults with hereditary or genetic-linked cancers. Researchers will use these samples to create lab-grown tumor models, like mini-tumors, to study how these cancers work and test new treatments. The goal is to better…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New eye imaging could reveal hidden clues to vision loss
Knowledge-focused By invitation onlyThis study explores whether combining three eye-imaging techniques can reveal how structural damage in the retina relates to vision loss in people with geographic atrophy, a form of age-related macular degeneration. Researchers will use OCT scans, ultra-high-resolution AOSLO imag…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists track rare eye disease to prepare for future treatments
Knowledge-focused OngoingThis study follows 68 people aged 12 and older who have ABCA4 gene mutations, which can cause vision loss from diseases like Stargardt disease. Over 10 years, researchers will collect blood and skin samples and perform detailed eye exams to understand how the disease progresses. …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Smart sensors could revolutionize rett syndrome monitoring
Knowledge-focused OngoingThis study tests whether wearable biosensors can accurately track symptoms like heart rate, breathing, sleep, and movement in people with Rett syndrome. Up to 30 participants will use the devices at home for 9 weeks and also undergo one overnight sleep study in the clinic. The go…
Sponsor: Rett Syndrome Research Trust • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Tiny study probes gene link to kidney stones
Knowledge-focused By invitation onlyThis study looks at how a specific gene change (AGXT) affects oxalate production in people who have had calcium oxalate kidney stones. Four participants will eat a low-oxalate diet for five days and then receive an intravenous dose of glycolate. Researchers will measure oxalate l…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
VHL tumor growth study aims to predict which lesions need surgery
Knowledge-focused OngoingThis 5-year study follows 250 people with von Hippel-Lindau disease who have brain or spinal cord tumors. Researchers use regular MRI scans and blood tests to see how fast tumors grow and what factors like hormones might affect growth. The goal is to better understand which tumor…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Scientists collect skin cells to pave way for future immune disease cures
Knowledge-focused By invitation onlyThis study collects small skin samples from people with primary immunodeficiency or immune regulation disorders, as well as from healthy volunteers. Researchers will use these cells to create cell lines for laboratory research. The goal is to better understand immune diseases and…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC